AIIMS

OPD Appointment

OPD Appointment

OPD Appointment

ORBO Donor Pledge Form

ORBO Donor Pledge Form

ORBO Donor Pledge Form

Emergency Dashboard

Emergency Dashboard

Emergency Dashboard

Accessibility Control

Default Woman Doctor Image

Dr.
Rachna Bhargava

Female

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Phone :
01126593236

General OPD

Tuesday

Special Clinic

Wednesday (Child Guidance Clinic, AIIMS New Delhi)
Thursday (Adolescent Clinic, NDDTC)
Saturday (Behavioral Addictions Clinic, AIIMS, New Delhi)
Default Doctor Image

Dr.
ASHWANI KUMAR MISHRA

Male

PhD Statistics, MSc Statistics, BSc: Statistic and Mathematics

Affiliation

Professor of Biostatistics
Department of
National Drug Dependence Treatment Centre

Contact

Email :
akmaiims@gmail.com
ashwanikm@aiims.edu
Phone :
01126593236

General OPD

A-306 (Tuesday)
A-306 (Wednesday)
A-306 (Friday)

Field of Interest

Broad Domain: Epidemiology, Biostatistics

Sub-Domain: Substance Abuse, Clinical Epidemiology, Medical Epidemiology, Dimension Reduction Techniques, Computational Statistics

Presentations Made At Scientific Meetings/ Conferences/ Workshops

Organization of symposium/workshops/conference

  • Organized ONLINE interactive workshop on Basics of Research Methodology in Addiction Sciences in the first conference of Association for Addiction Psychiatry at the ADDICON-2021
  • Organized ONLINE workshop on Operation alization and implementation of Nationwide Online Training Workshop on Statistical Analysis in Mental Health: Opportunities and Challenges, in World Association of Social Psychiatry Hybrid Congress 18th September 2021
  • Organized a nine-day ONLINE workshop on Analytical Techniques for Statistical Analysis in Mental Health, sponsored by the Department of Science and Technology (DST), Scientific and Engineering Research Board(SERB), under the Accelerate Vigyan Scheme, Government of India
  • Organized 25 hours online workshop for the Ph.D. Scholars on the course work Research Methodology (Research Methodology and Research Ethics, Planning and Conduct of Literature Review, Techniques of Data Collection, Research Designs, Introduction-Test of Significance, Fundamentals of Public Health Research, Quantitative Aspects of Data Analysis, Sample Size Estimation, Time to Event Analysis, Computational Aspects of Research Methods, Elements of Scientific Communication), HNB Uttarakhand Medical Education University, Dehradun.
  • Organized 25 hours online workshop on research methodology for faculty /Ph.D. Scholars/ resident son research methodology (nuts and bolts of database, what we do in statistics, elements of descriptive statistics, sampling distribution, test of significance, test of significance-quantitative variables, test of significance-categorical variables, epidemiology and study design, non-parametric test, psychometry-norms, psychometry-reliability, psychometric-validity, measures of disease frequency,diagnosticstest-part1,diagnosticstest-part2,basics of grounded theory-part1,basics of groundedtheory-part2,correlationandregression-introduction,coefficientofdetermination and standard error of estimate, binary logistic regression analysis)
  • Organized symposium on biostatistical aspects of research in addiction medicine in the 21st annual meeting of international society for addiction medicine, newdelhi,2019
  • Organized Symposium on Basics of Randomized Controlled Trial: Issues and Perspectives in the First Annual Conference of Addiction Psychiatry, AIIMS, New Delhi, 28-30November 2017
  • Organized Workshop in First Annual Conference on Addiction Psychology, NDDTC, AIIMS, 8thSeptember 2017, on the topic “What are the needs for Psychology Students”
  • Organized Workshop in the Department of Psychiatry and NDDTC on Research Methodology on topics-Research Methodology: An Introduction, Research Designs: An overview, Systematic Review and Meta-Analysis, Basics of Statistics and Biostatistics, Elements of Scientific Publications, Elements of Scientific Presentation, Bibliographic Management, and Data Analysis using Excel on19thAugust and 26thAugust 2017
  • Organized Workshop at Food and Safety Department, Government of NCT of Delhi 6-7th June 2017, and delivered lectures and practical hands on six topics-Elements of Descriptive Statistics, Techniques of Data Screening, Data considerations and analysis on SPSS on test of significance for the quantitative variables, Regression Analysis, Analyzing repeated measurement in health sciences, and Factor Analysis
  • Organized Workshop on Biostatistics in Research Methodology, at the Department of Paediatrics, Gandhi Medical College, Bhopal, from 22-23 February 2014 and delivered six talks on-Overview of Statistics and Biostatistics, Elements of Scientific Publications, Critical Appraisal of Scientific Papers, Hands on usage of MS Excel, Hands on usage of Epi-Info

Invited talks in conference, Symposium, Workshops

  • 2022: Guest Speaker on topic “Ethics in Medical Research”, for Faculty, Research Scholars, and Paramedical Staff at Banasthali University.
  • 2022: Guest Speaker on topic “Research Landscape of Psychiatric Epidemiology, Webinar Series, under the aegis of Indian Psychiatry Society (IPS), North Zone.
  • 2022: Guest Speaker on topic “Paradigm Shift in Statistical Methodologies in Mental Health”, in Webinar Series, under the aegis of Indian Psychiatry Society (IPS), North Zone.
  • 2022: Resource person in the Faculty Development Program at Indian Institute of Information Technology, Tiruchirappalli 8th March 2022.
  • 2021: Delivered lecture on Linear and Logistic Regression Analysis as Resource person for the Workshop on Bio-statistical Data Analysis, organized by the Department of Statistics, Assam University, Silchar 22 November 2022.
  • 2021: Delivered lecture on Sampling Techniques as the Resource Person in the Workshop –Cum – Hands on Training on Biostatistics and Health Data Analysis for Healthcare Professionals, Department of Clinical Research, School of Allied Sciences, Sharda University 24 September 2021.
  • 2021: Delivered lecture on Test of Significance as the Resource Person in the Workshop –Cum – Hands on Training on Biostatistics and Health Data Analysis for Healthcare Professionals, Department of Clinical Research, School of Allied Sciences, Sharda University 24 September 2021.
  • 2021: Attended Side Event organized by United Nations Statistical Commission (UNSC) in collaboration with International Association for Official Statistics (IAOS) side event.
  • 2021: Attended International Association for Survey Statisticians (IASS)Webinar on Positioning Household Surveys for Next Decade, organized by the International Statistical institute, November 23,2021.
  • 2021: Attended Frontiers Forum Speaker Series on Good Economics for Harder Times by Prof Esther Duflo, 28 April 2021.
  • 2021: Attended Frontiers Forum Speaker Series on Genomics-led solutions for all life on Earth by Prof Harris Lewin, 25 March 2021.
  • 2021: Attended Frontiers Forum Speaker Series on Equipping our Children to manage a Planet by Prof David Christian, 2 March 2021.
  • 2019: Presented invited talk on “Biostatistical Approaches in Molecular Epidemiology”, at the workshop on Molecular Techniques of Integrative Biology, sponsored by the Department of Health Research (DHR), Government of India and organized by the National Institute for Research in Environmental Research (NIREH), Indian Council of Medical Research (ICMR), Bhopal, India.
  • 2019: Attended 37th Annual Conference of the Indian Society for Medical Statistics (ISMS) and presented paper on “A Behavioral Economics Approach for understanding the Phenomena of Delay Discounting Rates among Alcohol and Opioid Dependence Syndrome, at AIIMS, Patna.
  • 2019: Attended 21st Annual Conference for the International Society for Addiction Medicine (ISAM) and presented seminar on Evidence informed Alcohol and Drug Policy reforms in India: Implications of the epidemic logical data; Method logical Approaches for epidemiology of substance use: Advances and innovations, New Delhi.
  • 2019: Attended Scientific Meeting on Presentation of Findings for Recommendation and Policy Implications under National Survey on Extent and Pattern of Substance use in India, 2019 at Ministry of Social Justice and Empowerment, Government of India, April 16th,2019.
  • 2019: Attended Scientific Meeting on Presentation of Findings for National Survey on Extent and Pattern of Substance use in India, 2019 at Ministry of Social Justice and Empowerment, Government of India, April 16th,2019.
  • 2019: Attended Scientific Meeting on Presentation of Findings for National Survey on Extent and Pattern of Substance Sein India, 2019 at Ministry of Social Justice and Empowerment, Government of India, April 9th,2019.
  • 2019: Presented Scientific Talk on Sampling Designs and Statistical Analysis for data on National Survey on Extent and Pattern of Substance Use in India, in the 7th National Federation of Indian NGOs for Drug Abuse Prevention FINGODAP Conference, March29th, 2019.
  • 2019: Attended Scientific Meeting on Presentation of Findings, Recommendations and Policy Implications for National Survey on Extent and Pattern of Substance use in India, 2019 at Ministry of Home Affairs, Government of India, March 12th,2019.
  • 2019: Presented Scientific talk on Analytical Methods in Clinical Studies in the National Symposium on Biostatistical techniques and its application in clinical studies, Department of Statistics, Panjab University, March 11th,2019.
  • 2019: Attended Scientific Meeting on Presentation of Findings and Recommendations for National Survey on Extent and Pattern of Substance use in India, 2019 at Ministry of Social Justice and Family Empowerment, Government of India, February 18th, 2019.
  • 2019: Attended Scientific Meetings on Presentation of Findings for National Survey on Extentand Pattern of Substance use in India,2019 at Ministry of Social Justice and Family Empowerment, Government of India, February 4th,2019.
  • 2018: Presented Scientific Talk on Elements of Inferential Statistics, during the 8th Refresher Course in Medical Sciences being organized at the University Grant Commission (UGC)-Human Resource Development Centre, BHU, Varanasi, June 2nd,2018.
  • 2018: Presented Scientific Talk on Elements of Descriptive Statistics, during the 8th Refresher Course in Medical Sciences being organized at the University Grant Commission (UGC)-Human Resource Development Centre, BHU, Varanasi, June2nd,2018
  • 2018: Presented Scientific Talk on Epidemiology of Substance Use in India-A Compilation from Multiple Sources, at 20th Annual Conference of International Society for Addiction Medicine, November 3rd,2018 at Busan, South Korea.
  • 2018: Presented Scientific Talk on Concepts of Drug Abuse Survey-Household, in the training program me on Planning and Designing of large-scale sample surveys for officers of States/UTs, at the National Statistical Systems Training Academy (NSSTA), September 25th, 2018.
  • 2018: Presented Scientific Talk on Concepts of Drug Abuse Survey-Respondent Driven Sampling, in the training programme on Planning and Designing of large-scale sample surveys for officers of States/UTs, at the National Statistical Systems Training Academy (NSSTA), September 25th, 2018.
  • 2017: Presented Scientific Talkon National Level Sampling Methodology, forthe commissioned study on National Survey on Extent an Pattern of Substance use in India, by Ministry of Social Justice and Family Empowerment (MoSJE), Government of India, Regional Training of Trainers, Imphal, Delhi November 3rd,2017.
  • 2017: Presented Scientific Talk on Sampling Methodology-Northeast Regions, for the commissioned study on National Survey on Extent an Pattern of Substance use in India, by Ministry of Social Justice and Family Empowerment (MoSJE),Government of India, Regional Training of Trainers, Imphal, October 24th,2017.
  • 2017: Presented Scientific Talk on Sampling Methodology-Central Regions, for the commissioned study on National Survey on Extent an Pattern of Substance use in India, by Ministry of Social Justice and Family Empowerment (MoSJE), Government of India, Regional Training of Trainers, Rachi, October 10th,2017.
  • 2017: Presented Scientific Talk on Sampling Methodology-Western Regions, for the commissioned study on National Survey on Extent an Pattern of Substance use in India, by Ministry of Social Justice and Family Empowerment (MoSJE), Government of India, Regional Training of Trainers, Bengaluru, October 9th,2017.
  • 2017: Presented Scientific Talk on Sampling Methodology-Northern Regions, for the commissioned study on National Survey on Extent an Pattern of Substance use in India, by Ministry of Social Justice and Family Empowerment (MoSJE), Government of India, Regional Training of Trainers, New Delhi on October 3rd,2017.
  • 2017: Presented Scientific Talk on Household Mapping and Listing, under the commissioned study on National Survey on Extent an Pattern of Substance use in India, by Ministry of Social Justice and Family Empowerment (MoSJE), Government of India, in the national Training of Trainers, New Delhi on September 18th2017.
  • 2017: Presented Scientific Talk on District Selection and State Stratification plan under the commissioned study on National Survey on Extent and Pattern of Substance use in India, by Ministry of Social Justice and Family Empowerment (MoSJE), Government of India, in the National Consultation workshop, Vigyan Bhawan, New Delhi on May5th2017.
  • 2017: Member for the panel discussion in the software development for the empaneled agencies for the software development under the National Survey on Extent and pattern of substance use in India, at the Ministry of Social Justice and Empowerment (MoSJE), Government of India, 9thJune 2017.
  • 2017: Lecture on Analytical Methods in Biostatistics in 3rd Workshop on Biomedical Data Analysis using R at National Institute of Pathology, ICMR, New Delhi, 24th January 2017 Food and Safety Department, Government of NCT of Delhi 5th June 2017.
  • 2017: Presentation on the State Stratification and District Selection by probability proportional to size (PPS), in the National Consultation Workshop of National Survey on Extent and Pattern of Substance Use in India, at Vigyan Bhawan, New Delhi,9th May 2017.
  • 2017: Lecture on Analytical Methods in Biostatistics in 3rd Workshop on Biomedical Data Analysis using Rat National Institute of Pathology, ICMR, New Delhi,24th January 2017.
  • 2017: Lecture on Implementation of Respondent Driven Sampling in Mapping and Size Estimation of Street Children whose Drugs, at the Dissemination Meeting of Department of Women and Child Development, Government of Delhi, Delhi, 11January 2017.
  • 2016: Invited Talk on" Dimension Reduction Techniques: An Overview", at 25th International Conference on Mathematics, Statistics and Computational Techniques, Forum for Interdisciplinary Mathematics (FIM), at Manipal University, Jaipur, Rajasthan, 22-24 December 2016.
  • 2016: Poster presentation on "Application of Geographical Information System for Understanding Epidemiology of Substance Use in India", at the Joint Conference: ISAM and CSAM-SMCA XXVII, Annual Meeting and Scientific Conference, October20-22, 2016, Montreal, Canada.
  • 2016: Presented or al paper on "A Descriptive Analysis of instructions to authors for statistical reporting of article in addiction medicine journals", at 68th Annual Conference on Indian Psychiatry Society, 21-24 January 2016.
  • 2016: Presented or al talking Symposium on" Cannabis in Modern Times-Challenges and Opportunities", at 68th Annual Conference on Indian Psychiatry Society, 21-24 January 2016.
  • 2016: Presented oral talk in Symposium on "Punjab Opioid Dependence Survey (PODS): What have we learnt from it?",68th Annual Conference on Indian Psychiatry Society, 21-24 January 2016.
  • 2015: Presented research paper entitled" A Systematic Analysis of Outputs in Medical Sciences for BRICS 33rd Annual Conference of Indian Society for Medical Statistics (ISMS),14-16 October 2015, Belgavi, Karnataka.
  • 2015: Delivered lecture on "Analytical Methods in Biostatistics" at the National Institute of Pathology, ICMR in the National Workshop on Bioinformatics Tools for Biomedical Research, 24th, March 2015, supported by Indian Council of Medical Research, Ministry of Health and Family Welfare Govt. of India, New Delhi.
  • 2015: Delivered lecture on "Biostatistics and Use of Software" at the National Institute of Pathology, Indian Council of Medical Research (ICMR) in the foundation workshop in Clinical and Laboratory Medicine Research for member countries of South Asian Forum for Health Research (SAFHeR), Feb2015.
  • 2014: Attended two days’ workshop on Evidence Based Clinical Practice-2014, from December 13th-14th December 2014.
  • 2014: Attended AIIMS-University of Michigan Research Methodology Course from 1st-5th December 2014.
  • 2014: Attended and presented research paper on "Descriptive Epidemiology of Cannabis "at Annual Conference of Indian Psychiatry Association, North Zone, Ludhiana, 20th-21st December 2014.
  • 2014: Attended and delivered lecture on Analytical Methods in Statistics at Annual Conference of Indian Association for Social Psychiatry, Mysore,21st-23rd November 2014.
  • 2014: Attended and deliver lecture on Sampling Methodology at Annual Conference of Indian Association for Social Psychiatry, Mysore, 21st-23rd November 2014.
  • 2014: Attended and presented poster presentation entitled "Basics of Research Methodology-Schematic Sensitization", at Conference on Stress Reduction Skills: Scientific Update, organized by Department of Psychiatry and Sri Sri Global Meditating Doctors Association (GMDA) at Indian Institute of Technology (IIT), Delhi, August30th-31st,2014.
  • 2014: Attended and presented contributed research paper entitled "Challenges in Teaching of Medical Statistics in Developing Country", at the 9th International Conference on Teaching Statistics (ICOTS-9) at Flagstaff, Arizona, USA,13th-18th July 2014.
  • 2014: Acted as the resource person for the workshop on Research Methods in Medical Sciences organized by the South Zone of Indian Psychiatry Society, at Kochi, Kerala, on 9th March 2014 and delivered talk on Sampling Methodology.
  • 2014: Acted as the resource person for the workshop on Research Methods in Medical Sciences organized by the South Zone of Indian Psychiatry Society, at Kochi, Kerala, on 9th March 2014 and delivered talk on Analytical Methods in Statistics.
  • 2013: Delivered invited talk on topic entitled "Synergistic Perspective of Clinicians and Biostatistician in an omics era", in the Silver Jubilee Conference of Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, from14-15December2013.
  • 2013: Delivered invited talk on topic entitled "Setting up of Research Database", in the symposium "Research Associated Priority Innovation Programme" of Indian Association of Social Psychiatry (IASP), at 20th Annual Conference of Indian Association for Social Psychiatry, held at Kolkata, 8th-9th, November 2013.
  • 2013: Delivered invited talk on 'Basics of Biostatistics and Data Management’, at 65th Annual Conference of the Indian Psychiatry Society’ at NIMHANS, Bangalore 10th-13th January 2013.
  • 2012: Delivered Invited Talk on Descriptive and Inferential Statistics at Jamia Millia Islami at Centre for Physiotherapy and Rehabilitation Science son November 2nd, 2012.
  • 2012: Delivered Invited Talk on Presentation of Data at Jamia Millia Islamiaat Centre for Physiotherapy and Rehabilitation Sciences on November 2nd2012.
  • 2012: Delivered Invited Talk on Biostatistics and Sampling Methods at National Institute of Pathology (NIP), Indian Council of Medical Research (ICMR)fortheworkshoponResearchMethodologiesforMedicalScientistonOctober10th, 2012.
  • 2012: Delivered Invited Talk on Statistical Software’ sat National Institute of Pathology (NIP), Indian Council of Medical Research (ICMR) forth workshop on Research Methodologies for Medical ScientistonOctober10th 2012.
  • 2012: Served as a resource person for the National Seminar on Scientific Writing, organized by Bakson Homoeopathic Medical College and Hospital, Greater Noida, sponsored by Commission for Scientific and Technical Terminology, Ministry of Human Resource Development, Government of India on March2nd,2012.
  • 2011: Served as faculty for the foundation workshop on Clinical and Laboratory Medicine Research, held at National Institute of Pathology (NIP), Indian Council of Medical Research (ICMR) from July 26th-28th, 2011 and delivered talk on Statistical Software’s.
  • 2010: Served as faculty for the second foundation workshop on Clinical and Laboratory Medicine Research, held at University College of Medical Sciences (UCMS), New Delhi from 17th-19th August 2010 and delivered talk on“ Basic Biostatistics”.
  • 2010: Served as faculty for the second foundation workshop on Clinical and laboratory Medicine Research, held at University College of Medical Sciences (UCMS), New Delhi from 17th-19th August 2010 and delivered talk on“ Data Management and Sample Size Determination”.
  • 2010: Served as faculty for the First foundation Workshop on Clinical and laboratory Medicine Research for undergraduate medical students, held at Institute of Pathology, Indian Council of Medical Research (ICMR), New Delhi from 12th-13th March 2010 and delivered invited talk on “Basic Biostatistics”.

Thesis supervised for MD/ PhD

  • - as guide (number only) -04 
  • -as co-guide (number only) - 39 
  • -as member of doctoral committee - 08

Significant events

  • Member of the Panel for test development and paper setting for Paper Environmental Sciences, National Testing Agency (NTA), Department of Higher Education, Ministry of Education, Government of India [2022].
  • Examiner for the course on Research Methodology for the Couse Work of Ph.D Scholars, HNB Medical Education University, Dehradun, Uttarakhand [2020].
  • External Examiner for the M.Phil. Course for the paper on the Research Methodology, IHBAS [2019].
  • External Examiner for the M.Phil. Course for the paper on the Research Methodology, IHBAS [2018].
  • External Examiner for the recruitment of Technical Assistant (Statistics), for the Model Rural Health Scheme, CHC, Muga, under the scheme of Department of Health Research (DHR), Government of India [2017].
  • External Examiner for the M.Phil. Course for the paper on the Research Methodology, IHBAS [2017].
  • Examiner for the M.Phil. Course for the paper on the Research Methodology, IHBAS [2016].

Other Relevant Information

Awards and Honours

Education

1999: First Class First for Post-GraduateExamination (GOLDMEDAL)

2001: Fellowship in Biostatistics from SGPGIMS, Lucknow

2003: Received Post Graduate Education Certificate for Advanced Course in Biostatistics and Epidemiology from Nordic School of Public Health, Goteborg and RD Gardi Medical College, Ujjain

2004: Faculty for the International Course on Health Intervention Studies, in collaboration with Nordic School of Public Health

2005: Faculty for the International Course in Research Methodology in collaboration with Nordic School of Public Health and RD Gardi Medical College, Ujjain

2013: Awarded Certificate of Accomplishment with Distinction for the course Mathematical Biostatistics Boot Camp, offering of John Hopkin's University, USA

2020: Received certification of completion with 91.2%Marks for the successful completion of the course on Systematic Review and Meta-Analysis, from John Hopkins University, USA

2020: Letter of Commemoration from Vice-Chancellor, HNB Uttarakhand Medical Education University for effective planning, management of the ONLINE course in Research Methodology as Course Coordinator

2020: Received DST Grant from Department of Science and Technology (DST) under the Accelerate Vigyan Scheme through Scientific and Engineering Research Board (SERB) for organizing 9 days online workshop on Analytical Techniques for Statistical Analysis in Mental Health

2021: Elected Member Education Subcommittee for International Society for Clinical Biostatistics (ISCB). This honour is quite prestigious in the sense that I happen to be not only the member from India, or Asia but the only member from the Developing world. In total there are 15 [14+1] members in this committee. The other 14 members belong developed/high income countries [1Member each from Australia (AU), Canada (CA), France (FR), Romania (RO),3 Members from New Zealand (NZ), 5 Members from United Kingdom (UK), and 2 Members from USA (US).This committee supports and organize education al activities, such as short-courses, webinars, and seminar son contemporary methods in Clinical Biostatistics.

2021: Successfully Completed Paid Course with Examination on Data Science and Machine Learning: Making Data Driven Decision conducted by Massachusetts Institute of Technology (MIT) and MIT Institute for Data, Systems, and Society (MIT-IDSS).

2022: Nominated as the Board Member by Department of Medical Education and Research (DMER) by Government of Haryana, for Promotion of Research in Medical Universities.

Research Awards

2007: World Bank Travel grant for attending 56th International Statistical Institute Conference held at Lisboa-Portugal, for thesis research paper Some Epidemiological Models for Parasitic Infections: Comparison between traditional and Hierarchical Logistic Regression Methods

2014: World Bank Travel grant for attending 9th International Conference on Teaching Statistics for the research paper Challenges in Teaching of Medical Statistics in Developing Country

2017: Award from AIIMS, Delhi forthe research paper Pattern of Drug Use and associated behaviors among Female Injecting Drug Users from Northeast India: A Multi-Centric, Cross-Sectional, Comparative Study. Substance Use & Misuse

Associate Editor

2022-till date: Statistical Editor, International Journal of Health Research and Medico-legal practice (IJHRMLP); Official publication of the Academy of Health research and Medical Education (AHRME)

2020-tilldate: Associate Editor, Frontiers in Public Health for the Speciality Section Public Mental Health

2017-tilldate: Associate Editor Tobacco and Regulatory Sciences

Reviewer

  • National Medical Journal of India
  • Indian Journal of Medical Research
  • Indian Journal of Nephrology
  • Indian Journal of Clinical Psychology
  • Current Science
  • Drug and Alcohol Review
  • Substance Use and Misuse
  • Health
  • International Journal of Clinical Biostatistics and Biometrics
  • American Journal of Alcohol and Drug Dependence
  • British Medical Journal Open
  • National Medical Journal of India
  • Acta Astronautica

Membership of the Scientific Societies

  • Elected Member-International Institute for Medical Statistics
  • Elected Member-International Association for Statistical Education
  • Member-International Association for Clinical Biostatistics
  • Member-Indian Society for Medical Statistics

Investigator In Funded Projects Along with Year and Title (Completed)

  • Analytical Techniques for Statistical Analysis in Mental Health [2021]
  • Internal Consistency and Divergent Validity of the Hindi Version of the Addiction Severity Index-Lite among Individuals with Alcohol and Opioid Dependence Syndrome [2019-2021]
  • Development of Indian Anxiety and Mania Questionnaire [2019-2022]

Investigator In Funded Projects Along With Year And Title (Ongoing)

  • Infrared signature of surgical wound: thermographic profiles and early stage test-accuracy study to predict the surgical site infection in paediatric surgical patients [2022-]
  • A study to examine psychosocial and behavioral domains among school going adolescents during COVID 19 pandemic -Mixed study design [2022-]

Investigator In Non-funded Projects Along With Year And Title (Completed)

  • Hindi Adaptation and Psychometric Validation of Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) among Participants with Alcohol Dependence [2020-2022]
  • Comparison of Delay Discounting Rate among current users of Heroin and abstinent: An Observational Study [2019-2021]
  • Delay Discounting Rates among Patients with Alcohol and Opioids Dependence: A Cross Sectional Comparative Study [2017-2019]

Investigator In Non-funded Projects Along With Year And Title (Ongoing)

  • Comparison of Different Methods for Estimation of Alcohol Consumption: A Cross-sectional Community based Study [2022-]

Co-investigator In Funded Projects Along With Year And Title (Completed)

  • Development and Validation of an Indian Instrument to Assess Severity of Substance Related Problems [2019-2022].
  • Screening and Intervention in School Students of Primary Classes for Substance use in Delhi”. Funding- Department of Education (DOE), Delhi Government [2019-2021].
  • Screening and Intervention in School Students of Secondary Classes for Substance use in Delhi”. Funding- Department of Education (DOE), Delhi Government [2019-2021].
  • National Survey on Extent and Pattern of Substance use in India [2016-2021].
  • Development of Indian Anxiety and Mania- Questionnaire [2018-2022].
  • Rates and Pattern of Psychoactive Substance use among Prison inmates in India [2018-2022].
  • Experience with Treatment among patients with substance use disorders [2018-2022].
  • Pattern of use of Psychoactive Substances (NPS) [2018-2021].
  • Substance use among Transport Workers [2018-2021].
  • Substance use among school and College students [2018-2021].
  • Behavioral and Biological Assessment of Vulnerabilities to acquisition of HIV, blood Borne viruses and Tuberculosis among Prison Inmates of Gujarat [2018-2020].
  • Development of Cognitive retraining module for improving cognitive deficits of abstinent patients with Alcohol, Cannabis and Opioid Dependence Syndrome in a Tertiary Care De-addiction Centre of Northern India [2017-2018].
  • Cognitive Behavioural Based Intervention in Group Setting for Tobacco Cessation in Tertiary de-addiction centre in Northern India [2015-2016].
  • Mapping and Size estimation of Street children who use drugs in Delhi [2015-2016].
  • Study on Size Estimation for Opioid Dependent Population in State of Punjab [2014-2015].
  • Community Based Brief Intervention with simple advice for women tobacco users.
  • Epigenetic studies in esophageal cancer in high-risk region of Northeast India [2011-2012].
  • Immunogenetic profile of NPC–Nasopharygeal Cancer in a high prevalence region of Northeast India [2010-2012].
  • Longitudinal Demographic, Socioeconomic survey and analysis in 60 villages of Ujjain district [2003-2006].
  • A study on availability of Health Facilities in the Ujjain district [2004-2005].
  • Assessment of disease burden due to Taenia Solium in a rural Community [2002-2003].

Co- Investigator In Non-funded Projects Along With Year And Title Completed

  • A Study to explore the of Gamma Synuclein as a Potential Biomarker in Breast Cancer [2020-2022].
  • Functional outcome of patients undergoing thoracic surgery for benign Pulmonary and pleural diseases: ambispective cohort study [2020-2022].
  • Exploratory study of problematic internet pornography use [2020-2022].
  • Impact of Screen Time on Mental, Behavioural and Social aspects among School going Adolescents [2020-2022].
  • Comparison of Double “J” and infant feeding tubes as stents in open Cohen’s ureteric reimplantation in terms of hospital stay -a Randomized study [2019-2022].
  • Circulating Micro RNA in Coronary Artery Disease [2019-2022].
  • Assessment of reasons, status of, and factors associated with drop-out in patients on Opioid Substitution Therapy: A cross-sectional, comparative, community-based study [2019-2022].
  • Endorsement and Concordance of ICD 11, ICD 10 and DSM 5 Diagnostic Guidelines for Alcohol and Opioid Use Disorders [2019-2021].
  • Psychological Correlates of Caregiving among the caregivers of patients with Schizophrenia [2018-2022].
  • Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: a double-blind, placebo-controlled trial [2018-2021].
  • Assessing client perceived barriers to initiate opioid substitution therapy among Injecting Drug Users A cross- sectional, comparative, community-based study [2018-2021].
  • Effectiveness of reminders using Phone call versus Short Message Service on treatment retention in patients with substance use disorders: An open label randomized trial [2018-2020].
  • Development of Cognitive Behavioural based Intervention Module for Adolescents in Conflict with Law [2017-2022].
  • A Pilot Follow-up Study on Retention and Outcome of Patients with Opioid Dependence after Discharge from Treatment Centre [2017-2019].
  • Cognitive Functioning in Buprenorphine maintained Opioid Dependent Patients at Peak and Trough Blood Buprenorphine Levels: An Experimental Study [2017-2019].
  • Study of Aspirin and Clopidogrel Resistance by Platlet Aggregation and its Association with Adverse Outcomes in Indian Stable Coronary Artery Disease Patients [2017-2019].
  • Intravenous Naloxone on Opioid Agonist Effects of Intravenous Buprenorphine: A Double-blind, Within-subject, Randomized, Cross-over Study among Opioid Dependent Subjects [2017-2019].
  • Depression, anxiety, quality of sleep and mental adjustment style among adult myeloma patients in active treatment and maintenance phase [2017-2019].
  • Family Interventions Addressing Expressed Emotions in Treatment Seeking Men with Opioid Dependence [2016-2021].
  • Association between C Reactive Protein Level and Alcohol Consumption Among patients of Alcohol Use Disorder: A Cross Sectional Exploratory Study [2016-2019].
  • A Cross-Sectional Observational Study to Assess Help seeking behaviour for Alcohol Use Disorders among Patients with Alcoholic Liver Diseases [2016-2019].
  • Knowledge, Risk Factors and Experience of Non-Fatal Overdose Among Injecting Drug Users: A Community- based, Cross-sectional Study [2016-2019].
  • To investigate the effect of polymorphisms and epigenetic modification on the expression of monoamine pathway genes in alcohol dependence [2015-2020].
  • Cognitive Representation and efficacy of Cognitive Therapy in individuals with alcohol dependence syndrome [2015-2019].
  • Oral Methadone versus Sublingual Buprenorphine for Treatment of Acute Opioid Withdrawal: A Randomized, Double-Blind, Double-Dummy, Controlled Study [2014-2016].
  • Economic analysis of Opioid Substitution Therapy under National AIDS Control Programme – a cross-sectional comparative study [2014-2016].
  • Anxiety Disorder amongst adolescents in rural Ballabgarh-A Community based study [2014-2016].
  • Two group randomized design for effectiveness of NRT with simple advice and NRT with counselling for the reduction in the smoking parameters [2014-2016].
  • Pattern of drinking and its relationship with consequences in subjects with harmful/hazardous alcohol use [2013-2015].
  • Effectiveness of Screening and Brief Intervention for Moderate/High Risk Alcohol Use Among Patients on Buprenorphine Maintenance: A Clinical and Alcohol-Biomarker Study [2013-2015].
  • Depression among Elderly Persons in Rural Area of Ballabgarh. Collaborated Research work along with department of Psychiatry, Department of Community Medicine and National Drug Dependence and Treatment Centre (NDDTC) [2012-2014].
  • MD Thesis dissertation work on Assessment of effect of sweet tastants on cue related craving recently detoxified alcohol dependent subjects [2012-2014].
  • MD Thesis dissertation work on Cue Induced Craving in Heroin Dependent Men [2012-2014].
  • DNB pathology thesis dissertation work Role of epithelial Mesenchymal transition in progression of bladder cancer: An Immunohistochemical analysis [2009-2011].

Co- investigator in funded projects along with year and title (ongoing)

  • Comparative mapping of common mental disorders (CMD) over lifespan [2022-].
  • A study to examine psychosocial and behavioral domains among school going adolescents during COVID 19 pandemic-Mixed study design [2022-].
  • Development and evaluation of artificial intelligence- based methods models for prediction of self-harm and suicide attempts amongst the patients of opioid dependence and depression [2021-].
  • Assessment of Rates and Causes of Mortality among People with Opioid dependence: A Longitudinal, Cohort Study [2021-].
  • Role of specific single-nucleotide gene polymorphisms (SNPs) with treatment adherence and outcome with naltrexone among patients with opioid dependence: A naturalistic follow-up study [2020-].

Co- investigator in non-funded projects along with year and title (ongoing)

  • Outcome of ASO in TGA intact ventricular septum with regressed LV in the age group 2-6 months using two stage VS integrated ECMO-A prospective observational study [2022-].
  • A pilot study to assess the items for the anxiety related events among blood donors and establish their face and content validity at a tertiary care academic institute in North India [2022-].
  • Quality of Life and Associated factors among recipients of Buprenorphine-Naloxone Maintenance Treatment [2021-].

Total number of publications till date

Thesis 2

Peer Reviewed Publications 106

Book Chapters 4

Edited Manuscript 36

Technical Reports 11

Total 159

Details of publications since 2000 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Thesis

  • Mishra AK,NathDC,SinghU,PrasadKN, GuptaRK,PandeyCM.TheEpidemiological Aspects of Taenia solium Infection in a Rural Community ofNorthern India.DemographyIndia,2009;38(2): 307-318.
  • AKMishra,CMPandey.SomeEpidemiologicalModelsforparasiticInfections:Comparison between traditional and hierarchical logistic regression methods(2007).BulletinoftheInternationalStatisticalInstitute-LXII(2007),5776-5779.

Official Statistics

  • AmbekarA, AgrawalA, RaoR, MishraAK, KhandelwalSK, ChaddaRK on behalf of the group of investigators for the National Survey on Extentand Pattern of Substance Use in India (2019). Magnitude of Substance Use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India.
  • SoodA, MishraA, AmbekarA. Trendsin alcohol consumption and expenditure: Analysis of household data from nationally representative sample from India. Asian J Psychiatr.2019 Feb22;40:116-123.
  • Atul Ambekar, Ravindra Rao R, Alok Agrawal, Ashwani K Mishra, Rajesh Kumar, Manish Kumar. Size Estimation of Opioid Dependent Population in Punjab – Punjab Opioid Dependence Survey. New Delhi: Ministry of Social Justice and Empowerment, Government of India; 2015.

Theoretical Statistics

  • Verma V, Verma A, Mishra AK, Khan HT, Nath DC, Narang R. Bayesian Estimation of Gender Differences in Lipid Profile, Among Patients with Coronary Artery Disease. Handbook of Intelligent Computing and Optimization for Sustainable Development.2022Feb25:753-69.
  • VermaV, MishraAK, VermaA, KhanHT, NathDC, NarangR. Impact of gender on the lipid profile of patients with coronary arteryisease: a Bayesian analytical approach. In Smart Computational Intelligence in Biomedical and Health Informatics 2021 Sep27(pp.1-12). CRC Press.
  • Verma,V., Mishra,A.K., Dhawan, A.etal. Diversity in substance use behaviour among street children of Delhi under Bay esian paradigm. BMC MedRes Methodol 20,291(2020).
  • Ashwani Kumar Mishra (IN). Handbook of Item Response Theory Volume Three: Applications.2019, ISCB,68:26.
  • Ashwani Kumar Mishra (IN). Multivariate Analysis with LISREL. 2017, ISCB,63,45.

Epidemiology of Drug Use

  • Singh, R., Gupta, R., Grover, T., Ambekar, A., Jain, R., Vaswani, M., Mishra, A., & Sharma, A. (2023). Role of the Serotonin and GABAA Receptor Gene Polymorphisms in patients with Alcohol Dependence. Asian Journal of Psychiatry, 80, 103326. https://doi.org/10.1016/j.ajp.2022.103326.
  • Ghosh, S., Jain, R., Rao, R., Mishra, A. K., & Jhanjee, S. (2022). Does ethyl glucuronide in hair correlates with alcohol consumption? A comparative study with other traditional biomarkers among individuals with alcohol dependence syndrome. Alcohol. https://doi.org/10.1016/j.alcohol.2022.10.005.
  • Singh VV, Sarkar S, Chadda RK, Mishra AK, Dhawan A. Reasons for leaving treatment among patients with opioid dependence: A 3-month prospective follow-up study. Journal of Opioid Management. 2022 Sep-Oct;18(5):455-466. DOI: 10.5055/jom.2022.0739. PMID: 36226785.
  • Singh, R., Gupta, R., Grover, T., Ambekar, A., Jain, R., Vaswani, M., Mishra, A., & Sharma, A. (2022). “Role of the Serotonin and GABAA Receptor Gene Polymorphisms in patients with Alcohol Dependence”. Asian Journal of Psychiatry, 103326. https://doi.org/10.1016/j.ajp.2022.103326.
  • Singh G, Kaloiya GS, Dhawan A, Mishra AK and Balhara YPS. Does Cognitive Therapy Change the Early Maladaptive Schemas in Individuals with Alcohol Dependence? Evidence from a Randomized Controlled Trial. Indian J Psychol Med. 2022;XX:1–8.
  • Singh G, Kaloiya GS, Dhawan A, Balhara YPS and Mishra AK. The Extent of End or sement of Distal to Proximal Dysfunctional Cognitions in Individuals with Alcohol Dependence: A Comparative Cross-Sectional Study in the Indian Context. Indian J Psychol Med.2022;44(3):239–245.
  • Saini R, Parmar A, Rao R, Mishra AK, Ambekar A, Agrawal A. Psychiatric and Substance Use Comorbidities among People who Inject Drugs in India: ACross-Sectional, Community BasedStudy.WorldSocPsychiatry2021;3:195-202.
  • SarkarS, SoodE, BhadR, MishraA. Validateds cales for substance use disordersin the geriatric population: A scoping review. J Geriatr Ment Health 2021;8:70-6.
  • Singh VV, Dhawan A, Chadda RK, Mishra AK and Sarkar S. A ProspectiveThree-MonthsNaturalisticFollow-UpStudyofOutcomesofPatientswithOpioid Dependence Discharged on Buprenorphine or Oral Naltrexone. Indian JPsycholMed.2022;XX:1–7.
  • Ghosh, S., Jain, R., Singh, S. et al. A simplified approach for determination of urinary ethyl glucuronide by gas chromatography–mass spectrometry. JAnalSciTechnol12,35 (2021). https://doi.org/10.1186/s40543-021-00290-6.
  • Singh A, Rao R, Chatterjee B, Mishra AK, Kaloiya GS, Ambekar A. Cognitive function in gin patients maintain edonbupre norphineat peak and trough buprenorphine levels: An experimental study. Asian J Psychiatry.2021;61:102697.
  • AnjuD, MishraAK, AmbekarA, ChatterjeeB, AgrawalA, BhargavaR. Estimating the size of substance using street children in Delhi using Respondent-Driven Sampling (RDS). Asian J Psychiatry.2020(48):101890.
  • Atul Ambekar, Goyal SG, Ambekar A, JainR, Mehta MM, MishraAK. Intravenous Buprenorphine does not impair psychomotor and cognitive functioning in opioid dependent patients using oral dextropropoxyphene: A randomised double-blind cross over study. J Mental Health Hum Behav 2020;25:45-52.
  • Saini R, Rao R, Parmar A, Mishra AK, Ambekar A, Agrawal A, Dhingra N.Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugsin India: A community-based study. Drug Alcohol Rev.2020;39(1):93-97.doi:10.1111/dar.13016.
  • Gupta S, Lal R, Ambekar A, Mishra AK, Rao R. The pattern of alcohol use and its relationship with consequences among problem alcohol users: A community‑based cross‑sectional study from India. Indian J Psychiatry 2020;62:152-8.
  • Dhagudu NK, Ambekar A, Agrawal A, Rao R, Mishra AK, Jain R, Singh S. Is there enough naloxone to deter the diversion? Effect of con current administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: Arandomised, double-blind, within-subject, cross over study among opioid-dependent subjects. Drug Alcohol Rev.2020.DOI: 10.1111/dar.13057.
  • Tripathi R, Dhawan A, Rao R, Mishra AK, Jain R, Sinha S. Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine. J Addict Med. 2020;14(2): 132-138.doi:10.1097/ADM.0000000000000539.
  • Ghosh S, Jain R, Jhanjee S, Rao R, Mishra AK. Alcohol Biomarkers and their Relevance in Detection of Alcohol Consumption in Clinical Settings. Int Arch Subst Abuse Rehabil.2019,1:002.
  • AmbekarA, MishraAK, ParmarA, KumarR, KumarM, RaoR, AgrawalA. Are non-injecting opioid users at risk of transition to injecting druguse? Amulti-sitestudy from India. AsianJ Psychiatr.2019;42:79-84.
  • SinghG,KaloiyaGS,DhawanA,BalharaYPS,MishraAK.Needforevaluationof underlying dysfunctional cognition in problem drinkers. Asian J Psychiatr.2018;31:71-72.
  • Snehil Gupta,Rakesh Lal,Ravindra Rao,Ashwani Kumar Mishra & Atul Ambekar (2017) Pattern of alcohol use among problem alcohol users in acommunity-based setting in India: A cross-sectional study, Journal of Substance Use,23:2,130-135.
  • Quraishi R, Jain R, Mishra AK, Ambekar A. Association of ankyrin repeats & kinase domain containing 1 (ANKK1) gene polymorphism with co-morbid alcohol & nicotine dependence: A pilot study from a tertiary care treatment center in north India. Indian J Med Res.2017;145(1):33-38.
  • Jhanjee S, Lal R, Mishra AK, Yadav D. A randomized pilot study of brief intervention vs simple advice for women tobacco users in an urban community in India. Indian J Psychol Med.2017;39(2):131-136.
  • Balhara YP, Mishra A. Sethi H, Singh S, Khandelwal SK. Time trends of cannabis use among treatment-seeking individuals at government de-addiction centers across India over aperiodof7years.IndianJPsycholMed2016;38:331-5.
  • Rao R, Ambekar A, Agrawal A, Pawar AKS, Mishra AK, Khandelwal SK. Evaluation of a five-day training programmer on Opioid Substitution Therapy in India. Drugs Educ Prev Pol,2016;23(6): 471–475.
  • Rao, R., Mandal, P., Gupta, R., Ramshankar, P., Mishra, A., Ambekar, A., Jhanjee, S., Dhawan, A. Factors affecting drug use during in car creation: across-sectional study of opioid-dependent persons from India. J Subst Abuse Treat.2016;61:13-7.
  • DayalP, BalharaYPS, MishraAK. An open label naturalistic study of predictors of retention and compliance to Naltrexone maintenance treatment among patients with opioid dependence. Journal of Substance Use 2015. J Subst Use. 2016;21(3): 309–316.
  • Varshney M, Rao R, Mishra AK, Ambekar A. Brief Interventions for harmful alcohol use in opioid-dependent patients on maintenance treatment with buprenorphine: A prospective study from India. Addictive Disorders & TheirTreatments 2015.DOI: 10.1097/ADT.0000000000000076.
  • Jhanjee S, Lal R, MishraA, Yadav D. Tobacco use and dental myths In India: need for specific intervention.Gerodontology.2015May18.doi:10.1111/ger.12200.
  • Ambekar A, Agrawal A, Rao R, Goyal S, Mishra AK, Mukherjee D, Kishore K,Albertin C. Pattern of drug use and associated behaviours among female injecting drug users from northeast India: a multi-centric, cross-sectional, comparative study. Substance Use & Misuse.2015; 50:1332-1340.
  • Ambekar A, Rao R, Mishra AK, Agrawal A. Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs. Drug Alcohol Rev.2015;34(1):97-104.
  • Balhara YPS ,Mishra A,Sethi H,Ray R.A retrospective chart review of treatment seeking middle aged individuals at a tertiary caresubstance use disorder treatment centre in north part of India over five successive years-findings from Drug Abuse Monitoring System (DAMS). The Scientific World Journal 2013:316372.

Applied Statistics-Public Mental Health

  • Madasu S, Malhotra S, Kant S, Sagar R, Mishra AK, Misra P, et al. Anxiety disorders among adolescents in a rural area of northern India using screen forchildanxiety-related emotional disorders tool: A community-based study. Indian J Community Med 2019;44:317-21.
  • Swapna Madasu, Sumit Malhotra, Shashi Kanta, Rajesh Sagar, Ashwani KMishra, Puneet Misra, Farhad Ahamed. Prevalence and determinants of anxiety disorders among adolescents in a rural community from northern India. Asian JPsychiatr.2019;43:137-142.
  • SoodM, ChaddaRK, MishraAK, KumariK, KukretiR. Attitude toward Antipsychotics and its Correlation with Psychopathology and Insight in Patients with Schizophrenia. Indian JSoc Psychiatry.2018; 34:200-2.
  • KhandelwalSK, BhatiaA, MishraAK. Psychological adaptation of Indian expeditioners during prolonged residence in Antarctica.Indian J Psychiatry.2017Jul-Sep;59(3):313-319.doi:10.4103/psychiatry.IndianJPsychiatry_296_16.
  • Khandelwal S, Bhatia A, Mishra AK. Psychological health in the summer team of an Indian expedition to Antarctica. J Mental Health Hum Behav 2015; 20:65-70.
  • MSood, RKChadda, KSinhaDeb, RBhad, AMahapatra, RVerma, AKMishra. Scope of Mobile Phones in Mental Health Care in Low Resource Settings. Journal MTM 6:3:43–47,2017doi:10.7309/jmtm.6.3.7.
  • Behera P, Gupta SK, Nongkynrih B, Kant S, Mishra AK, Sharan P. Screening Instruments for assessments of Depression. Indian Journal of Medical Specialties. 2017;8:31-37.
  • Behera P, Sharan P, Mishra AK, Nongkynrih B, Kant S, Gupta SK. Prevalence and determinants of depression among elderly persons in a rural community from North India. NatlMedJIndia2016;29:129–35.
  • Kathiresan P, Sharan, Nongkynrih B, Mishra AK. Registration and definitions of mental disorders in Swedish survivors of the 2004 southeast Asia tsunami. The Lancet Psychiatry.2015;2:962.
  • Patil V, Pattanayak R, Mishra A.Predictors of suicide attempt in early-onset cases: Methodological issues and concerns. JClinPsychiatry.2013;74(12):1264.

Applied Statistics-Clinical Sciences

  • Deval, R., Saxena, P., Pradhan, D. et al. A Machine Learning–Based Intrauterine Growth Restriction (IUGR) Prediction Model for Newborns. Indian J Pediatr (2022). https://doi.org/10.1007/s12098-022-04273-2.
  • SinglaV,BhattacharjeeHK,GuptaE,SinghD,MishraAK,KumarD.Performance of three-dimensional and ultra-high-definition (4K) technology inlaparoscopic surgery: A systematic review and meta-analysis. J Minim AccessSurg.2022;18(2):167-175.doi:10.4103/jmas.jmas_122_21.
  • HemangaK.Bhattacharjee,HarshitAgarwal,VitishSingla,ShafneedChaliyadan, Ashwani K. Mishra, Suhani Suhani, Mohit Joshi, and RajinderParshad. Learning Pattern of Two Dimensional, Three-Dimensional, and Ultra-High-Definition Endovision System on Standardized Phantom Tasks: An ExVivo Randomized StudyJournal of Laparoendoscopic & Advanced SurgicalTechniques.aheadofprinthttp://doi.org/10.1089/lap.2021.0530.
  • Chaudhary T, Kanodia A, Verma H, Singh CA, Mishra AK, Sikka K. A PilotStudy Comparing Teletherapy with the Conventional Face-to-Face Therapy forSpeech-Language Disorders. Indian J Otolaryngol Head Neck Surg. 2021 May28:1-5.doi:10.1007/s12070-021-02647-0.
  • Sengupta D, Bindra A, Kumar N, Goyal K, Singh PK, Chaturvedi A, MalhotraR, Mishra AK. Respiratory morbidity and mortality of traumatic cervical spinalcord injury at a level I trauma center in India. Spinal Cord Ser Cases. 2021 May13;7(1):36.doi:10.1038/s41394-020-00371-5.PMID:33986249;PMCID:PMC8117130.
  • Bhattacharjee, H.K., Chaliyadan, S., Mishra, A.K. et al. Comparison of two-dimensionalhigh-definition,ultrahigh-definitionandthree-dimensional endovisionsystems:anex-vivorandomisedstudy. SurgEndosc (2020). https://doi.org/10.1007/s00464-020-07980-z.
  • Verma V, Mishra AK, Narang R. Application of Bayesian analysis in medicaldiagnosis.JPract Cardiovasc Sci.2019;5:136-41.
  • Malhotra P, Goel H, Mishra AK. Inflammatory lymphadenopathy in renal cellcarcinoma: prognostic tool? Ann Transl Med 2019;7(9):189. doi: 10.21037/atm.2019.03.47.
  • SharmaI, SinghAP, SinghLC, MishraAK, RameshV, SaxenaS.IsCXCL10/CXCR3 axis over expression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase? IndianJMedRes.2015;142(6):681-9.
  • Ramesh V, Kaushal H, Mishra AK, Singh R, Salotra P. Clinico-epidemio logical analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study. BMC Public Health.2015;15(1):1092.
  • SharmaI, KaurM, MishraAK, SoodN, RameshV, KubbaA, SinghA. Histopathological Diagnosis of Leprosy Type 1 Reaction with Emphasis on Inter observer Variation. Indian JLepr.2015;87:101-107.
  • Soni S, Rath G, Deval R, Salhan S, Mishra AKumar, Saxena S. Prognostic significance of soluble Fas and soluble Fas ligand in serum of patients with complete hydatidiform moles. AmJReprod Immunol 2011;66: 230–236.
  • ChaswalM, DasS, PrasadJ, KatyalA, MishraAK, FahimM.Effect of Losartanan angiotensin II Type 1 Receptor Antagonist on Cardiac Autonomic Functions of Rats During Acute and Chronic Inhibition of Nitric Oxide Synthesis. Physiol.Res.2012;61:135-144.
  • Tomar R, Mishra AK, Mohanty NK, Jain AK. Altered Expression of Succinic Dehyrdogenase in Asthenozoospermia Infertile Male. American Journal of Reproductive Immunology.2012;68:486-490.
  • Fochsen G, Deshpande K, Diwan V, Mishra A, Diwan VK, Thorson A. HealthCare seeking among individuals with cough and Tuberculosis: a population-based study from rural India.The International Journal of Tuberculosis and Lung Disease.2006;10(9):995-1000.

Applied Statistics-Scientometrics

  • Dhua AK, Garg M, Mishra AK, Goel P, Jain V, Yadav DK. A bibliometric study of the pediatric inguinal hernia publication landscape from the web of science database. J Indian Assoc Pediatr Surg 2022;27:689-98.
  • Dhua AK, Kumar V, Mishra AK, Jain V, Yadav D, Bajpai M, et al. Fifty most influential articles on anorectal malformations: A tribute through bibliometric ranking. J Indian Assoc Pediatr Surg 2022;27:419-27.
  • Mohit Varshney, Arpit Parmar & Ashwani Kumar Mishra (2020) The Past,Present and Future of Literature Pertaining to Betel (Areca) Nut: A Citation Analysis, Substance Use & Misuse,55:9,1403-1412,DOI:10.1080/10826084.2019.1660677.
  • ParmarA, GaneshR,MishraAK.The top 100 cited article on Obsessive Compulsive Disorder (OCD): A Citation Analysis. Asian J Psychiatr. 2019;42:34-41.
  • Parmar A, Kumar Dubey D, Singh Balhara YP, Kumar Mishra A. Do Addiction Science Journals Endorse Unbiased Reporting of Research? A Systematic Evaluation of Instructions for Authors. Subst Use Misuse. 2019;54(10):1734-1742.
  • BalharaYPS,MishraAK.Compliance of Retraction notices for retracted articles on mental disorders with COPE guidelines on retraction. Current Science.2014;107(5):757-760.
  • BalharaYPS,Mishra AK. A study exploring attributes and nature of the retracted literature on mental disorders. Indian J Med Ethics.2014;11(4):1-12.
  • Mishra AK, Balhara YPS. Statistical Methodology for the Scinto metrics Study of the Growth of Medical Sciences in India. Current Science 2013;105(6):821-826.

Applied Statistics-Cancer Epidemiology & Population Genetics

  • SaxenaS, ChakrabortyA, KaushalM, MohilRS, MishraAK, SinghLC, SharmaJ, Bansal A, Agrawal U, Mehta J, Asthana S, Kataki AC, Kapur S, Chintamani, Dinesh Bhatnagar. Breast Cancer in Indian Women: Genetic Risk Factors and Predictive Biomarkers. AnnNatlAcad Med Sci(India)2019; 55:34–47.
  • Malhotra P, Goel H, Mishra AK. Inflammatory lymphadenopathy in renal cell carcinoma: prognostic tool? Ann TranslMed 2019;7(9):189.
  • KumarN, AgrawalU, MishraAK, KumarA, VasudevaP, MohantyNK, Saxena S. Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer. Tumor Biology.2017;1-14.
  • Agrawal U, Kumar N, Mishra AK, Vaudeva P, Kumar A, MohantyNK, Saxena S. Immune signature of urothelial cancer associated with grade,recurrence,andinvasion. UrolOncol.2016;34(9):418.e17-26.
  • ChakrabortyA,MishraAK,SaxenaS. Polymorphism of Hormone Synthesis and Metabolizing Genes and Breast Cancer Risk: A Multigenic Case-control Study. Biomed ResJ.2016;3(1):73–87.
  • Sawlani K, Kumari N, Mishra AK, Agrawal U. Oral Cancer Prevalence in a Tertiary Care Hospital in India. J Family Med Community Health 2014;1(4):1022.
  • IhsanR,ChauhanPS,MishraAK,SinghLC,SharmaJD,ZomawiaE,VermaY,Kapur S,. Saxena S. Copy number polymorphism of glutathione-S-transferase genes (GSTM1&GSTT1) in susceptibility to lung cancer in a high-risk population from north-east India. IndianJ MedRes2014(139):720-729.
  • PaliwalPAroraD,MishraAK. Epithelial-Mesenchymal Transition in Urothelial Carcinoma: Twist in the tale. Indian Journal of Pathology and Microbiology.2012;55(4):25-31.
  • Kaushal M, Mishra AK, Sharma JV, Kataki A, Kapur S, Saxena S. Genomic alteration analysis of breast cancer patients in correlation with betel quid chewing in Northeast India. PLoSOne.2012;7(8):e43789.
  • ChauhanPS,IhsanR,MishraAK,YadavDS,Yadav,SalujaS,MittalV,SaxenaS, Kapur S. High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia. EnvironMolMutagen.2012;53(8):619-30.
  • Soni A, Bansal A, Mishra AK, Batra J, Singh LC, Chakraborty A, Yadav DS,Mohanty NK, Saxena S. Association of androgen receptor, prostate-specificantigen, and CYP19 gene polymorphisms with prostate carcinoma and benignprostatic hyperplasia in a north Indian population. Genet Test Mol Biomarkers.2012;16(8):835-40.
  • Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, Verma Y,PhukanR,MahantaJ,KatakiAC,KapurS,SaxenaS. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North EastIndia.DNACellBiol.2011; 30(3):163-71.
  • IhsanR,ChauhanPS,MishraAK,YadavDS,KaushalM,SharmaJD,ZomawiaE, Verma Y, Kapur S, Saxena S. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non-smokers in lung cancer. PLoSOne.2011;6(12):e29431.
  • ChauhanPS,BhushanB,SinghLCSingh,MishraAK,SalujaS,MittalV,GuptaDK,KapurS.Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy. Exp MolPathol.2011;92(1):44-49.
  • Singh A, Mishra AK, Ylaya K, Hewitt SM, Sharma KC, Saxena S. Wilm’s Tumor-1, Claudin-1 and Ezrin are useful immunohistochemical markers that help to distinguish Schwannoma from Fibroblastic Meningioma. Pathol Oncol Res.2012;18(2):383-9.
  • Bansal A, Soni A, Rao P, Singh LC, Mishra AK, Mohanty NK, Saxena S. Implication of DNA repair genes in prostate tumorigenesis in Indian males. Indian J MedRes.2012Oct;136(4):622-32.
  • MishraAK,AgrawalU,NegiS,BansalA,BhatnagarA,BhatnagarD,Chintamani,MohilR,SaxenaS. Study on expression of AR in Breast Cancer and its correlation with other steroid receptors and growth factors. IndianJMedRes.2012:135;843-852.
  • Singh LC, Chakraborty A, Mishra AK, Devi TR, Sugandhi N, Chintamani C,Bhatnagar D, Kapur S, Saxena S. Study on predictive role of AR and EGFR family genes with response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer in Indian women. MedOncol.2012;29(2):539-46.
  • Chintamani, Tandon M, Mishra A, Agarwal U, Saxena S. Sentinel lymph node biopsy can be a reliable alternative to axillary dissection after neo-adjuvant chemotherapy in patients with locally advanced breast cancer-a prospective study. WorldJ SurgOncol.2011;8:9-1.
  • SoniA,BansalA,SinghLC,MishraAK,MajumdarM,ReginaT,MohantyNK,Saxena S. Gene expression profile and mutational analysis of DNA mismatch repair genes in carcinoma prostate in Indian population.OMICS.2011;15(5):319-24.
  • Ihsan R, Chattopadhyay I, Phukan R, Mishra AK, Purkayastha J, Sharma J,Zomawia E, Verma Y. Role of EPHX1 gene polymorphisms in esophagealcancer of high-risk area in India. J Gastroenterol Hepatol. 2010; 25(8):1456-62.
  • Yadav DS, Devi TR, Ihsan R, Mishra AK, Kaushal M, Chauhan PS, Bagadi SA,SharmaJ,ZamoawiaE,VermaY,NandkumarA,SaxenaS,KapurS.Polymorphisms of Glutathione-S-transferase(GST) genes and the risk of aerodigestive cancers in Northeast Indian population. Genetic Testing and Molecular Biomarker,2010;14(5):715-723.
  • Chintamani,KulshreshthaP,ChakrabortyA,SinghL,MishraAK,BhatnagarD,SaxenaS.Androgen receptor predicts response todrugs not risk in Breast Cancer in Indian Women.WorldJ Surg Oncol2010;8: 64.
  • Chauhan PS, Ihsan R, Yadav DS, Mishra AK, Bhushan B, Soni A, Kaushal M,DeviTR,SalujaS,GuptaDK,MittalV,SaxenaS,KapurS. Association of GST,EPHX and p53 codon gene polymorphism with adult acute myeloid leukemia. DNA CellBiol.2011;30(1):39-46.
  • Kaushal M, Mishra AK, Raju BS, Ihsan R, Chakraborty A, Sharma J, ZomawiaE,VermaY,KatakiA,KapurS,SaxenaS.Betel quidchewing as an environmental risk factor for breast cancer. MutatRes.2012;703(2):143-8.
  • Agrawal U, Mishra AK, Salgia P, Verma S, Mohanty NK, Saxena S. Role of tumor suppressor and angiogenesis markers in prediction of recurrence of non-muscle invasive bladder cancer. PatholOncol Res.2011;17(9):91-101.
  • Chauhan PS, Bhushan B, Mishra AK, Singh LC, Saluja S, Verma S, Gupta DK,Mittal V, Chaudhry S, Kapur S. Mutation of FLT3 gene in acute Myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features. MedOncol.2011;28(2):544-51.
  • Thoudam RD, Yadav DS, Mishra AK, Kaushal M, Ihsan R, Chattopadhyay I,ChauhanPS,SarmaJ,ZomawiaE,VermaY,NandkumarA,MahantaJ,PhukanR, Kapur S, Saxena S. Distribution of GSTT1 and GSTM1 polymorphisms in Northeast Indians: A Potential Report. GenetTestMolBiomarkers.2010;14(2):163-9.
  • Bhushan B, Chauhan PS, Saluja S, Verma S, Mishra AK, Siddiqui S, Kapur S. Aberrant Phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and adverse outcomes. ClinExpMed.2010;10(1):33-40.
  • ChakrabortyA,MishraAK,SoniA,ReginaT,MohilR,BhatnagarD,BhatnagarA,ChintamaniC,SharmaPC,SaxenaS.Vitamin D Receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detection andPrevention.2009;32:386-394.
  • Singh A, Kapur S, Chattopadhyay I, Purkayastha J, Sharma J, Mishra A, HewittSM, Saxena S. Cytokeratin immunoexpress ion in esophageal squamous cell carcinoma of high risk population in North East India. Appl ImmunohistochemMol Morphol.2009;17(5):419-24.

Edited Manuscript-Associate Editor

 

  • Abota, T. L., Gashe, F. E., & Deyessa, N. (2022). Perinatal intimate partner violence and postpartum contraception timing among currently married women in Southern Ethiopia: A multilevel Weibull regression modeling. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2022.913546.
  • Zhou R, Lin X, Xu J, Lin X and Wu Z (2022) Knowledge mapping analysis of mental health research on COVID-19. Front. Psychiatry 13:931575. doi: 10.3389/fpsyt.2022.931575.
  • Chen S, Hong H and Xu G (2022) Prevalence and related factors of depressive symptoms among HIV/AIDS in Ningbo, China: A cross-sectional study. Front. Psychiatry 13:1004318. doi: 10.3389/fpsyt.2022.1004318.
  • Ventura-León J, López-Jurado R, Porturas E, León-Mostacero I and Canchanya-Balbin SE (2022) Anxiety, depression, stress, worry about COVID-19 and fear of loneliness during COVID-19 lockdown in Peru: A network analysis approach. Front. Public Health 10:946697. doi: 10.3389/fpubh.2022.946697.
  • Gao Q, Xu H, Shi K, Zhang Y, Zhang C, Jiang Q, Wei X and Liu T (2022) Quarantine and demographic characteristics as predictors of perceived stress and stress responses during the third year of COVID-19 in China. Front. Psychiatry 13:962285. doi: 10.3389/fpsyt.2022.962285.
  • Chen Y, Lian B, Li P, Yao S and Hou Z (2022) Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis. Front. Public Health 10:947097. doi: 10.3389/fpubh.2022.947097.
  • Adedeji A, Buchcik J, Akintunde TY and Idemudia ES (2022) Racial identity as a moderator of the association between socioeconomic status and quality of life. Front. Sociol. 7:946653. doi: 10.3389/fsoc.2022.946653.
  • Li X, Yu J and Shu C (2022) Bibliometric analysis of global research trends on post-stroke pneumonia: Current development status and research Frontiers. Front. Public Health 10:950859. doi: 10.3389/fpubh.2022.950859.
  • Chou P-H, Wang S-C, Wu C-S, Horikoshi M and Ito M (2022) A machine-learning model to predict suicide risk in Japan based on national survey data. Front. Psychiatry 13:918667. doi: 10.3389/fpsyt.2022.918667.
  • JiangX(2022) Does Public Service Motivation Affect Teacher Satisfaction From the Perspective of Urban and Rural Dual Structure? Empirical Analysis Based on Estonia TALI S2018Data. Front.Psychiatry13:727659.doi:10.3389/fpsyt.2022.727659.
  • GouY,WuN,XiaJ,LiuY,YangH,WangH,YanTandLuoD(2022) Province-and Individual-Level Influential Factors of Depression: Multi level Cross-Provinces Comparison in China. Front. Public Health10:893280.doi:10.3389/fpubh.2022.893280.
  • XuZ,ZhangW,ZhangX,WangY,ChenQ,GaoBandLiN (2022) Multi-Level Social Capital and Subjective Wellbeing Among the Elderly: Understanding the Effect of Family, Workplace, Community, and Society Social Capital. Front. Public Health 10:772601.doi:0.3389/fpubh.2022.772601.
  • ChenX,ChenJ,ZhangM,DongRK,LiJ,DongZ,YeY,TongL,Zhao R,CaoW, Li P and Zhang SX (2022) Meta-Regression on the Heterogenous Factors Contributing to the Prevalence of Mental Health Symptoms During the COVID-19 Crisis Among Healthcare Workers. Front.Psychiatry13:833865.doi:10.3389/fpsyt.2022.833865.
  • Almatroudi A(2022)The Incidence Rate of Esophageal Cancer in Saudi Arabia: An Observational and a Descriptive Epidemiological Analyses. Front. Public Health 10:818691.doi:10.3389/fpubh.2022.818691.
  • GhazwaniEY(2022)Prevalence and Determinants of Burnout Among Palliative Care Clinicians in Saudi Arabia. Front. Public Health9:834407.doi:10.3389/fpubh.2021.834407.
  • Van Orden KA, Lutz J, Conner KR, Silva C, Hasselberg MJ, Fear K, LeadleyAW, WittinkM N and BaumhauerJF(2022) URMC Universal Depression Screening Initiative: Patient Reported Outcome Assessments to Promote a Person-Centered Biopsychosocial Population Health Management Strategy. Front.Psychiatry12:796499.doi:10.3389/fpsyt.2021.796499.
  • Wang K-C, Lo Y-TC, Liao C-C, Jou Y-Y and Huang H-B (2022) Associations Between Symptoms of Depression and Air Pollutant Exposure Among Older Adults: Results from the Taiwan Longitudinal Study on Aging (TLSA). Front. Public Health 9:779192.doi:10.3389/fpubh.2021.779192.
  • vanZy,lLEandtenKlooster,PM(2022) Exploratory Structural Equation Modeling: Practical Guidelines and Tutorial With a Convenient Online Tool forM plus. Front.Psychiatry12:795672.doi:10.3389/fpsyt.2021.795672.
  • Smith CM, Feigal J, Sloane R and Biederman DJ (2021) Differences in Clinical Outcomes of Adults Referred to a Homeless Transitional Care Program Based on Multimorbid Health Profiles: A Latent Class Analysis.Front.Psychiatry12:780366.doi:10.3389/fpsyt.2021.780366.
  • HeL,WangK,ZhangZ,WangJ,LiT,WangY,YangL,WuY,ZhangS,ZhangS and Yang H (2021) Depression Levels of State Functionaries: Empirical Evidence From China. Front. Psychiatry12:754182.doi:10.3389/fpsyt.2021.754182.
  • Peng F, Zhan X, Yang B and Tian Y (2022) A Quantitative Study of Early Childhood Care and Education Services Under the Age of Three: Evidence From Sichuan Province, China. Front.PublicHealth10:794967.doi:10.3389/fpubh.2022.794967.
  • Al-Shatanawi TN, Sakka SA, Kheirallah KA, Al-Mistarehi A-H, Al-Tamimi S,Alrabadi N, Alsulaiman J, Al Khader A, Abdallah F, Tawalbeh LI, Saleh T,HijaziW,AlnsourARandYounesNA (2021) Self-ReportedObsessionTowardCOVID-19PreventiveMeasuresAmongUndergraduateMedicalStudentsDuring the Early Phase of Pandemic in Jordan. Front. Public Health 9:719668.doi:10.3389/fpubh.2021.719668.
  • Jia P, Zhuang J, Vaca Lucero AM, Osei CD and Li J (2021) Does Participation in Local Non-agricultural Employment Improve the Mental Health of Elderly Adults in Rural Areas? Evidence From China. Front. Public Health 9:746580.doi:10.3389/fpubh.2021.746580.
  • Mounir I, Menvielle L, Perlaza S, Chênevert D, Planchard J-H, Fabre R, BenoitM, Benyamina A, Rolland B, Cherikh F and David R (2021) PsychologicalDistress and Tobacco Use Among Hospital Workers During COVID-19. Front.Psychiatry12:701810.doi:10.3389/fpsyt.2021.701810.
  • Willems RCWJ, Drossaert CHC, Miedema HS and Bohlmeijer ET (2021) HowDemanding Is Volunteer Work at a Crisis Line? An Assessment of Work- andOrganization-Related Demands and the Relation With Distress and Intention toLeave.Front.PublicHealth9:699116.doi:10.3389/fpubh.2021.699116.
  • Yang H-l, Wu Y-y, Lin X-y, Xie L, Zhang S, Zhang S-q, Ti S-m and Zheng X-d(2021) Internet Use, Life Satisfaction, and Subjective Well-Being Among theElderly:EvidenceFrom2017ChinaGeneralSocialSurvey.Front.PublicHealth9:677643.doi:10.3389/fpubh.2021.677643.
  • KousoulisAAandGoldieI(2021)AVisualizationofaSocio-EcologicalModelforUrbanPublicMentalHealthApproaches.Front.PublicHealth9:654011.doi:10.3389/fpubh.2021.654011.
  • Ventuneac A, Hecht G, Forcht E, Duah BA, Tarar S, Langenbach B, Gates J,Cain D, Rendina HJ, Aberg JA and Perlman DC (2021) Chronic High RiskPrescriptionOpioidUseAmongPersonsWithHIV.Front.Sociol.6:645992.doi:10.3389/fsoc.2021.645992.
  • KousoulisAAandGoldieI(2021)AVisualizationofaSocio-EcologicalModelforUrbanPublicMentalHealthApproaches.Front.PublicHealth9:654011.doi:10.3389/fpubh.2021.654011.
  • Zhao L, Yang F, Sznajder KK, Zou C, Jia Y and Yang X (2021) Resilience asthe Mediating Factor in the Relationship Between Sleep Disturbance and Post-stroke Depression of Stroke Patients in China: A Structural Equation ModelingAnalysis.Front.Psychiatry12:625002.doi:10.3389/fpsyt.2021.625002.
  • Carballeira Carrera L, Lévesque-Daniel S, Radjack R, Moro MR and Lachal J(2020) Clinical Approaches to Cultural Diversity in Mental Health Care andSpecificities of French Transcultural Consultations: A Scoping Review. Front.Psychiatry11:579147.doi:10.3389/fpsyt.2020.579147.
  • Ellis K, Walters S, Friedman SR, Ouellet LJ, Ezell J, Rosentel K and Pho MT(2020)Breaching Trust: A Qualitative Study of Health care Experiences of People Who Use Drug sina Rural Setting. Front.Sociol.5:593925.doi:10.3389/fsoc.2020.593925.
  • LuanR, PuW, DaiL, Yang Rand Wang P(2020) Comparison of Psycho logical Stress Levels and Associated Factors Among Healthcare Workers, Front line Workers, and the General Public During the Novel Coronavirus Pandemic. Front.Psychiatry11:583971.doi:10.3389/fpsyt.2020.583971.
  • Esteves CS, Oliveira CRd and ArgimonIIdL(2021) Social Distancing: Prevalence of Depressive, Anxiety, and Stress Symptoms Among Brazilian Students During the COVID-19 Pandemic. Front. Public Health 8:589966. doi:10.3389/fpubh.2020.589966.
  • Des Jarlais DC, Arasteh K, Barnes DM, Feelemyer J, Berg H, Raag M, Talu A, Org G, Tross S and Uuskula A (2021) A Multistage Process Model of How a Person Who Currently Injects Drugs Comesto Assist Persons Who Donot Inject with Their First Injections. Front.Sociol.6:619560.doi:10.3389/fsoc.2021.619560.
  • Al-Zawaadi A, Hesso I and Kayyali R (2021) Mental Health Among School-Going Adolescents in Greater London: ACross-SectionalStudy.Front.Psychiatry12:592624.doi:10.3389/fpsyt.2021.592624.

Technical Reports, Manual, Reports

  • Dhawan A, Bhargava R, Mishra AK, Chatterjee B, Mandal P (2021). Report of Project Screening & Intervention for Drug/ Substance abuse among School going Children. New Delhi: Samagra Shiksha- Delhi, Education Department, GNCT of Delhi.
  • Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda RK Experience with Treatment among patients with substance use disorders. Focused Thematic Study- National Survey on Extent and Pattern of Substance Use in India (2019). New Delhi: Ministry of Social Justice and Empowerment, Government of India.
  • Dhawan A, Bhargava R, Mishra AK, Chatterjee B, Mandal P (2021). Survey on Substance Use Among School and College Students. Focused Thematic Study- National Survey on Extent and Pattern of Substance Use in India (2019). New Delhi: Ministry of Social Justice and Empowerment, Government of India. National Investigator and Lead Biostatistician
  • Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda RK. Rates and pattern of substance use among people in prisons in India. Focussed Thematic Study- National Survey on Extent and Pattern of Substance Use in India (2019). New Delhi: Ministry of Social Justice and Empowerment, Government of India.
  • Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda RK. Substance Use among Transport Workers. Focussed Thematic Study- National Survey on Extent and Pattern of Substance Use in India (2019). New Delhi: Ministry of Social Justice and Empowerment, Government of India.
  • Ambekar A, Mishra AK, Agrawal A, Rao R. Do drug policies impede the availability of treatment of opioid dependence in India (and more so for non-injecting opioid users)? Analysis of epidemiological data from Punjab, India. 12th International Society for the Study of Drug Policy, Vancouver, Canada, 23-25 May 2017.
  • Sood A, Ambekar A, Mishra AK. Can economic analysis of household income and expenditure inform alcohol policies? Analysis of household data from nationally representative sample from India. 12th International Society for the Study of Drug Policy, Vancouver, Canada, 23-25 May 2017.
  • Anju Dhawan, Atul Ambekar, Rachna Bhargava, Alok Agrawal, Biswadip Chatterjee, Ashwani K Mishra, Anita Chopra, Faizan Khan. A Field manual for Respondent Driven Sampling Survey and Mapping Study. Department of Women and Child Development. Government of NCT, Delhi. 2016, New Delhi
  • Ambekar A, Rao R, Agrawal A, Mishra A, Kumar R, Kumar M. Field Manual for Implementation of Respondent Driven Sampling for Punjab Opioid Dependence Survey. New Delhi.
  • Sonali Jhanjee, Rakesh Lal, Ashwani K Mishra, Deepak Yadav. Community Based Brief Intervention with simple advice for women tobacco users. Indian Council of Medical Research. 2015
  • Ashwani K Mishra, Ray R. Alcohol availability, Price, Taxation and Consumption: A Technical Note for Ministry of Health and Family Welfare, by National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS). Submitted to Department of Revenue, Ministry of Revenue, Government of India 2013.
Dr. Ravindra Rao

Dr.
Ravindra Rao

Male

MD (Psychiatry)

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
dr.rvenkatrao@aiims.gov.in
drrvrao@gmail.com
Phone :
01126593236

General OPD

Tuesday

Special Clinic

Wednesday (Ward Rounds)
Thursday (Community Clinic, Sundarnagri)
Friday (Consultation Liaison Addiction Psychiatry-CLAP at AIIMS, Delhi)

Field of Interest:

Addiction Psychiatry; Public Health related to substance use disorder; Community-based treatment for substance use disorder; Consultation Liaison Addiction Psychiatry

Editor / Associate editor / Author of books/manuals

  • Rao R. One stop integrated model for women who use drugs in Punjab: An Implementation Document. Alliance India, New Delhi, 2020
  • Rao R, Kathiresan P. Assessment of Standards of Care in Services for People Who Use Drugs in India. Alliance India, 2020.
  • Ambekar A, Agrawal A, Rao R, Mishra AK, Khandelwal SK, Chadda R on behalf of the group of investigators for the National Survey on Extent and Pattern of Substance Use in India (2019). Magnitude of Substance Use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India.
  • Rao R, Ambekar A, Agrawal A. Opioid Substitution Therapy under National AIDS Control Programme: Clinical Practice Guidelines for treatment with Methadone. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, 2017
  • Ambekar A, Rao R, Agrawal A, Varshney M. Methadone Maintenance Treatment under National AIDS Control Programme: Training Manual. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, 2016
  • Rao R, Arumugam V, Sharma C, Beddoe S, Peters T, Mehta A, Robertson J. Community Action on Harm Reduction in India: Impact Assessment, India HIV/AIDS Alliance, 2015
  • Ambekar, A., Kumar, R., Rao, R., Agrawal, A., Kumar, M., & Mishra, A. K. (2015). Punjab Opioid Dependence Survey. Retrieved from http://pbhealth.gov.in/scan0003%20(2).pdf
  • Rao R, Agrawal A, Ambekar A. Opioid Substitution Therapy under National AIDS Control Programme: Clinical Practice Guidelines for treatment with Buprenorphine. New Delhi: Department of AIDS Control, Ministry of Health and Family Welfare, Government of India, 2014
  • Dhawan, A., Rao, R., Ambekar, A., Chopra, A., Jain, R., Yadav, D., Ray, R. Methadone Maintenance Treatment in India: A feasibility and effectiveness Report. New Delhi: UNODC (ROSA) and NDDTC (AIIMS), 2014
  • Ambekar A, Rao R, Varshney M, Prashanth R, Dhawan A, Jain R, Ray R, Bhola S, Gupta N, Chopra A, Sethi H. Post Marketing Surveillance of Methadone in India – Report submitted to Drug Controller General (India), Central Drug Standards Control Organisation, Ministry of Health and Family Welfare, Government of India. New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, 2014
  • Ambekar A, Rao R, Dhawan A, Ray R. Quality Assurance of Opioid Substitution Treatment in India – A reference guide for mentors. NDDTC, AIIMS and National AIDS Control Organisation, 2013.
  • Rao R, Kumar M, Singh M. Evolution of Targeted Intervention programme for High Risk Groups in Punjab under National AIDS Control Programme-III – A documentary. Punjab State AIDS Control Society and Society for Promotion of Youth and Masses, 2013. DOI: 10.13140/RG.2.1.2159.5366
  • Ambekar A, Rao R. Training of General Physicians on Substance Use Disorders: A manual for facilitators. National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences, 2013.
  • Rao R, Ambekar A, Agrawal A. Opioid Substitution Therapy under National AIDS Control Programme: A situation analysis. Report prepared under Global Fund to fight AIDS, Tuberculosis and Malaria, Round 9 HIV-IDU Grant, New Delhi, 2012.
  • Kumar MS, Rao R, Chengappa M. Methadone Maintenance Treatment in the Republic of Maldives: Standard operating Procedure. United Nations Office on Drugs and Crime, Regional Office for South Asia, 2012.
  • Rao R, Mittal A. Opioid overdose prevention and management for injecting drug users: standard operating procedures. United Nations Office on Drugs and Crime, Regional Office for South Asia, 2012.
  • Ambekar A, Rao R, Mukherjee D, Kedia S. Counselling in Targeted Interventions for Injecting Drug Users – A Training module. United Nations Office on Drugs and Crime, Regional Office for South Asia and Tata Institute of Social Sciences, New Delhi, 2011
  • Rao R, Tripathi R. Stimulants and Sleep. In: Gupta R., Neubauer D.N., Pandi-Perumal S.R. (eds) Sleep and Neuropsychiatric Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-16-0123-1_40
  • Substance Use Disorders – An Introduction. In Kaloiya G et al. (Eds.). Basics of Addiction Psychology. New Delhi: National Drug Dependence Treatment Centre, AIIMS, 2019.
  • Rao R, Kathiresan P. Opioid Substitution Therapy – Past, Present and Future. In: Psychiatry Update, 21st Mid-term CME, Indian Psychiatric Society, East Zone & National CME, Addiction Psychiatry sub-specialty section, Indian Psychiatric Society, 2018.

Presentations made at scientific meetings/ conferences/ workshops

  • Patient experience of take-home methadone compared to daily methadone maintenance treatment: A cross-sectional study from India. Poster presentation in the 2022 NIDA International Forum, from 9-10 June 2022.
  • Overdose prevention and management among People Who Inject Drugs. Invited lecture delivered at AIDSCON – 11 organised by Chandigarh State AIDS Control Society on 12 March 2022.
  • Chronic pain and opioid misuse. CME organised by Indian Psychiatric Society North Zone (online)
  • Basics of Research Methods in Addiction Science. Workshop conducted in ADDICON 2021, an online national conference organised by Addiction Psychiatry Society of India on 10-11 December 2021
  • From Sharabi to Devdas: How Bollywood portrays substances: A mixed-methods study. Symposium presented at ADDICON 2021, an online national conference organised by Addiction Psychiatry Society of India on 10-11 December 2021
  • Avenues for growth of addiction psychiatry in India: Recent Initiatives and advances. Symposium presented in the World Association of Social Psychiatry Asia Pacific Congress 2021
  • Addiction treatment services during COVID 19 pandemic- Experience from a Community Drug Treatment Clinic in Delhi, India. Symposium presented in the International Society of Addiction Medicine 2021 Congress on 21 November 2021
  • The unmet needs of wives of people Who Inject Drugs. Symposium presented in the National Conference of the Indian Association of Social Psychiatry 2021
  • Rates and knowledge of non-fatal Opioid Overdose among people who inject drugs in India. Poster presentation in ‘National Institute of Drug Abuse (NIDA) International Forum’ held online from June 21 – 24, 2020
  • Mobile Methadone Dispensing: An innovative model for opioid agonist maintenance treatment delivery in India. Symposium presented at the International Society of Addiction Medicine (ISAM) congress, 2020 held online from November 12 – 14, 2020
  • Adapting digital technology for delivering opioid agonist maintenance treatment for post-pandemic world. Symposium presented at the International Society of Addiction Medicine (ISAM) congress, 2020 held online from November 12 – 14, 2020
  • Portrayal of psychoactive substances in Bollywood movies – a mixed-methods study. Symposium presented at the National Conference of Indian Association of Social Psychiatry held in Bhubaneshwar, Odisha from 29 November – 1 December 2019
  • Magnitude of Substance Use in India. Symposium presented at the Indian Psychiatric Society North Zone Conference in Amritsar, Punjab from 2 – 3 November 2019
  • Opioid Substitution Therapy: Canada versus India Experience. Symposium presented at the International Society of Addiction Medicine Annual meet in New Delhi from 13 – 16 November 2019
  • New Psychoactive Substances: An Emerging Challenge in Addiction Psychiatry (Symposium) presented at the Annual National Conference of Indian Psychiatric Society, 2019
  • Rao R, Gupta SK, Ramshankar P, Agrawal A, Ambekar A, Dhawan A. Factors affecting Long-term Retention on Opioid Agonist Maintenance Treatment in a Community Drug Treatment Clinic: A Retrospective Cohort Study from India. Poster presentation in the 28th Annual meeting and scientific symposium of the American Academy of Addiction Psychiatry, held in San Diego, CA, USA from 7 – 10 December 2017
  • Bagra I, Rao R, Dhawan A, Agrawal A. A cross-sectional study of cannabis use among opioid dependent patients maintained on buprenorphine in a community-based drug treatment clinic. Oral presentation in International Society of Addiction Medicine Congress, at Montreal, Canada, 2016
  • Ambekar A, Singh T, Mishra AK, Rao R, Agrawal A. Factors associated with risk of transition to injecting among men using opioids through non-injecting routes: A multi-site study from North India. Poster presentation in International Society of Addiction Medicine Congress, at Montreal, Canada, 2016
  • Deb KS, Rao R, Kedia S. Psychosocial Rehabilitation in Resource Limited Settings. Symposium presented at the National Workshop on Psychosocial Rehabilitation organised by the World Association of Psychosocial Rehabilitation held in Dharan, Nepal from 1 – 2 April 2016
  • Rao R, Mandal P, Gupta R, Ramshankar P, Mishra A, Jhanjee S, Ambekar A, Dhawan A. Knowledge of drug related laws and legal rights among people who use drugs. Poster presented at the International Society of Addiction Medicine Congress at Dundee, UK, 2015
  • Rao R, Ambekar A, Pawar Aditya Singh, Agrawal A, Mishra A, Khandelwal SK. Impact of five-day training on opioid substitution therapy on knowledge and skills of various cadres of service providers. Poster presented at the International Society of Addiction Medicine Congress at Dundee, UK, 2015
  • Rao R, Ambekar A, Khandelwal SK. Policy and practice of harm reduction in India. Symposium presented at the International Society of Addiction Medicine Congress at Dundee, UK, 2015
  • Dhawan A, Ambekar A, Lenin Singh RK, Rao R. How to deliver methadone maintenance treatment for opioid dependence. Workshop presented at the Annual National Conference of Indian Psychiatric Society, Hyderabad, 2015.
  • Rao R, Pawar AKS, Agrawal A, Ambekar A, Khandelwal S. Can a five‐day training programme on Opioid Substitution Therapy (OST) improve scores on knowledge and skills of different cadre of service providers? Analysis of routine programme data. Oral presentation at the Annual National Conference of Indian Psychiatric Society, Hyderabad, 2015.
  • Kuppili PP, Bhad R, Rao R, Dayal P, Ambekar A. Opioid dependence in somatisation disorder. Oral presentation Annual National Conference of Indian Psychiatric Society, Hyderabad, 2015.
  • Rao R. Research Study Designs. Symposium on “Basics of Medical Research” conducted at National Conference of Indian Association of Social Psychiatry, Mysore, November 2014
  • Ambekar A, Rao R, Agrawal A. National Scale Up Of Opioid Substitution Therapy For Injecting Drug Users In India: The Journey So Far And The Road Ahead. Symposium at the Annual National Conference of Indian Psychiatric Society, Pune, 2014.
  • Dhawan A, Rao R, Ambekar A. Methadone Maintenance Therapy in India. Symposium at the Annual National Conference of Indian Psychiatric Society, Pune, 2014.
  • Krishnan V, Rao R, Ambekar A, Agrawal A. Retention in Opioid Substitution Therapy: How do you define it and does it matter? Oral Presentation at the Annual National Conference of Indian Psychiatric Society, Pune, 2014.
  • Prashanth R, Ambekar A, Rao R. Safety Of Methadone For Treatment Of Opioid Dependence: Should India Be Concerned? Oral Presentation at the Annual National Conference of Indian Psychiatric Society, Pune, 2014.
  • Rao R. Injecting Drug Use and HIV. Invited lecture at Indian Association of Preventive and Social Medicine (Gujarat Chapter), March 2013.
  • Ambekar A, Rao R, Agrawal A. Principles and Practice of Harm Reduction in Substance Use Disorders – Symposium presented at the Annual National Conference of Indian Psychiatric Society (ANCIPS), 2013.
  • Rao R. Harm reduction for HIV prevention among Injecting Drug Users. Invited lecture at AIDSCON-2, a conference on HIV/AIDS organized by Chandigarh State AIDS Control Society, March 2013.
  • Rao R. Community response to changing pattern of substance use. Invited lecture at XIX Annual conference of Indian Association for Social Psychiatry, Chandigarh, November 2012.
  • Rao R. OST in South Asia – operational issues and supply chain management. Presentation at Project Steering Committee: “Prevention of transmission of HIV among Drug Users in SAARC countries” (Project RAS/H13), organised by United Nations Office on Drugs and Crime, Regional Office for South Asia, Colombo, 2012
  • Ambekar A, Kumar MS, Rao R, Agrawal A. Agonist maintenance treatment for opioid dependence. Facilitators for Workshop conducted at Annual National Conference of Indian Psychiatric Society, Kochi, 2012.
  • Rao R. OST: Procurement, supply chain and service delivery. Presentation at Opioid Substitution Therapy Regional workshop, organised by World Bank, South Asia and United Nations Office on Drugs and Crime, Regional Office for South Asia, Maldives, 2011.
  • Speaker at Continued Medical Education organized by Indian Psychiatric Society and Indian Medical Association, Jalandhar Branch, Punjab on the topic of Addictive disorders at Jalandhar, Punjab on 7 – 8 May 2011

Investigator/ Co-investigator in funded projects along with year completed/ongoing

Principal Investigator

  • Assessment of rates and causes of mortality among people with opioid dependence: a longitudinal, cohort study. Supported by Indian Council of Medical Research, Ministry of Health and Family Welfare, Govt. of India (ongoing)
  • Assessment of HIV, other Blood-borne Viruses, TB and Risk Behaviours among Prison Inmates in Gujarat. Supported by UNODC, Regional Office for South Asia (completed)
  • Rates and Pattern of Psychoactive Substance Use among Prison Inmates in India: Supported by Ministry of Social Justice and Empowerment, Govt. of India (completed)
  • Developing and testing an online training programme for medical officers on treatment of substance use disorders: Supported by Ministry of Social Justice and Empowerment, Govt. of India (completed)
  • Assessment of pattern and trends of Amphetamine type Stimulants use in Manipur and Mizoram: a cross-sectional, multi-site study. Supported by Alliance, India (completed)
  • Assessment of HIV-related risk behaviours and vulnerabilities among female spouse of male injecting drug users in Delhi – a cross-sectional, observational study. Supported by Alliance, India (completed)
  • Rates of non-fatal opioid overdose among people who inject drugs in Delhi: A cross-sectional study. Supported by Alliance, India (completed)
  • Portrayal of psychoactive substance use in Bollywood movies: a mixed methods study: supported by AIIMS, New Delhi (completed)

Co-investigator

  • Field Testing of the International Standards for the Treatment Drug Use Disorders (The Standards) in India (completed)
  • Service -based field testing of ICD-11: Public Health/Clinical Utility and Comparability with ICD-10 in India (completed)
  • Detection of New Psychoactive Substances among Substance Abuse Treatment Seekers in India: A multi-centric Study: Supported by the National Fund for Control of Drug Abuse (NFCDA), Department of Revenue, Ministry of Finance, Government of India. (completed)
  • Developing and Implementing Training Mechanism for use of Essential Narcotic Drugs (ENDs) for treatment of Opioid Dependence: Supported by the National Fund for Control of Drug Abuse (NFCDA), Department of Revenue, Ministry of Finance, Government of India. (completed)
  • National Survey to estimate extent and pattern of substance use in India: supported by Ministry of Social Justice and Empowerment (completed)
  • Strengthening Drug De-addiction Programme (DDAP) through establishing Drug Treatment Clinics (DTCs) in India supported by DDAP, Ministry of Health and Family Welfare (completed)
  • Developing and testing an online training programme on implementing opioid substitution therapy: supported by Public Health Foundation of India (completed)
  • Size estimation of Drug Dependent Population in the state of Punjab: supported by Ministry of Social Justice and Empowerment (completed)
  • Methadone Maintenance Treatment in India: a multi-site feasibility and effectiveness study: supported by UNODC, Regional office for South Asia, New Delhi (completed)
  • Post Marketing Surveillance of Methadone: supported by Rusan Pharmaceuticals, India (completed)
  • National Technical Training Centre: Supported by Global Fund to Fight AIDS, Tuberculosis and Malaria-Round 9, HIV-IDU project (completed)

Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing

Thesis supervised for MD/ DM/PhD

- as guide (number only): 6

-as co-guide (number only): 12

Awards and Honours

  • Delivered TILAK VENKOBA RAO ORATION held in Annual National Conference of Indian Psychiatric Society (ANCIPS), 2017
  • Awarded CERTIFICATE OF COMMENDATION for paper titled “Pattern of Drug Use and Associated Behaviours among Female Injecting Drug Users from Northeast India: A Multi-Centric, Cross-Sectional, Comparative Study” at AIIMS, New Delhi in 2016
  • Any other relevant information

Total number of publications till date: 87

Details of publications since 2010 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Peer reviewed publications:

  • Ghosh S, Jain R, Rao R, Mishra AK, Jhanjee S. Does ethyl glucuronide in hair correlates with alcohol consumption? A comparative study with other traditional biomarkers among individuals with alcohol dependence syndrome. Alcohol, Nov 2022. https://doi.org/10.1016/j.alcohol.2022.10.005
  • Rao R, Chadda R, Kathiresan P, Gupta R, Bhad R, Mishra AK, Deb KS, Rajhans P, Ganesh R. Prevalence of substance use and substance use disorder in medically ill patients: A cross-sectional, hospital-based study from India. National Medical Journal of India, 2022. (Accepted for publication)
  • Kainth D, Kathiresan P, Bhad R, Rao R, Verma A. A Hyperalert Newborn. Neoreviews, 2022;23(6):e413-415
  • Quraishi R, Varshney M, Rao R, Ambekar A. Evaluation of alcohol use pattern among OST patients using alcohol biomarkers: Report from community clinics in India. Indian Journal of Psychiatry, 2022;64(3):312-15
  • Rao R, Kathiresan P, Kishore K, Kumar P, Sharma C, Mishra JK. Physical and mental health of women whose spouses inject drugs – A cross-sectional, multi-site study. Indian Journal of Public Health, 2022;66(1):57-60
  • Quraishi R, Kathiresan P, Verma K, Rao R, Jain R. Effect of chronic opioid use on the hematological and inflammatory markers: A retrospective study from North India. Indian Journal of Psychiatry, 2022;64(3):252-256
  • Saini R, Parmar A, Rao R, Mishra AK, Ambekar A, Agrawal A. Psychiatric and substance use comorbidities among people who inject drugs in India: A cross-sectional, community-based study. World Soc Psychiatry 2021;3:195-202
  • Garcia RR, Keeley J, Vega-Ramirez H, Cruz-Islas et al. Validity of Categories Related to Gender Identity in ICD-11 and DSM-5 Among Transgender Individuals who Seek Gender-Affirming Medical Procedures. International Journal of Clinical and Health Psychology 2021. DOI: 10.1016/j.ijchp.2021.100281
  • Mathur R, Parmar A, Singh S, Tandup T, Bhad R, Rao R. Sildenafil misuse for its psychoactive properties? A case report. Journal of Addiction Medicine 2021; 15(6):522-524
  • Singh B, Rao R. Is there an opioid epidemic in India? Journal of Public Health, 2021;43 (Suppl 2). https://doi.org/10.1093/pubmed/fdab322
  • Ganesh R, Rao R, Deb KS, Bhad R, Yadav D. Digital Capacity and Interest in mHealth Interventions Among Individuals on Opioid Agonist Maintenance Treatment: A Cross-Sectional Community-Based Study. Indian Journal of Psychological Medicine. July 2021. https://doi:10.1177/02537176211027239&
  • Ghosh S, Jain R, Singh S, Rao R, Mishra AK, Jhanjee S. A simplified approach for determination of urinary ethyl glucuronide by gas chromatography–mass spectrometry. Journal of Analytic Science and Technology, 2021;12:35. https://doi.org/10.1186/s40543-021-00290-6
  • Singh A, Rao R, Chatterjee B, Mishra AK, Kaloiya G, Ambekar A. Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study. Asian Journal of Psychiatry, 2021. https://doi.org/10.1016/j.ajp.2021.102697
  • Rao R, Dhawan A, Parmar A, Yadav D, Bhad R. Improving Treatment of Substance Use Disorders through Community Drug Treatment Clinics: An Experiential Account. Indian Journal of Community Medicine, 2021; 46(3):370-3
  • Rao R, Yadav D, Bhad R, Rajhans P. Mobile Methadone Dispensing – Experience of a new model of methadone delivery from India: An Implementation Research. Bulletin of the World Health Organization, 2021;99:422–28 doi: http://dx.doi.org/10.2471/BLT.20.251983
  • Kathiresan P, Bhad R, Rao R. What’s in a name? Nosological issues in substance use and addictive disorders: perspectives form ICD-11. Asian J Psychiatry. 2021, Feb 10;57: 102585.
  • Sartaj D, Krishnan V, Rao R, Ambekar A, Dhingra N, Sharan P. Mental illnesses and related vulnerabilities in the Hijra community: a cross-sectional study from India. International Journal of Social Psychiatry, 2020. Aug 20:20764020950775. 
  • Kathiresan P, Rao R, Narnoli S, Hans G, Sharan P. Adjuvant Trazodone for management of Protracted Delirium Tremens. Indian Journal of Psychological Medicine, 2020. https://doi.org/10.1177/0253717620933436
  • Dhagudu NK, Ambekar A, Agrawal A, Rao R, Mishra AK, Jain R, Singh S. Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects. Drug and Alcohol Review, 2020. (doi.org/10.1111/dar.13057)
  • Rao R, Gupta SK, Ramshankar P, Gupta V, Dhawan A, Agrawal A, Ambekar A. Predictors of long-term retention on opioid agonist treatment with buprenorphine: a six-year, community-based retrospective cohort study in India. Journal of Substance Use, 2020. DOI: 10.1080/14659891.2020.1736666
  • Rao R, Panda U, Gupta SK, Ambekar A, Gupta S, Agrawal A. Portrayal of alcohol in Bollywood movies: A mixed methods study. Indian Journal of Psychiatry, 2020; 62(2):159-166. DOI: 10.4103/psychiatry.IndianJPsychiatry_294_19
  • Gupta S, Lal R, Rao R, Mishra AK, Ambekar A. The Pattern of Alcohol Use and Its Relationship with Consequences Among Problem Alcohol Users: A Community Based Cross-Sectional Study from India. Indian Journal of Psychiatry, 2020; 62(2):152-158. DOI: 10.4103/psychiatry.IndianJPsychiatry_194_19
  • Kathiresan P, Rao R, Joshi T, Bhad R, Bhatnagar S, Deb KS, Chadda RK. Chronic non-cancer pain and opioid addiction – diagnostic and management challenges. Indian Journal of Palliative Care, 2020. 26(4):544-547
  • Saini R, Rao R, Parmar A, Mishra AK, Ambekar A, Agrawal A, Dhingra N. Rates, knowledge and risk factors of non-fatal opioid overdose among People Who Inject Drugs in India: A community-based study. Drug and Alcohol Review. 2020 Jan;39(1):93-97. doi: 10.1111/dar.13016.
  • Dhagudu N, Gupta S, Bhad R, Rao R. Community‑based Management of Opioid Use Disorder: Role of Nursing Professionals and Paramedical Workers. Indian J Psy Nsg 2019; 16:43-8
  • Tripathi R, Rao R, Dhawan A, Jain R, Sinha S. Opioid and Sleep – A Review of Literature. Sleep Medicine, 2020 Mar;67:269-275. doi: 10.1016/j.sleep.2019.06.012.
  • Tripathi R, Dhawan A, Rao R, Mishra AK, Jain R, Sinha S. Assessment of subjective sleep problems in males with opioid dependence maintained on buprenorphine. Journal of Addiction Medicine, 2019.doi: 10.1097/ADM.0000000000000539
  • Rao R, Varshney M, Singh S, Agrawal A, Ambekar A. Mental Healthcare Act, 2017 and Addiction Treatment: Potential Pitfalls and Trepidations. Indian Journal of Psychiatry, 2019;61:208-12. DOI: 10.4103/psychiatry.IndianJPsychiatry_463_18
  • Quraishi R, Varshney M, Singh A, Singh D, Kumar M, Rao R, Jain R, Ambekar A. Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study. Indian J Psychol Med 2019;Nov 11;41(6):529-534.
  • Modak T, Bhad R, Rao R. A rare case of physical dependence with psychedelic LSD – A case Report. J Subst Use. 2019. DOI: 10.1080/14659891.2019.1581286
  • Ghosh S, Jain R, Jhanjee S, Rao R, Mishra AK. Alcohol Biomarkers and their Relevance in Detection of Alcohol Consumption in Clinical Settings. International Archives of Substance Abuse and Rehabilitation,2019;1:1-8
  • Ambekar A, Rao R, Agrawal A, Kathiresan P. Research on Opioid Substitution Therapy in India: a brief, narrative review. Indian Journal of Psychiatry, 2018;60(3):265-70
  • Modak T, Bhad R, Rao R. Utility of Aripiprazole in co-occurring problem gambling and toluene dependence: A case report. Journal of Substance Use 2019;24:117-19 DOI: 10.1080/14659891.2018.1523964
  • Singh J, Gupta R, Prajapati DC, Rao R. Use of opium containing herbal drug and associated mania. Asian Journal of Psychiatry (2018). 36, 36-37
  • Bagra I, Krishnan V, Rao R, Agrawal A. Does cannabis use influence opioid-related outcomes and quality of life among buprenorphine-maintained patients? - a cross-sectional, comparative study. Journal of Addiction Medicine (2018); 12(4):315-320. DOI: 10.1097/ADM.0000000000000406.
  • Parmar A, Patil V, Sarkar S, Rao R. An observational study of treatment seeking users of natural opiates from India. Substance Use and Misuse, 2017, Dec 8:1-7. DOI: 10.1080/10826084.2017.1400564.
  • Gupta S, Lal R, Rao R, Mishra AK, Ambekar A. Pattern of alcohol use among problem alcohol users in a community-based setting in India: A cross-sectional study. Journal of Substance Use, 2017: 130-135. DOI: 10.1080/14659891.2017.1366557
  • Dhawan A, Rao R, Ambekar A, Pusp A, Ray R. Treatment of Substance Use Disorders through the Government Health facilities: Developments in the ‘Drug De-Addiction Programme’ of Ministry of Health and Family Welfare, Government of India. Indian Journal of Psychiatry, 2017;59(3):380-84
  • Rajhans P, Rao R. Book review: Demons: Our changing attitudes to alcohol, tobacco, & drugs. National Medical Journal of India, 2017;30(3):174-75
  • Rao R. The Journey of Opioid Substitution Therapy in India: Achievements and Challenges. Indian Journal of Psychiatry, 2017; 59(1): 39-45.
  • Patil V, Tewari A, Rao R. New Psychoactive Substances: Issues and Challenges. J Mental Health Hum Behav 2016;21(2):98-104
  • Rao R, Ambekar A, Agrawal A, Pawar AKS, Mishra A, Khandelwal SK. Evaluation of a five-day training programme on Opioid Substitution Therapy in India, 2016. Drugs: Education, Prevention & Policy. DOI: 10.3109/09687637.2016.1167166
  • Rao R, Mandal P, Gupta R, Ramashankar P, Mishra AK, Ambekar A, Jhanjee S, Dhawan A. Factors affecting drug use during incarceration: a cross-sectional study of opioid-dependent persons from India. Journal of Substance Abuse Treatment, 2015 DOI: 10.1016/j.jsat.2015.08.009
  • Kuppuli PP, Bhad R, Rao R, Dayal P, Ambekar A. The mis-adventurous use of prescription opioids in chronic non-cancer pain: a case report. The National Medical Journal of India, 2015, 28(6):284-85.
  • Varshney M, Ambekar R, Lal R, Yadav D, Rao R, Mishra A. Brief interventions for harmful alcohol use in opioid-dependent patients on maintenance treatment with buprenorphine: a prospective study from India. Addictive Disorders and their Treatment, 2015. DOI: 10.1097/ADT.0000000000000076
  • Ambekar A, Rao R, Agrawal A, Goyal S, Mishra A, Kishore K, Mukherjee D, Albertin C. Pattern of Drug Use and Associated Behaviors Among Female Injecting Drug Users From Northeast India: A Multi-Centric, Cross-Sectional, Comparative Study. Substance Use and Misuse, 2015, 50(10): 1332-1340. DOI: 10.3109/10826084.2015.1013130
  • Ambekar A, Rao R, Mishra AK, Agrawal A. Types of Opioids injected – Does it matter? A multi-centric cross-sectional study of people who inject drugs. Drug and Alcohol Review, 2015, 34: 97-104
  • Ambekar A, Rao R, Pun A, Kumar MS, Kishore K. The trajectory of methadone maintenance treatment in Nepal. International Journal of Drug Policy, 2013. DOI: 10.1016/j.drugpo.2013.06.001
  • Ambekar A, Rao R, Agrawal A. India’s National Narcotic Drugs and Psychotropic Substances Policy, 2012: A 20th century document in 21st Century. International Journal of Drug Policy, 2013;24:374-75
  • Rao R, Agrawal A, Kishore K, Ambekar A. Delivery models of opioid agonist maintenance treatment in South Asia: A good beginning. Bull World Health Organ 2013;91:150–153. doi:10.2471/BLT.12.111815
  • Chengappa M, Rao R, Kumar MS. The development of Methadone Maintenance Treatment in the Maldives. International Journal of Drug Policy, 2013;24(2):164-65 .
  • Rao R, Ambekar A, Yadav S, Sethi H, Dhawan A. Slow release morphine as a maintenance agent in opioid dependence syndrome: an exploratory study from India. Journal of Substance Use 2012,17(3):294-300
Dr. Yatan Pal Singh Balhara

Dr.
Yatan Pal Singh Balhara

Male

MD, DNB (Psychiatry), MNAMS, Masters in Addiction Studies (King’s College London, UK; University of Adelaide, Australia; Virginia Commonwealth University, USA), International Masters in Mental Health Policy and Services

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
ypsbalhara@gmail.com
Phone :
01126593236

General OPD

Thursday

Special Clinic

Tuesday (Dual Diagnosis Clinic)
Friday (Ward Rounds)
Saturday (Behavioral Addictions Clinic & Dual Diagnosis Clinic)

Fields Of Interest

Mental health (including addictive disorders) policy and services; Co-occurring disorders (Interface of psychiatric disorders, medical disorders, Addictive disorders- dual disorders); Behavioral Addictions (Internet addiction, gaming addiction etc.); eHealth

Professional Associations And Recognition  

  • Secretary General, World Association of Dual Disorders (WADD).
  • Elected Member, Advisory Committee of World Association of Dual Disorders (WADD), 2018-2021.
  • Member, Expert group for formulation of cyber safety guidelines for schools by the National Commission for Protection of Child Rights (NCPCR).
  • Member, Expert Working Group for finalising the Advanced Level Universal Treatment Curriculum (UTC) for Substance Use Disorders of the Colombo Plan Drug Advisory Programme (CPDAP), 2017 onwards.
  • Member, Advisory Board, the Southeast Asia - HIV Addiction Technology Transfer Center (SEA-HATTC).
  • Member, Awards Committee, College on Problems of Drug Dependence (CPDD), USA.
  • Member, Advisory Panel on Cyber Awareness Ambassador Program, South- East District, Delhi Police, India, 2017 onwards.
  • Global Master Trainer, UNODC on Drug Demand Reduction, 2019 onward.
  • Global Master Trainer, The Colombo Plan on Drug Demand Reduction, 2015 onward.
  • Nominated as Zonal Representative of World Association of Dual Disorders (WADD), 2015 onwards.
  • Member, Addiction Psychiatry Section of World Psychiatric Association (WPA), 2011 onwards.
  • Member, Dual Disorder/ Pathology Section of World Psychiatric Association (WPA), 2014 onwards.
  • Elected Member, Education Core Committee of World Psychiatric Association (WPA), 2014- onwards.
  • Nominated Member, Specialty sub-group Psychiatry, Task force for development of standard treatment guidelines for India, Ministry of Health and Family Welfare, Government of India, 2015 onwards.
  • Member, Addiction psychiatry Section of Indian Psychiatric Society (IPS), 2015 onwards.
  • Member, Education Committee of the International Society for Bipolar Disorders (ISBD), 2011 onwards.
  • Certified Trainer, WHO ASSIST, WHO.
  • Trainer, The Colombo Plan International Centre for Credentialing and Education of Addiction Professionals (ICCE)
  • Member, Editorial Board, Current Psychiatry Reviews, 2019 onwards.
  • Associate Editor, International Journal of Mental Health and Addiction. 2016-2017.
  • Member, Editorial Board, Journal of Addiction Medicine-The official journal of the American Society of Addiction Medicine.
  • Member, Editorial Board, Academic Psychiatry-The Official Journal of the American Association of Chairs of Departments of Psychiatry; American Association of Directors of Psychiatric Residency Training; Association for Academic Psychiatry
  • Section Editor, Substance Abuse and Addiction, ASEAN Journal of Psychiatry- The official journal of the ASEAN Federation of Psychiatry and Mental Health (AFPMH)
  • Member, Editorial Board, Journal of Social Health in Diabetes (JoSH)
  • Section Editor (Psychiatry), The Journal of Medical Nutrition and Nutraceuticals (JMNN)
  • Global Mental Health Scholar, Columbia University, USA.
  • Collaborative Member, Gulbenkian Global Mental Health Platform- a collaborative effort by Calouste Gulbenkian Foundation, Department of Mental Health of the Faculty of Medical Sciences (NOVA University of Lisbon), and World Health Organization (WHO)
  • Elected Member, Board of Councilors of International Society for Bipolar Disorders (ISBD)
  • Elected Member Representative, Early Career Psychiatrist Council (ECPC) of World Psychiatric Association (WPA) (2011-2014)
  • Awarded fellowship to the Global mHealth Research Training Institute organized by Fogarty's Center for Global Health Studies (CGHS) from June 6- 9, 2016 at the U.S. National Institutes of Health's main campus in Bethesda, Maryland, USA.
  • Awarded the Young Psychiatrist Award of the Indian Psychiatric Society, 2016.
  • Awarded the Bhagwat Award of the Indian Psychiatric Society for best research paper, 2016.
  • Awarded the fellowship by Faculty of Medical Sciences (Faculdade de Ciencias Medicas) of the New Lisbon University (Universidade Nova de Lisboa) and Department of Mental Health and Substance Abuse of World Health Organisation (WHO) in the year 2009 towards the IMMHPS.
  • Awarded International Scholars in Addiction Studies (ISAS) award for 2009 byUniversity of Adelaide, Australia; Virginia Commonwealth University, USA & King’s College, London.
  • Awarded VIDYA SAGAR GOLD medal award for performance during postgraduation (MD) in Psychiatry at AIIMS, New Delhi

Technical Expert/ Consultancy 

  • Establishment of regional resource hub for the South East Asian region on behavioral addictions (BehavioR) for World Health Organization (WHO) SEARO.
  • Technical Reviewer. Resources on adolescent substance misuse to be used for the training of the state master trainers under the Rashtriya Kishor Swasthya Karyakram (RKSK) for Ministry of Health and Family Welfare, Government of India.
  • Regional Expert during the Regional Technical Consultation (Virtual) with Member States on the Working Document for Development of the Action Plan (2022-2030) to implement the Global Strategy to Reduce the Harmful Use of Alcohol organized by the World Health Organization Regional office for South East Asia (WHO SEAR).
  • Technical Expert. Focused Group Discussion (FGD) to formulate Regional Media Guidelines for Reporting of Suicide for the WHO Regional Office for South East Asia organised by the WHO SEAR.
  • Technical Reviewer. Advisory on managing drug and alcohol withdrawal in the context of Lockdown as a response to COVID-19 Pandemic. Developed by National Health Mission (NHM), Ministry of Health and Family Welfare, Government of India.
  • Technical Reviewer. Standard Treatment Guidelines for the Management of Substance Use Disorders & Behavioural Addictions, 2020. Developed by Ministry of Health and Family Welfare, Government of India.
  • Drug Research Consultant to provide technical assistance to research agency on assessment of evidence based drug treatment approaches in drug treatment facilities in cross border locations of South Asia for the project XSAJ81 (Component: Strengthening cross-border and community responses to illicit drugs in south Asia) for United Nations Office on Drugs and Crime.
  • To review the national policies on narcotic drugs and psychotropic substances across WHO South-East Asia Region for World Health Organization (WHO) SEARO.
  • To develop WHO South-East Asia Regional collaborative framework for a coordinated response to MHPSS in emergencies for World Health Organization (WHO) SEARO.
  • To develop recommendations on identification and management of behavioural addictions for World Health Organization (WHO) SEARO.
  • A situation analysis of the status of policy, plans and programme for addressing depressive disorders among persons with physical Non-Communicable Diseases (NCDs) and substance use disorders across the WHO South East Asian Region (SEAR) fro World Health Organization (WHO) SEARO.
  • Development of recommendations for screening and management of depressive disorders and substance use disorders co-occurring with diabetes mellitus in South East Asia Region (SEAR) for World Health Organization (WHO) SEARO.
  • Review of Secondary and Tertiary Prevention Strategies for Illicit Substance Use Disorders for World Health Organization (WHO) SEARO.
  • Development of Modules for the Online Portal for Management of Problematic Alcohol Use (Phase I) for World Health Organization (WHO) SEARO.
  • Development of Guidelines on Field Operations for Delivery of Immediate Mental Health and Psychosocial Care in Disaster Settings for World Health Organization (WHO) SEARO.
  • A review of literature on drink driving related morbidity and mortality in South East Asian Region (SEAR) for World Health Organization (WHO) SEARO.
  • First suicide prevention action plan for Bhutan titled “Suicide Prevention in Bhutan: A three year action plan for the Ministry of health, Government of Bhutan.
  • Development of guidelines on Identification and management of psychosocial distress for disaster management personnel for World Health Organization (WHO) SEARO
  • To review primary prevention strategies for prevention of substance use disorders for World Health Organization (WHO) SEARO.
  • Operationalization and costing of the Mental Health Strategic Plan for Maldives for World Health Organization (WHO) SEARO.
  • Technical review of the Interpersonal Psychotherapy for Groups (IPT-G) developed by WHO, Geneva for World Health Organization (WHO) SEARO.
  • Member, Expert Committee for Regional Suicide Prevention Strategy of World Health Organisation- South East Asia Regional office (WHO- SEARO).
  • Member, Expert Committee for Regional Strategy on Autism Spectrum Disorders of World Health Organisation- South East Asia Regional office (WHO- SEARO).
  • Contributed to the "WHO Global Survey on Alcohol and Health-2015" for World Health Organization.
  • Technical review of the 2010 mhGAP guideline for World Health Organization-South East Asia Regional office (WHO- SEARO).
  • Technical review of the WHO 2015 Global Alcohol Policy Questionnaire for World Health Organization-South East Asia Regional office (WHO- SEARO).
  • Technical review of the Global Information System on Alcohol and Health (GISAH) User Evaluation Questionnaire for the World Health Organization-South East Asia Regional office (WHO- SEARO).
  • Technical review of the first suicide prevention action plan for Bhutan titled “Suicide Prevention in Bhutan: A three year action plan (July 2015-June 2018)” for the Ministry of health, Government of Bhutan.
  • Technical resource person and Mental Health Expert for National Disaster Response Force (NDRF), 2014 onwards.- carried out screening, assessment and intervention sessions for the NDRF personnel.
  • Background note on Internet Addiction: Public Health Implications in Indian Context and Way Forward for World Health Organization (WHO), Geneva.
  • Development of minimum standards of care for Psychiatric establishments in India for Director General of Health Sciences (DGHS), Minsitry of Health and Family Welfare, Government of India

Research Projects

  • Development and validation of an Indian Instrument to assess severity of Nomophobia. Principle Investigator. Funding Agency- Socio-Behavioural & Health Systems Research (SBHSR) Division, Indian Council of Medical Research (ICMR)
  • ‘MANAS-UTKALAN’: Mental ANdAddictive and Sleep disorders - prevention, early detection and Treatment in the state of UTtaraKhAnd under Leadership of AIIMS-Rishikesh and NIMHANS). Funding Agency- Department of Health, Government of Uttarakhand, India.
  • Setting up of a TeleMedicine and online resource hub on mental health and addictive disorders for South East Asia. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Development of module on prevention of substance use and addiction among students for the teachers from the state of Chhattisgarh. Funding Agency- Department of Health, Government of Chhattisgarh, India.
  • Leveraging Digital Technology for Health Care Delivery: A randomised controlled trial to assess effectiveness of an e- Health intervention to manage gaming disorder. Funding Agency- Indian Council of Medical Research (ICMR).
  • Information, Education, Communication (IEC) material on screen time and gaming behaviour in context of the COVID- 19 for the WHO South East Asia Region. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Setting up of an online learning portal on alcohol use disorders- AlcOL (Alcohol use disorders Online Learning). Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Recommendations on addressing mental health needs of the persons engaged in care delivery in wake of COVID-19. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Use of online web-based applications as a platform to strengthen the services for management of addictive disorders in the state of Odisha. Funding Agency- Department of Health, Government of Odisha.
  • Review of Mental Health Services in Sri Lanka. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Development of National Suicide Prevention Strategy for the Maldives. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Assessment of bone health in transgender population of India. Funding Agency- Indian Council of Medical Research (ICMR).
  • To review the national policies on narcotic drugs and psychotropic substances across WHO South-East Asia Region. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • To develop WHO South-East Asia Regional collaborative framework for a coordinated response to MHPSS in emergencies. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • To develop recommendations on identification and management of behavioral addictions. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Brain stimulation as a novel technique for cognitive dysfunction and craving management to enhance treatment outcome in patients with alcohol dependence: A prospective, randomized controlled trial. Funding agency- Department of Science & Technology (DST), Government of India.
  • Development of Cognitive Retraining Module for Improving Cognitive Deficits of Abstinent Patients with Alcohol Dependence Syndrome, Cannabis Dependence Syndrome and Opioid Dependence Syndrome in a Tertiary Care De-Addiction Centre of Northern India. Funding agency- Department of Science & Technology (DST), Government of India.
  • An exploratory case- control study to assess the protective genetic factors against alcoholic liver disease among population from northern part of India. Funding Agency- AIIMS, New Delhi.
  • Bone mineral density and chronic alcoholism and changes following disulfiram deaddiction therapy. Funding agency- Department of Bio- Technology (DBT), Ministry of Science and Technology, Government of India.
  • Relationship of serotonin pathway polymorphisms with self-harm behaviour among patients with opioid dependence. Funding Agency- DST.
  • A comparative study of status of reproductive and sexual health and prevalence of sexual dysfunction among young individuals with mental and substance use disorder related disability. Funding Agency- Indian Council of Medical Research (ICMR).
  • Strengthening cross-border and community responses to illicit drugs in south Asia (XSAJ81). Funding Agency- United Nations Office on Drugs and Crime (UNODC).
  • A situation analysis of the status of policy, plans and programme for addressing depressive disorders among persons with physical Non-Communicable Diseases (NCDs) and substance use disorders across the WHO South East Asian Region (SEAR). Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Development of recommendations for screening and management of depressive disorders and substance use disorders co-occurring with diabetes mellitus in South East Asia Region (SEAR). Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Review of Secondary and Tertiary Prevention Strategies for Illicit Substance Use Disorders. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Development of Modules for the Online Portal for Management of Problematic Alcohol Use (Phase I). Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Development of Guidelines on Field Operations for Delivery of Immediate Mental Health and Psychosocial Care in Disaster Settings. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • A review of literature on drink driving related morbidity and mortality in South East Asian Region (SEAR). Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • Development of guidelines on Identification and management of psychosocial distress for disaster management personnel. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • To review primary prevention strategies for prevention of substance use disorders. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • To assess burden and socio-economic cost attributable to alcohol use among individuals seeking treatment at a de-addiction centre. Funding Agency- World Health Organisation- South East Asia Regional Office (WHO- SEARO).
  • To identify mental health issues and provide help to the professionals engaged in disaster management to improve their mental health. Funding Agency- World Health Organisation- South East Asia Regional office (WHO- SEARO).
  • A cross-sectional study evaluating the socio-demographic and psychosocial profile and motivations for use for individuals with prescription opioid abuse. Funding Agency- Indian Council of Medical Research (ICMR).
  • A comparative study of prevalence of metabolic syndrome among patients with Opioid and Alcohol Dependence Syndrome. Funding Agency- AIIMS, New Delhi.
  • Translation, Validation of AUDIT and Brief Intervention Module for Alcohol and Substance Use Disorders. Funding Agency- WHO-SEARO.
  • Training of medical officers across all districts in India on Substance Use Disorders as part of NFCDA funded trainings. Funding Agency- Department of Revenue, Ministry of Finance, Govt of India.
  • Curriculum Development for Preventive Psychiatry: Global Survey of Current Medical School Curricula. Sponsors- Section of Preventive Psychiatry and Section of Education in Psychiatry, World Psychiatric Association (WPA).
  • Development of a Web Portal for Problem Drinking. Funding Agency- WHO, Geneva.
  • Exploring existence of New Type Depression/Hikikomori (NTD/HI) in countries beyond Japan. Funding Agency- World Psychiatric Association (WPA).

Publications 

Total number of publications: 350  

  • Balhara, Y. P. S. (2006). References: Far from uniformity. Indian Journal of Medical Sciences, 60(6), 249–250./li>
  • Balhara, Y. P. S. (2011a). Culture-bound Syndrome: Has it Found its Right Niche? Indian Journal of Psychological Medicine, 33(2), 210–215. https://doi.org/10.4103/0253-7176.92055
  • Balhara, Y. P. S. (2011b). Diabetes and psychiatric disorders. Indian Journal of Endocrinology and Metabolism, 15(4), 274–283. https://doi.org/10.4103/2230-8210.85579
  • Balhara, Y. P. S. (2011c). Publication: An essential step in research. Lung India : Official Organ of Indian Chest Society, 28(4), 324–325. https://doi.org/10.4103/0970-2113.85752
  • Balhara, Y. P. S. (2012a). Post-publication review: Will it hold its ground? Lung India : Official Organ of Indian Chest Society, 29(1), 94. https://doi.org/10.4103/0970-2113.92383
  • Balhara, Y. P. S. (2012b). Tobacco and metabolic syndrome. Indian Journal of Endocrinology and Metabolism, 16(1), 81–87. https://doi.org/10.4103/2230-8210.91197
  • Balhara, Y. P. S. (2012c). Indexed journal: What does it mean? Lung India : Official Organ of Indian Chest Society, 29(2), 193. https://doi.org/10.4103/0970-2113.95345
  • Balhara, Y. P. S. (2013a). [Prevention of schizophrenia: A review]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 24(2), 130–139.
  • Balhara, Y. P. S. (2013b). Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines. Journal of Opioid Management, 9(4), 237.
  • Balhara, Y. P. S. (2013c). A curious case of the World Health Organization’s (WHO) approach on alcohol use disorders—Inferences from the WHO list of essential drugs. Addiction (Abingdon, England), 108(11), 2030. https://doi.org/10.1111/add.12312
  • Balhara, Y. P. S. (2014a). Dextropropoxyphene ban in India: Is there a case for reconsideration? Journal of Pharmacology & Pharmacotherapeutics, 5(1), 8–11. https://doi.org/10.4103/0976-500X.124406
  • Balhara, Y. P. S. (2014b). A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center. Journal of Opioid Management, 10(3), 200–206. https://doi.org/10.5055/jom.2014.0208
  • Balhara, Y. P. S. (2018). Behavioural addictions: Need to correct misnomers. Asian Journal of Psychiatry, 36, 118. https://doi.org/10.1016/j.ajp.2018.07.014
  • Balhara, Y. P. S. (2022). Does the gaming disorder as listed in ICD-11 include “the observers”? Asian Journal of Psychiatry, 80, 103365. https://doi.org/10.1016/j.ajp.2022.103365
  • Balhara, Y. P. S., & Anwar, N. (2019). BehavioR: a digital platform for prevention and management of behavioural addictions. WHO South-East Asia Journal of Public Health, 8(2), 101–103. https://doi.org/10.4103/2224-3151.264854
  • Balhara, Y. P. S., Bhargava, R., Pakhre, A., & Bhati, N. (2018). The “Blue Whale Challenge”?: The first report on a consultation from a health care setting for carrying out “tasks” accessed through a mobile phone application. Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists, 10(3), e12317. https://doi.org/10.1111/appy.12317
  • Balhara, Y. P. S., & Chandiok, K. (2020). Can #PlayOurpartTogether help prevent miscommunication? Asian Journal of Psychiatry, 52, 102123. https://doi.org/10.1016/j.ajp.2020.102123
  • Balhara, Y. P. S., Chattopadhyay, A., & Sarkar, S. (2022). The “Hidden Story” about Change in Alcohol Use in India over the Past Two Decades: Insights from a Secondary Analysis of Data from the National Family Health Survey. Indian Journal of Psychological Medicine, 44(3), 234–238. https://doi.org/10.1177/02537176211033004
  • Balhara, Y. P. S., Chawla, J. M., & Sagar, R. (2009). Olanzapine induced tardive dystonia in case of adolescent bipolar disorder. Journal of Pediatric Neurosciences, 4(1), 30–32. https://doi.org/10.4103/1817-1745.49105
  • Balhara, Y. P. S., Dahiya, N., Varshney, M., Garg, S., & Bhargava, R. (2018). Awareness, Self-Assessment and Help Seeking Behavior for Behavioral Addictions Related to Use of Mobile Technology Among Attendees of a Health Camp. The Journal of the Association of Physicians of India, 66(1), 45–48.
  • Balhara, Y. P. S., & Dayal, P. (2016). Development of Hindi Version of Alcohol Use Disorder Identification Test (AUDIT): An Update. Indian Journal of Psychological Medicine, 38(1), 85–86. https://doi.org/10.4103/0253-7176.175138
  • Balhara, Y. P. S., & Deb, K. S. (2013). Impact of alcohol use on thyroid function. Indian Journal of Endocrinology and Metabolism, 17(4), 580–587. https://doi.org/10.4103/2230-8210.113724
  • Balhara, Y. P. S., Garg, H., Kumar, S., & Bhargava, R. (2018). Gaming disorder as a consequence of attempt at self- medication: Empirical support to the hypothesis. Asian Journal of Psychiatry, 31, 98–99. https://doi.org/10.1016/j.ajp.2018.02.013
  • Balhara, Y. P. S., Gauba, D., & Deshpande, S. N. (2011). Profile difference between male and female psychiatric patients seeking certificate of disability. Oman Medical Journal, 26(6), 410–415. https://doi.org/10.5001/omj.2011.105
  • Balhara, Y. P. S., & Goyal, R. (2011). Culture bound syndromes: Need to relook, relabel and include? Asian Journal of Psychiatry, 4(1), 75. https://doi.org/10.1016/j.ajp.2011.01.007
  • Balhara, Y. P. S., & Goyal, R. (2012). An unusual presentation of dhat syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences, 24(3), E19-20. https://doi.org/10.1176/appi.neuropsych.11070153
  • Balhara, Y. P. S., Gupta, P., & Elwadhi, D. (2017). Co-occurring depression and alcohol-use disorders in South-East Asia: A narrative review. WHO South-East Asia Journal of Public Health, 6(1), 50–59. https://doi.org/10.4103/2224-3151.206166
  • Balhara, Y. P. S., & Gupta, R. (2015). Revised Size of Pictorial Warning on Cigarette Packages-A Step in Right Direction. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, 17(11), 1401–1402. https://doi.org/10.1093/ntr/ntv023
  • Balhara, Y. P. S., Gupta, R., Atilola, O., Knez, R., Mohorović, T., Gajdhar, W., Javed, A. O., & Lal, R. (2015). Problematic Internet Use and Its Correlates Among Students from Three Medical Schools Across Three Countries. Academic Psychiatry : The Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 39(6), 634–638. https://doi.org/10.1007/s40596-015-0379-9
  • Balhara, Y. P. S., Harshwardhan, M., Kumar, R., & Singh, S. (2018). Extent and pattern of problematic internet use among school students from Delhi: Findings from the cyber awareness programme. Asian Journal of Psychiatry, 34, 38–42. https://doi.org/10.1016/j.ajp.2018.04.010
  • Balhara, Y. P. S., & Jain, R. (2012a). A urinalysis-based study of buprenorphine and non-prescription opioid use among patients on buprenorphine maintenance. Journal of Pharmacology & Pharmacotherapeutics, 3(1), 15–19. https://doi.org/10.4103/0976-500X.92496
  • Balhara, Y. P. S., & Jain, R. (2012b). Urinalysis-based comparative evaluation of pattern of use of dextropropoxyphene and buprenorphine among opioid-dependent subjects. Journal of Opioid Management, 8(1), 45–49.
  • Balhara, Y. P. S., & Jain, R. (2013). A receiver operated curve-based evaluation of change in sensitivity and specificity of cotinine urinalysis for detecting active tobacco use. Journal of Cancer Research and Therapeutics, 9(1), 84–89. https://doi.org/10.4103/0973-1482.110384
  • Balhara, Y. P. S., & Jain, R. (2014). Cannabis use among opioid-dependent individuals on opioid substitution therapy. Journal of Pharmacology & Pharmacotherapeutics, 5(3), 203–205. https://doi.org/10.4103/0976-500X.136106
  • Balhara, Y. P. S., Jain, R., Sundar, A. S., & Sagar, R. (2012). Use of cotinine urinalysis to verify self-reported tobacco use among male psychiatric out-patients. Lung India : Official Organ of Indian Chest Society, 29(3), 217–220. https://doi.org/10.4103/0970-2113.99102
  • Balhara, Y. P. S., Jain, R., Sundar, S. A., & Sagar, R. (2011). A comparative study of reliability of self report of tobacco use among patients with bipolar and somatoform disorders. Journal of Pharmacology & Pharmacotherapeutics, 2(3), 174–178. https://doi.org/10.4103/0976-500X.83282
  • Balhara, Y. P. S., & Kalra, S. (2017). Indian and American Guidance on Psychosocial Care of Persons with Diabetes. Indian Journal of Endocrinology and Metabolism, 21(3), 486–487. https://doi.org/10.4103/ijem.IJEM_545_16
  • Balhara, Y. P. S., Kalra, S., Bajaj, S., Kuppili, P. P., Himanshu, D., Atam, V., Usman, K., Singh, V., Chaudhary, S. C., Chakravorty, S., Wakhlu, A., Fatma, J., Tandon, S., Maheshwari, A., Gupta, A., Parvez, A., Chakravarty, J., Chaudhary, R. R., Singh, A. K., … Agarwal, S. (2017). Uttar Pradesh Association of Physicians of India Position Statement: Tobacco Use and Metabolic Syndrome. The Journal of the Association of Physicians of India, 65(12), 66–72
  • Balhara, Y. P. S., Kalra, S., Bajaj, S., Kuppili, P. P., Himanshu, D., Atam, V., Usman, K., Singh, V., Usman, K., Singh, V., Chaudhary, S. C., Chakravorty, S., Wakhlu, A., Fatma, J., Tandon, S., Maheshwari, A., Gupta, A., Parvez, A., Chakravarty, J., … Agarwal, S. (2018). Uttar Pradesh Association of Physicians of India Position Statement: Betel Quid (Paan) and Diabetes. The Journal of the Association of Physicians of India, 66(12), 11–12
  • Balhara, Y. P. S., Kalra, S., Kuppili, P. P., Kalaiselvan, V., Unnikrishnan, A. G., Tiwaskar, M., Sharma, P. K., Sahay, M., Sahay, R., Saboo, B., Nadkar, M. Y., Muruganathan, A., Khandelwal, D., Jeloka, T., Ghosh, S., Dhorepatil, B., Dhamija, P., Das, A. K., Bantwal, G., & Badani, R. (2017). Indian College of Physicians Position Statement: Addictive Disorders Among Persons with Diabetes Mellitus. The Journal of the Association of Physicians of India, 65(12), 11–12
  • Balhara, Y. P. S., Kattula, D., Singh, S., Chukkali, S., & Bhargava, R. (2020). Impact of lockdown following COVID-19 on the gaming behavior of college students. Indian Journal of Public Health, 64(Supplement), S172–S176. https://doi.org/10.4103/ijph.IJPH_465_20
  • Balhara, Y. P. S., Kumar, S., Singh, S., Singh, K., & Rajkumar, S. (2021). Challenges with use of internet use duration criteria as a marker of problematic internet use: Observations based on the receiver-operator curve-based analysis of data from the students. Asian Journal of Psychiatry, 64, 102770. https://doi.org/10.1016/j.ajp.2021.102770
  • Balhara, Y. P. S., Kuppili, P. P., & Gupta, R. (2017). Neurobiology of Comorbid Substance Use Disorders and Psychiatric Disorders: Current State of Evidence. Journal of Addictions Nursing, 28(1), 11–26. https://doi.org/10.1097/JAN.0000000000000155
  • Balhara, Y. P. S., Lev-Ran, S., Martínez-Raga, J., Benyamina, A., Singh, S., Blecha, L., & Szerman, N. (2016). State of Training, Clinical Services, and Research on Dual Disorders Across France, India, Israel, and Spain. Journal of Dual Diagnosis, 12(3–4), 252–260. https://doi.org/10.1080/15504263.2016.1254309
  • Balhara, Y. P. S., Mahapatra, A., Sharma, P., & Bhargava, R. (2018). Problematic internet use among students in South-East Asia: Current state of evidence. Indian Journal of Public Health, 62(3), 197–210. https://doi.org/10.4103/ijph.IJPH_288_17
  • Balhara, Y. P. S., & Mathur, S. (2009). Addiction versus dependence: Carrying the debate forward. Journal of Opioid Management, 5(4), 187. https://doi.org/10.5055/jom.2009.0019
  • Balhara, Y. P. S., & Mathur, S. (2012). ECT prohibition for children and adolescents in Mental Health Care Act of India: A step in the right direction??? The Journal of ECT, 28(1), 1–2. https://doi.org/10.1097/YCT.0b013e3182496014
  • Balhara, Y. P. S., & Mathur, S. (2013). A comparative study of attitudes toward psychiatry among nursing students across successive training years. Indian Journal of Psychological Medicine, 35(2), 159–166. https://doi.org/10.4103/0253-7176.116246
  • Balhara, Y. P. S., & Mathur, S. (2014). Bhang—Beyond the purview of the narcotic drugs and psychotropic substances act. Lung India : Official Organ of Indian Chest Society, 31(4), 431–432. https://doi.org/10.4103/0970-2113.142109
  • Balhara, Y. P. S., Mathur, S., & Anand, N. (2012). A Study of Attitude and Knowledge of the Psychiatry Resident Doctors toward Clinician-Pharmaceutical Industry Interaction. Indian Journal of Psychological Medicine, 34(1), 61–65. https://doi.org/10.4103/0253-7176.96162
  • Balhara, Y. P. S., Mathur, S., & Kataria, D. K. (2012). Body shape and eating attitudes among female nursing students in India. East Asian Archives of Psychiatry : Official Journal of the Hong Kong College of Psychiatrists = Dong Ya Jing Shen Ke Xue Zhi : Xianggang Jing Shen Ke Yi Xue Yuan Qi Kan, 22(2), 70–74.
  • Balhara, Y. P. S., & Mishra, A. (2015). A study exploring attributes and nature of the retracted literature on mental disorders. Indian Journal of Medical Ethics, 12(1), 30–37. https://doi.org/10.20529/IJME.2015.007
  • Balhara, Y. P. S., Mishra, A., Sethi, H., & Ray, R. (2013). A retrospective chart review of treatment seeking middle aged individuals at a tertiary care substance use disorder treatment centre in North Part of India over five successive years: Findings from drug abuse monitoring system. TheScientificWorldJournal, 2013, 316372. https://doi.org/10.1155/2013/316372
  • Balhara, Y. P. S., Mishra, A., Sethi, H., Singh, S., & Khandelwal, S. K. (2016). Time Trends of Cannabis Use Among Treatment-seeking Individuals at Government De-addiction Centers Across India Over a Period of 7 Years. Indian Journal of Psychological Medicine, 38(4), 331–335. https://doi.org/10.4103/0253-7176.185961
  • Balhara, Y. P. S., Narang, P., Saha, S., Kandasamy, D., Chattopadhyay, N., & Goswami, R. (2022). Bone Mineral Density, Bone Microarchitecture and Vertebral Fractures in Male Patients with Alcohol Use Disorders. Alcohol and Alcoholism (Oxford, Oxfordshire), 57(5), 552–558. https://doi.org/10.1093/alcalc/agab084
  • Balhara, Y. P. S., Parmar, A., Modak, T., & Vikram, V. (2022). From “Bhang Shops” to “Cannabis in Coffee Shops”: Time to Debate the Option? Indian Journal of Psychological Medicine, 44(3), 285–289. https://doi.org/10.1177/0253717620957501
  • Balhara, Y. P. S., Parmar, A., & Sarkar, S. (2018). Use of Tramadol for Management of Opioid Use Disorders: Rationale and Recommendations. Journal of Neurosciences in Rural Practice, 9(3), 397–403. https://doi.org/10.4103/jnrp.jnrp_42_18
  • Balhara, Y. P. S., Ranjan, R., Dhawan, A., & Yadav, D. (2014). Experiences from a community based substance use treatment centre in an urban resettlement colony in India. Journal of Addiction, 2014, 982028. https://doi.org/10.1155/2014/982028
  • Balhara, Y. P. S., & Sagar, R. (2011). Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian Journal of Endocrinology and Metabolism, 15(Suppl 1), S50-54. https://doi.org/10.4103/2230-8210.83057
  • Balhara, Y. P. S., Sarkar, S., & Gupta, R. (2015). Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Endocrinology and Metabolism, 19(4), 451–461. https://doi.org/10.4103/2230-8210.159023
  • Balhara, Y. P. S., Sarkar, S., Laspal, N., Bhargava, R., & Yadav, Z. (2022). A randomized controlled trial to assess effectiveness of GamE- an e-Health intervention to self-manage gaming with an aim to prevent gaming disorder. Asian Journal of Psychiatry, 80, 103389. https://doi.org/10.1016/j.ajp.2022.103389
  • Balhara, Y. P. S., Sharma, P., & Chawla, N. (2021). Education and training on addiction psychiatry in low and middle income countries: Observations from existing literature and recommendations going ahead. Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists, 13(4), e12492. https://doi.org/10.1111/appy.12492
  • Balhara, Y. P. S., Singh, P. K., Sarkar, S., Chattopadhyay, A., & Singh, S. (2022). How and What are Indians Drinking? Findings from the National Family Health Survey. Alcohol and Alcoholism (Oxford, Oxfordshire), 57(6), 674–677. https://doi.org/10.1093/alcalc/agac035
  • Balhara, Y. P. S., Singh, S., & Bhargava, R. (2020). The pattern of problematic internet use and mental health-related internet use among psychiatric outpatients at a tertiary care center. Ci Ji Yi Xue Za Zhi = Tzu-Chi Medical Journal, 32(2), 198–204. https://doi.org/10.4103/tcmj.tcmj_50_19
  • Balhara, Y. P. S., Singh, S., & Kalra, S. (2020). Pragmatic Opioid Use in Painful Diabetic Neuropathy. European Endocrinology, 16(1), 21–24. https://doi.org/10.17925/EE.2020.16.1.21
  • Balhara, Y. P. S., Singh, S., Modak, T., & Sarkar, S. (2017). A Cross-sectional Study to Assess Disability and Its Correlates among Treatment Seeking Individuals with Alcohol Use Disorders. Indian Journal of Psychological Medicine, 39(1), 40–45. https://doi.org/10.4103/0253-7176.198941
  • Balhara, Y. P. S., Singh, S., & Narang, P. (2020). Effect of lockdown following COVID-19 pandemic on alcohol use and help-seeking behavior: Observations and insights from a sample of alcohol use disorder patients under treatment from a tertiary care center. Psychiatry and Clinical Neurosciences, 74(8), 440–441. https://doi.org/10.1111/pcn.13075
  • Balhara, Y. P. S., Singh, S., Saini, R., Dahiya, N., Singh, A. B., & Kumar, R. (2021). Should Internet gaming disorder be considered a subtype of generalized problematic internet use? Findings from a study among medical college students. Perspectives in Psychiatric Care, 57(1), 272–278. https://doi.org/10.1111/ppc.12558
  • Balhara, Y. P. S., Singh, S., Saini, R., Kattula, D., Chukkali, S., & Bhargava, R. (2020). Development and validation of gaming disorder and hazardous gaming scale (GDHGS) based on the WHO framework (ICD-11 criteria) of disordered gaming. Asian Journal of Psychiatry, 54, 102348. https://doi.org/10.1016/j.ajp.2020.102348
  • Balhara, Y. P. S., Singh, S., & Sarkar, S. (2019). Are the Patients Ready for the Change?: An Empirical Study to Evaluate the Impact of Change in Formulation of Buprenorphine-Naloxone on Prescription Pattern, Treatment Adherence, and Patient Satisfaction. Substance Use & Misuse, 54(2), 307–314. https://doi.org/10.1080/10826084.2018.1517799
  • Balhara, Y. P. S., Singh, S., & Yadav, Z. (2022). Media reporting on deaths due to suicide attributed to gaming in digital news: A case of misrepresentation and missed opportunities. Asian Journal of Psychiatry, 68, 102955. https://doi.org/10.1016/j.ajp.2021.102955
  • Balhara, Y. P. S., & Tarwani, J. (2021). Is there a case for inclusion of medicines used to manage alcohol use disorder in the World Health Organization Model List of Essential Medicines? Indian Journal of Psychiatry, 63(3), 297–298. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_305_20
  • Balhara, Y. P. S., Varghese, S. T., & Kayal, M. (2006). Neuroacanthocytosis: Presenting with depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 18(3), 426. https://doi.org/10.1176/jnp.2006.18.3.426
  • Balhara, Y. P. S., Verma, K., & Bhargava, R. (2018). Screen time and screen addiction: Beyond gaming, social media and pornography- A case report. Asian Journal of Psychiatry, 35, 77–78. https://doi.org/10.1016/j.ajp.2018.05.020
  • Balhara, Y. P. S., & Verma, R. (2014). A review of web based interventions for managing tobacco use. Indian Journal of Psychological Medicine, 36(3), 226–235. https://doi.org/10.4103/0253-7176.135367
  • Balhara, Y. P. S., Verma, R., & Deshpande, S. N. (2011). A Comparative Study of Treatment-seeking Inhalant Abusers Across Two Cohorts from a Tertiary Care Center in India. Indian Journal of Psychological Medicine, 33(2), 129–133. https://doi.org/10.4103/0253-7176.92058
  • Balhara, Y. P. S., Verma, R., & Deshpande, S. N. (2013). A study of profile of disability certificate seeking patients with schizophrenia over a 5 year period. Indian Journal of Psychological Medicine, 35(2), 127–134. https://doi.org/10.4103/0253-7176.116235
  • Balhara, Y. P. S., Verma, R., Sharma, S., & Mathur, S. (2012). A study of predictors of anxiety and depression among stroke patient-caregivers. Journal of Mid-Life Health, 3(1), 31–35. https://doi.org/10.4103/0976-7800.98815
  • Balhara, Y. P. S., Yadav, T., Arya, K., Mathur, S., & Kataria, D. K. (2012). A cross-sectional study of body shape and eating attitude among Indian female healthcare students. International Journal of Psychiatry in Medicine, 43(4), 309–323. https://doi.org/10.2190/PM.43.4.b
  • Balhara, Y., Sagar, R., & Varghese, S. T. (2007). Bleeding gums: Duloxetine may be the cause. Journal of Postgraduate Medicine, 53(1), 44–45. https://doi.org/10.4103/0022-3859.30328
  • Balhara, Y., & Verma, R. (2014). A review of web based interventions focusing on alcohol use. Annals of Medical and Health Sciences Research, 4(4), 472–480. https://doi.org/10.4103/2141-9248.139272
  • Balhara, Y., Yadav, T., Mathur, S., & Kataria, D. (2012). The Impact of A “Brief ECT Orientation Module” on The Knowledge and Attitudes of Medical Students Towards ECT in India. Annals of Medical and Health Sciences Research, 2(2), 140–145. https://doi.org/10.4103/2141-9248.105661
  • Behera, C., Gupta, S. K., Singh, S., & Balhara, Y. P. S. (2021). Trends in deaths attributable to suicide during COVID-19 pandemic and its association with alcohol use and mental disorders: Findings from autopsies conducted in two districts of India. Asian Journal of Psychiatry, 58, 102597. https://doi.org/10.1016/j.ajp.2021.102597
  • Bergen, S. E., Balhara, Y. P. S., Christoforou, A., Cole, J., Degenhardt, F., Dempster, E., Fatjó-Vilas, M., Khedr, Y., Lopez, L. M., Lysenko, L., McGrath, L. M., Mühleisen, T. W., Neves, F. S., Nymberg, C., Ozomaro, U., Verweij, K. J. H., Voineskos, A. N., Zai, C. C., O’Shea, A., & DeLisi, L. E. (2011). Summaries from the XVIII World Congress of Psychiatric Genetics, Athens, Greece, 3-7 October 2010. Psychiatric Genetics, 21(3), 136–172. https://doi.org/10.1097/YPG.0b013e3283469aa9
  • Bhad, R., Gupta, R., & Balhara, Y. P. S. (2020). A study of pathways to care among opioid dependent individuals seeking treatment at a community de-addiction clinic in India. Journal of Ethnicity in Substance Abuse, 19(3), 490–502. https://doi.org/10.1080/15332640.2018.1542528
  • Bhad, R., Lal, R., & Balhara, Y. P. S. (2015). Disorders Related to Use of Psychoactive Substances in DSM-5: Changes and Challenges. Indian Journal of Psychological Medicine, 37(4), 470–472. https://doi.org/10.4103/0253-7176.168613
  • Bhutani, J., Bhutani, S., Balhara, Y. P. S., & Kalra, S. (2012). Compassion fatigue and burnout amongst clinicians: A medical exploratory study. Indian Journal of Psychological Medicine, 34(4), 332–337 https://doi.org/10.4103/0253-7176.108206
  • Anwar, N., Kuppili, P. P., & Balhara, Y. P. S. (2017). Depression and physical noncommunicable diseases: The need for an integrated approach. WHO South-East Asia Journal of Public Health, 6(1), 12–17. https://doi.org/10.4103/2224-3151.206158
  • Atilola, O., Stevanovic, D., Balhara, Y. P. S., Avicenna, M., Kandemir, H., Knez, R., Petrov, P., Franic, T., & Vostanis, P. (2014). Role of personal and family factors in alcohol and substance use among adolescents: An international study with focus on developing countries. Journal of Psychiatric and Mental Health Nursing, 21(7), 609–617. https://doi.org/10.1111/jpm.12133
  • Bagheri, Z., Chamanpara, P., Jafari, P., Balhara, Y. P. S., Arya, S., Ransing, R., Đorić, A., Knez, R., Thi, T.-V. V., Huong, T. N., Kafali, H. Y., Erzin, G., Vally, Z., Chowdhury, M. R. R., Sharma, P., Shakya, R., Campos, L. A. M., Szczegielniak, A. R., & Stevanović, D. (2022). Cross-cultural measurement invariance of the Quality of Life Enjoyment and Satisfaction Questionnaire-Short form across ten countries: The application of Bayesian approximate measurement invariance. BMC Psychology, 10(1), 160. https://doi.org/10.1186/s40359-022-00864-y
  • Chawla, J. M., Balhara, Y. P. S., Mohan, I., & Sagar, R. (2006). Chronic mania: An unexpectidly long episode? Indian Journal of Medical Sciences, 60(5), 199–201.
  • Chawla, J. M., Balhara, Y. P. S., Sagar, R., & Shivaprakash. (2012). Undergraduate medical students’ attitude toward psychiatry: A cross-sectional study. Indian Journal of Psychiatry, 54(1), 37–40. https://doi.org/10.4103/0019-5545.94643
  • Chawla, J. M., Pal, H., Lal, R., Jain, R., Schooler, N., & Balhara, Y. P. S. (2013). Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects. Journal of Opioid Management, 9(1), 35–41. https://doi.org/10.5055/jom.2013.0145
  • Chawla, N., Gyawali, S., Sharma, P., & Balhara, Y. P. S. (2022). Internet-Based Learning for Professionals in Addiction Psychiatry: A Scoping Review. Indian Journal of Psychological Medicine, 44(4), 325–331. https://doi.org/10.1177/02537176221082897
  • Chawla, N., Kumar, S., & Balhara, Y. P. S. (2017). Olanzapine-induced Skin Eruptions. Indian Journal of Psychological Medicine, 39(4), 537–538. https://doi.org/10.4103/0253-7176.211763
  • Choudhary, V., Balhara, Y. P. S., & Lal, R. (2022). How Could I Do Something So Wrong? Restirring concept of Moral Injury & healing within health care context of COVID-19 pandemic. Asian Journal of Psychiatry, 70, 103017. https://doi.org/10.1016/j.ajp.2022.103017
  • Das, N., Narnoli, S., Kaur, A., Sarkar, S., & Balhara, Y. P. S. (2020). Attitude to telemedicine in the times of COVID-19 pandemic: Opinion of medical practitioners from India. Psychiatry and Clinical Neurosciences, 74(10), 560–562. https://doi.org/10.1111/pcn.13109
  • Dayal, P., & Balhara, Y. P. S. (2014). Catatonia as presenting clinical feature of subacute sclerosing panencephalitis. Journal of Pediatric Neurosciences, 9(1), 57–59. https://doi.org/10.4103/1817-1745.131489
  • Dayal, P., & Balhara, Y. P. S. (2016). Profile of female patients seeking in-patient treatment for prescription opioid abuse from a tertiary care drug dependence treatment centre from India. The Indian Journal of Medical Research, 143(1), 95–100. https://doi.org/10.4103/0971-5916.178616
  • Dayal, P., & Balhara, Y. P. S. (2017). A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders. Journal of Substance Abuse Treatment, 80, 1–5. https://doi.org/10.1016/j.jsat.2017.06.004
  • Dayal, P., Sarkar, S., & Balhara, Y. P. S. (2017). Predictors of Inpatient Treatment Completion among Females with Opioid Use Disorder: Findings from a Tertiary Care Drug Dependence Treatment Centre of India. Indian Journal of Psychological Medicine, 39(4), 464–468. https://doi.org/10.4103/0253-7176.211769
  • Deb, K. S., & Balhara, Y. P. S. (2013). Dhat syndrome: A review of the world literature. Indian Journal of Psychological Medicine, 35(4), 326–331. https://doi.org/10.4103/0253-7176.122219
  • Dhamija, P., Kalra, S., Sharma, P. K., Kalaiselvan, V., Muruganathan, A., Balhara, Y. P. S., Badani, R., Bantwal, G., Das, A. K., Dhorepatil, B., Ghosh, S., Jeloka, T., Khandelwal, D., Nadkar, M. Y., Patnaik, K. P., Saboo, B., Sahay, M., Sahay, R., Tiwaskar, M., & Unnikrishnan, A. G. (2017). Indian College of Physicians (ICP) Position Statement on Pharmacovigilance. The Journal of the Association of Physicians of India, 65(3), 63–66.
  • Gauba, D., Thomas, P., Balhara, Y. P. S., & Deshpande, S. N. (2016). Psychiatric Comorbidity and Physical Correlates in Alcohol-dependent Patients. Indian Journal of Psychological Medicine, 38(5), 414–418. https://doi.org/10.4103/0253-7176.191397
  • Ghosh, A., Mahintamani, T., Balhara, Y. P. S., Roub, F. E., Basu, D., Bn, S., Mattoo, S. K., Mishra, E., & Sharma, B. (2021). Disulfiram Ethanol Reaction with Alcohol-Based Hand Sanitizer: An Exploratory Study. Alcohol and Alcoholism (Oxford, Oxfordshire), 56(1), 42–46. https://doi.org/10.1093/alcalc/agaa096
  • Giasuddin, N. A., Nahar, J. S., Morshed, N. M., & Balhara, Y. P. S. (2012). Combination of CBT with fluoxetine works better for obsessive-compulsive disorder. Asian Journal of Psychiatry, 5(1), 113. https://doi.org/10.1016/j.ajp.2011.11.013
  • Giasuddin, N. A., Nahar, J. S., Morshed, N. M., Balhara, Y. P. S., & Sobhan, M. A. (2013). Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder. Pakistan Journal of Pharmaceutical Sciences, 26(1), 95–98.
  • Goyal, S., Balhara, Y. P. S., & Khandelwal, S. K. (2012). Revisiting Classification of Eating Disorders-toward Diagnostic and Statistical Manual of Mental Disorders-5 and International Statistical Classification of Diseases and Related Health Problems-11. Indian Journal of Psychological Medicine, 34(3), 290–296. https://doi.org/10.4103/0253-7176.106041
  • Gupta, P., Gupta, R., & Balhara, Y. P. S. (2017). Obsessive-Compulsive Symptoms Associated With Aripiprazole Treatment in Bipolar Disorder: A Case Report. Journal of Clinical Psychopharmacology, 37(1), 108–109. https://doi.org/10.1097/JCP.0000000000000629
  • Gupta, P., Gupta, R., & Balhara, Y. P. S. (2018). Acute-onset Orofacial Dyskinesia with a Single Low Dose of Oral Flupentixol: A Case Report. Indian Journal of Psychological Medicine, 40(2), 189–190. https://doi.org/10.4103/IJPSYM.IJPSYM_170_17
  • Gupta, R., & Balhara, Y. P. S. (2014). Antipsychotic induced chronic recurrent oculogyric crisis in a patient with obsessive compulsive disorder. Psychopharmacology, 231(15), 3065–3066. https://doi.org/10.1007/s00213-014-3638-7
  • Gupta, R., Balhara, Y. P. S., & Sagar, R. (2012). Acute psychosis with a favorable outcome as a complication of central pontine/extrapontine myelinolysis in a middle aged man. Journal of Mid-Life Health, 3(2), 103–105. https://doi.org/10.4103/0976-7800.104475
  • Gupta, R., Narnoli, S., Das, N., Sarkar, S., & Balhara, Y. P. S. (2019). Patterns and predictors of self-harm in patients with substance-use disorder. Indian Journal of Psychiatry, 61(5), 431–438. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_578_18
  • Gupta, R., Sarkar, S., & Balhara, Y. P. S. (2012). Use of a “microecologic technique” to study crime incidents around methadone maintenance treatment centers—A response: The journal publishes both invited and unsolicited letters. Addiction (Abingdon, England), 107(10), 1883. https://doi.org/10.1111/j.1360-0443.2012.03956.x
  • Gupta, S., Bhatia, G., Sarkar, S., Chatterjee, B., Balhara, Y. P. S., & Dhawan, A. (2020). Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence: An exploratory study. Indian Journal of Psychiatry, 62(5), 501–508. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_705_19
  • Gyawali, S., Sarkar, S., Balhara, Y. P. S., Kumar, S., Patil, V., & Singh, S. (2018). Perceived stigma and its correlates among treatment seeking alcohol and opioid users at a tertiary care centre in India. Asian Journal of Psychiatry, 37, 34–37. https://doi.org/10.1016/j.ajp.2018.07.018
  • Hackmann, C., Balhara, Y. P. S., Clayman, K., Nemec, P. B., Notley, C., Pike, K., Reed, G. M., Sharan, P., Rana, M. S., Silver, J., Swarbrick, M., Wilson, J., Zeilig, H., & Shakespeare, T. (2019). Perspectives on ICD-11 to understand and improve mental health diagnosis using expertise by experience (INCLUDE Study): An international qualitative study. The Lancet. Psychiatry, 6(9), 778–785. https://doi.org/10.1016/S2215-0366(19)30093-8
  • Hossain, M. S., Irfan, M., Balhara, Y. P. S., Giasuddin, N. A., & Sultana, S. N. (2015). A SURVEY OF DEATH ADJUSTMENT IN THE INDIAN SUBCONTINENT. Journal of Ayub Medical College, Abbottabad : JAMC, 27(1), 36–39.
  • Jain, R., & Balhara, Y. P. S. (2008). Neurobiology of cannabis addiction. Indian Journal of Physiology and Pharmacology, 52(3), 217–232.
  • Jain, R., & Balhara, Y. P. S. (2010). Impact of alcohol and substance abuse on adolescent brain: A preclinical perspective. Indian Journal of Physiology and Pharmacology, 54(3), 213–234.
  • Jain, R., Balhara, Y. P. S., Jhanjee, S., & Sethi, H. (2012). Concordance between urinary cotinine levels and self-reported tobacco use among drug-dependent persons: A pilot study. Substance Abuse, 33(2), 99–102. https://doi.org/10.1080/08897077.2011.630947
  • Jain, R., Mukherjee, K., & Balhara, Y. P. S. (2008). The role of NMDA receptor antagonists in nicotine tolerance, sensitization, and physical dependence: A preclinical review. Yonsei Medical Journal, 49(2), 175–188. https://doi.org/10.3349/ymj.2008.49.2.175
  • Jain, U., Soni, S., Balhara, Y. P. S., Khanuja, M., & Chauhan, N. (2020). Dual-Layered Nanomaterial-Based Molecular Pattering on Polymer Surface Biomimetic Impedimetric Sensing of a Bliss Molecule, Anandamide Neurotransmitter. ACS Omega, 5(19), 10750–10758. https://doi.org/10.1021/acsomega.0c00285
  • Kalra, B., Kalra, S., & Balhara, Y. P. S. (2013). Psychological assessment and management in diabetes. JPMA. The Journal of the Pakistan Medical Association, 63(12), 1555–1557.
  • Kalra, B., Sridhar, G. R., Madhu, K., Balhara, Y. P. S., Sahay, R. K., & Kalra, S. (2013). Psychosocial management of diabetes in pregnancy. Indian Journal of Endocrinology and Metabolism, 17(5), 815–818. https://doi.org/10.4103/2230-8210.117216
  • Kalra, S., & Balhara, Y. P. S. (2014). Euthyroid depression: The role of thyroid hormone. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 8(1), 38–41. https://doi.org/10.2174/1872214807666131229130540
  • Kalra, S., & Balhara, Y. P. S. (2017). Comment on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126-2140. Diabetes Care, 40(9), e126. https://doi.org/10.2337/dc16-2599
  • Kalra, S., Balhara, Y. P. S., Baruah, M. P., Chadha, M., Chandalia, H. B., Chowdhury, S., Kumar, K. M. P., Modi, S., Pitale, S., Shukla, R., Sahay, R., Sundaram, A., Unnikrishnan, A. G., & Wangnoo, S. K. (2012). Forum for injection techniques, India: The first Indian recommendations for best practice in insulin injection technique. Indian Journal of Endocrinology and Metabolism, 16(6), 876–885. https://doi.org/10.4103/2230-8210.102929
  • Kalra, S., Balhara, Y. P. S., & Bathla, M. (2018). Euthymia in Diabetes. European Endocrinology, 14(2), 18–19. https://doi.org/10.17925/EE.2018.14.2.18
  • Kalra, S., Balhara, Y. P. S., & Mithal, A. (2013). Cross-cultural variation in symptom perception of hypoglycemia. Journal of Mid-Life Health, 4(3), 176–181. https://doi.org/10.4103/0976-7800.118998
  • Kalra, S., Balhara, Y. P. S., Sahay, B. K., Ganapathy, B., & Das, A. K. (2013). Why is premixed insulin the preferred insulin? Novel answers to a decade-old question. The Journal of the Association of Physicians of India, 61(1 Suppl), 9–11.
  • Kalra, S., Balhara, Y. P. S., Verma, K., & Kalra, B. (2018). The GlucoCoper—A Tool for the Assessment of Coping Mechanisms. European Endocrinology, 14(1), 52–55. https://doi.org/10.17925/EE.2018.14.1.52
  • Kalra, S., Balhara, Y. P. S., Verma, K., & Unnikrishnan, A. G. (2013). Asian paradox of psychological support: Findings from the second Diabetes Attitudes Wishes and Needs study (DAWN-2). Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists, 5(4), 354–355. https://doi.org/10.1111/appy.12107
  • Kalra, S., Joshi, A., Kalra, B., Shanbhag, V. G., Bhattacharya, R., Verma, K., Baruah, M. P., Sahay, R., Bajaj, S., Agrawal, N., Chakraborty, A., Balhara, Y. P. S., Chaudhary, S., Khandelwal, D., Aggarwal, S., Ram, N., Jacob, J., Julka, S., Priya, G., … Dalal, K. (2017). Bhagavad Gita for the Physician. Indian Journal of Endocrinology and Metabolism, 21(6), 893–897. https://doi.org/10.4103/ijem.IJEM_259_17
  • Kalra, S., Sridhar, G. R., Balhara, Y. P. S., Sahay, R. K., Bantwal, G., Baruah, M. P., John, M., Unnikrishnan, A. G., Madhu, K., Verma, K., Sreedevi, A., Shukla, R., & Prasanna Kumar, K. M. (2013). National recommendations: Psychosocial management of diabetes in India. Indian Journal of Endocrinology and Metabolism, 17(3), 376–395. https://doi.org/10.4103/2230-8210.111608
  • Kalra, S., Verma, K., & Balhara, Y. P. S. (2017). Thyro-stress. Indian Journal of Endocrinology and Metabolism, 21(4), 632–633. https://doi.org/10.4103/ijem.IJEM_136_17
  • Kato, T. A., Balhara, Y. P. S., Chawla, J. M., Tateno, M., & Kanba, S. (2013). Undergraduate medical students’ attitudes towards psychiatry: An international cross-sectional survey between India and Japan. International Review of Psychiatry (Abingdon, England), 25(4), 378–384. https://doi.org/10.3109/09540261.2013.812959
  • Kato, T. A., Shinfuku, N., Fujisawa, D., Tateno, M., Ishida, T., Akiyama, T., Sartorius, N., Teo, A. R., Choi, T. Y., Wand, A. P. F., Balhara, Y. P. S., Chang, J. P.-C., Chang, R. Y.-F., Shadloo, B., Ahmed, H. U., Lerthattasilp, T., Umene-Nakano, W., Horikawa, H., Matsumoto, R., … Kanba, S. (2011). Introducing the concept of modern depression in Japan; an international case vignette survey. Journal of Affective Disorders, 135(1–3), 66–76. https://doi.org/10.1016/j.jad.2011.06.030
  • Kato, T. A., Tateno, M., Shinfuku, N., Fujisawa, D., Teo, A. R., Sartorius, N., Akiyama, T., Ishida, T., Choi, T. Y., Balhara, Y. P. S., Matsumoto, R., Umene-Nakano, W., Fujimura, Y., Wand, A., Chang, J. P.-C., Chang, R. Y.-F., Shadloo, B., Ahmed, H. U., Lerthattasilp, T., & Kanba, S. (2012). Does the “hikikomori” syndrome of social withdrawal exist outside Japan? A preliminary international investigation. Social Psychiatry and Psychiatric Epidemiology, 47(7), 1061–1075. https://doi.org/10.1007/s00127-011-0411-7
  • Kato, T. A., Tateno, M., Umene-Nakano, W., Balhara, Y. P. S., Teo, A. R., Fujisawa, D., Sasaki, R., Ishida, T., & Kanba, S. (2010). Impact of biopsychosocial factors on psychiatric training in Japan and overseas: Are psychiatrists oriented to mind, brain, or sociocultural issues? Psychiatry and Clinical Neurosciences, 64(5), 520–530. https://doi.org/10.1111/j.1440-1819.2010.02133.x
  • Kato, T., Tateno, M., Nakano, W., Balhara, Y. P. S., Teo, R. T., Fujisawa, D., Sasaki, R., & Uchida, M. (2009). [Re-evaluation of the “road to becoming a psychiatrist”—Learning from the interaction with young psychiatrists from overseas]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 111(10), 1226–1233.
  • Kayal, M., Varghese, S. T., & Balhara, Y. P. S. (2006). Psychiatric manifestation of SSPE. The Journal of Neuropsychiatry and Clinical Neurosciences, 18(4), 560. https://doi.org/10.1176/jnp.2006.18.4.560
  • Kogan, C. S., Maj, M., Rebello, T. J., Keeley, J. W., Kulygina, M., Matsumoto, C., Robles, R., Huang, J., Zhong, N., Chakrabarti, S., Figueira, M. L., Stein, D. J., Strakowski, S. M., Garcia-Pacheco, J. A., Burns, S., Montoya, M., Andrade, L., Ayuso-Mateos, J. L., Arango, I., … Reed, G. M. (2021). A global field study of the international classification of diseases (ICD-11) mood disorders clinical descriptions and diagnostic guidelines. Journal of Affective Disorders, 295, 1138–1150. https://doi.org/10.1016/j.jad.2021.08.050
  • Kumar, S., Singh, S., Singh, K., Rajkumar, S., & Balhara, Y. P. S. (2019). Prevalence and pattern of problematic internet use among engineering students from different colleges in India. Indian Journal of Psychiatry, 61(6), 578–583. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_85_19
  • Kumar, V., Garg, R., Bharati, S. J., Gupta, N., Bhatanagar, S., Mishra, S., & Balhara, Y. P. S. (2015). Long-Term High-dose Oral Morphine in Phantom Limb Pain with No Addiction Risk. Indian Journal of Palliative Care, 21(1), 85–87. https://doi.org/10.4103/0973-1075.150198
  • Kuppili, P. P., Parmar, A., Gupta, A., & Balhara, Y. P. S. (2018). Role of Yoga in Management of Substance-use Disorders: A Narrative Review. Journal of Neurosciences in Rural Practice, 9(1), 117–122. https://doi.org/10.4103/jnrp.jnrp_243_17
  • Mahal, P., Nishanth, K. N., Mahapatra, A., Sarkar, S., & Balhara, Y. P. S. (2018). Trihexyphenidyl Misuse in Delusional Disorder. Journal of Neurosciences in Rural Practice, 9(3), 428–430. https://doi.org/10.4103/jnrp.jnrp_569_17
  • Majumder, P., Sarkar, S., Gupta, R., Patra, B. N., & Balhara, Y. P. S. (2016). Predictors of retention in treatment in a tertiary care de-addiction center. Indian Journal of Psychiatry, 58(1), 27–30. https://doi.org/10.4103/0019-5545.174359
  • Mina, S., Verma, R., Balhara, Y. P. S., & Ul-Hasan, S. (2014). Road rage: Prevalence pattern and web based survey feasibility. Psychiatry Journal, 2014, 897493. https://doi.org/10.1155/2014/897493
  • Modak, T., Sarkar, S., & Balhara, Y. P. S. (2021). A review of the evidence to explain pharmacological basis of injection (ab)use of buprenorphine-naloxone tablets. Journal of Opioid Management, 17(7), 141–152. https://doi.org/10.5055/jom.2021.0651
  • Nadkar, M. Y., Tiwaskar, M., Kalra, S., Shah, S. N., Bansode, B. R., Dutta, A., Bajaj, S., Aggarwal, S., Balhara, Y. P. S., Das, A. K., Dhamija, P., Gupta, Y. K., Jacob, J., Mishra, S., Narasingan, S. N., Ponde, C. K., Prabhoo, R., S, B., Sahay, M., … Vora, A. (2017). Association of Physicians of India: Position Statement on Role of Chirally Pure Molecules in Clinical Practice. The Journal of the Association of Physicians of India, 65(12), 49–60.
  • Pahuja, E., Kumar, S., Kumar, A., Uzzafar, F., Sarkar, S., Manjunatha, N., Balhara, Y. P. S., Kumar, C. N., & Math, S. B. (2020). Collaborative Video Consultations from Tertiary Care Based Telepsychiatrist to a Remote Primary Care Doctor to Manage Opioid Substitution Therapy Clinic. Journal of Neurosciences in Rural Practice, 11(3), 498–501. https://doi.org/10.1055/s-0040-1713293
  • Pal, A., & Balhara, Y. P. S. (2016). A Review of Impact of Tobacco Use on Patients with Co-occurring Psychiatric Disorders. Tobacco Use Insights, 9, 7–12. https://doi.org/10.4137/TUI.S32201
  • Patil, V., Gupta, R., Verma, R., & Balhara, Y. P. S. (2016). Neuroleptic Malignant Syndrome Associated with Lithium Toxicity. Oman Medical Journal, 31(4), 309–311. https://doi.org/10.5001/omj.2016.59
  • Patra, B. N., & Balhara, Y. P. S. (2012). Creativity and mental disorder. The British Journal of Psychiatry : The Journal of Mental Science, 200(4), 346; author reply 348. https://doi.org/10.1192/bjp.200.4.346
  • Patra, B. N., Patil, V., Balhara, Y. P. S., & Khandelwal, S. K. (2022). Self-stigma in patients with major depressive disorder: An exploratory study from India. The International Journal of Social Psychiatry, 68(1), 147–154. https://doi.org/10.1177/0020764020975811
  • Pirkis, J., Gunnell, D., Shin, S., Del Pozo-Banos, M., Arya, V., Aguilar, P. A., Appleby, L., Arafat, S. M. Y., Arensman, E., Ayuso-Mateos, J. L., Balhara, Y. P. S., Bantjes, J., Baran, A., Behera, C., Bertolote, J., Borges, G., Bray, M., Brečić, P., Caine, E., … Spittal, M. J. (2022). Suicide numbers during the first 9-15 months of the COVID-19 pandemic compared with pre-existing trends: An interrupted time series analysis in 33 countries. EClinicalMedicine, 51, 101573. https://doi.org/10.1016/j.eclinm.2022.101573
  • Prakash, S., & Balhara, Y. P. S. (2016). Rare Form of Dyskinetic Movements Associated with Alcohol Withdrawal. Indian Journal of Psychological Medicine, 38(2), 163–164. https://doi.org/10.4103/0253-7176.178816
  • Prashanth, R., Balhara, Y. P. S., & Sagar, R. (2010). The pontomedullary region: Role in affect, behavior, and appetite regulation. The Journal of Neuropsychiatry and Clinical Neurosciences, 22(2), E14. https://doi.org/10.1176/jnp.2010.22.2.247.e14
  • Quraishi, R., Jain, R., & Balhara, Y. P. S. (2014). Profile of nicotine use among alcohol dependent patients visiting a tertiary care center in north India. Indian Journal of Psychological Medicine, 36(2), 174–178. https://doi.org/10.4103/0253-7176.130987
  • Roy, N., Nadda, N., Kumar, H., Prasad, C., Kumar Jha, J., Pandey, H. C., Vanamail, P., Saraya, A., Balhara, Y. P. S., Shalimar, & Nayak, B. (2022). Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility. Frontiers in Immunology, 13, 975027. https://doi.org/10.3389/fimmu.2022.975027
  • Sagar, R., Varghese, S. T., & Balhara, Y. P. S. (2005a). Dysphagia due to olanzepine, an antipsychotic medication. Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology, 24(1), 37–38.
  • Sagar, R., Varghese, S. T., & Balhara, Y. P. S. (2005b). Olanzapine-induced double incontinence. Indian Journal of Medical Sciences, 59(4), 163–164.
  • Sarkar, S., & Balhara, Y. P. S. (2012). Needles in legs: A response to command hallucinations. The Journal of Neuropsychiatry and Clinical Neurosciences, 24(2), E10-12. https://doi.org/10.1176/appi.neuropsych.11050111
  • Sarkar, S., & Balhara, Y. P. S. (2014). Diabetes mellitus and suicide. Indian Journal of Endocrinology and Metabolism, 18(4), 468–474. https://doi.org/10.4103/2230-8210.137487
  • Sarkar, S., Balhara, Y. P. S., Gautam, N., & Singh, J. (2016). A Retrospective Chart Review of Treatment Completers Versus Noncompleters Among In-patients at a Tertiary Care Drug Dependence Treatment Centre in India. Indian Journal of Psychological Medicine, 38(4), 296–301. https://doi.org/10.4103/0253-7176.185943
  • Sarkar, S., Balhara, Y. P. S., Kumar, S., Saini, V., Kamran, A., Patil, V., Singh, S., & Gyawali, S. (2019). Internalized stigma among patients with substance use disorders at a tertiary care center in India. Journal of Ethnicity in Substance Abuse, 18(3), 345–358. https://doi.org/10.1080/15332640.2017.1357158
  • Sarkar, S., Balhara, Y. P. S., Tewari, A., Singh, J., & Gautam, N. (2017). Reasons of Disciplinary Discharges from a Tertiary Care De-addiction Setting in India. Indian Journal of Psychological Medicine, 39(3), 378–379. https://doi.org/10.4103/0253-7176.207321
  • Sarkar, S., Lal, R., Varshney, M., & Balhara, Y. P. S. (2017). Tramadol for maintenance in opioid dependence: A retrospective chart review. Journal of Opioid Management, 13(5), 329–334. https://doi.org/10.5055/jom.2017.0401
  • Sarkar, S., Majumder, P., Gupta, R., Das, N., Narnoli, S., & Balhara, Y. P. S. (2021). Prevalence and socio-demographic correlates of law enforcement involvement among treatment-seeking adult males with opioid use disorder. International Journal of Law and Psychiatry, 74, 101653. https://doi.org/10.1016/j.ijlp.2020.101653
  • Schaub, M. P., Tiburcio, M., Martinez, N., Ambekar, A., Balhara, Y. P. S., Wenger, A., Monezi Andrade, A. L., Padruchny, D., Osipchik, S., Gehring, E., Poznyak, V., Rekve, D., & Souza-Formigoni, M. L. O. (2018). Alcohol e-Help: Study protocol for a web-based self-help program to reduce alcohol use in adults with drinking patterns considered harmful, hazardous or suggestive of dependence in middle-income countries. Addiction (Abingdon, England), 113(2), 346–352. https://doi.org/10.1111/add.14034
  • Senjam, S. S., Balhara, Y. P. S., Kumar, P., Nischal, N., Manna, S., Madan, K., Ahmed, N. H., Gupta, N., Vashist, P., & Guleria, R. (2022). A Comprehensive Assessment of Self-Reported Post COVID-19 Symptoms Among Beneficiaries of Hospital Employee Scheme at a Tertiary Healthcare Institution in Northern India. International Journal of General Medicine, 15, 7355–7372. https://doi.org/10.2147/IJGM.S381070
  • Shah, B., Gupta, R., Sarkar, S., & Balhara, Y. P. S. (2018). Injection Butorphanol dependence: A case report. Asian Journal of Psychiatry, 35, 45–46. https://doi.org/10.1016/j.ajp.2018.05.008
  • Sharma, R. K., Balhara, Y. P. S., Sagar, R., Deepak, K. K., & Mehta, M. (2011). Heart rate variability study of childhood anxiety disorders. Journal of Cardiovascular Disease Research, 2(2), 115–122. https://doi.org/10.4103/0975-3583.83040
  • Sharma, R. K., Sagar, R., Deepak, K. K., Mehta, M., & Balhara, Y. P. S. (2011). Clinical and autonomic functions: A study of childhood anxiety disorders. Annals of Saudi Medicine, 31(3), 250–257. https://doi.org/10.4103/0256-4947.81533
  • Singh, G., Kaloiya, G. S., Dhawan, A., Balhara, Y. P. S., & Mishra, A. K. (2018). Need for evaluation of underlying dysfunctional cognition in problem drinkers. Asian Journal of Psychiatry, 31, 71–72. https://doi.org/10.1016/j.ajp.2018.01.007
  • Singh, G., Kaloiya, G. S., Dhawan, A., Balhara, Y. P. S., & Mishra, A. K. (2022). The Extent of Endorsement of Distal to Proximal Dysfunctional Cognitions in Individuals with Alcohol Dependence: A Comparative Cross-Sectional Study in the Indian Context. Indian Journal of Psychological Medicine, 44(3), 239–245. https://doi.org/10.1177/02537176221091673
  • Singh, S., & Balhara, Y. P. S. (2016). A Review of Indian Research on Co-occurring Psychiatric Disorders and Alcohol use Disorders. Indian Journal of Psychological Medicine, 38(1), 10–19. https://doi.org/10.4103/0253-7176.175089
  • Singh, S., & Balhara, Y. P. S. (2017). A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders. The Indian Journal of Medical Research, 146(2), 186–195. https://doi.org/10.4103/ijmr.IJMR_791_15
  • Singh, S., & Balhara, Y. P. S. (2021). “Screen-time” for children and adolescents in COVID-19 times: Need to have the contextually informed perspective. Indian Journal of Psychiatry, 63(2), 192–195. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_646_20
  • Singh, S., Balhara, Y. P. S., Gupta, P., & Christodoulou, N. G. (2020). Primary and secondary prevention strategies against illicit drug use among adults aged 18-25: A narrative review. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists, 28(1), 84–90. https://doi.org/10.1177/1039856219875048
  • Singh, S., Dahiya, N., Singh, A. B., Kumar, R., & Balhara, Y. P. S. (2019). Gaming disorder among medical college students from India: Exploring the pattern and correlates. Industrial Psychiatry Journal, 28(1), 107–114. https://doi.org/10.4103/ipj.ipj_96_18
  • Singh, S., Kumar, S., Sarkar, S., & Balhara, Y. P. S. (2018). Quality of Life and its Relationship with Perceived Stigma among Opioid Use Disorder Patients: An Exploratory Study. Indian Journal of Psychological Medicine, 40(6), 556–561. https://doi.org/10.4103/IJPSYM.IJPSYM_171_18
  • Singh, S., Sharma, P., & Balhara, Y. P. S. (2020). The impact of nationwide alcohol ban during the COVID-19 lockdown on alcohol use-related internet searches and behaviour in India: An infodemiology study. Drug and Alcohol Review, 40(2), 196–200. https://doi.org/10.1111/dar.13187
  • Szerman, N., Torrens, M., Maldonado, R., Balhara, Y. P. S., Salom, C., Maremmani, I., Sher, L., Didia-Attas, J., Chen, J., & Baler, R. (2022). Addictive and other mental disorders: A call for a standardized definition of dual disorders. Translational Psychiatry, 12(1), 446. https://doi.org/10.1038/s41398-022-02212-5
  • Tandon, N., Kalra, S., Balhara, Y. P. S., Baruah, M. P., Chadha, M., Chandalia, H. B., Chowdhury, S., Jothydev, K., Kumar, P. K. M., V, M. S., Mithal, A., Modi, S., Pitale, S., Sahay, R., Shukla, R., Sundaram, A., Unnikrishnan, A. G., & Wangnoo, S. K. (2015). Forum for Injection Technique (FIT), India: The Indian recommendations 2.0, for best practice in Insulin Injection Technique, 2015. Indian Journal of Endocrinology and Metabolism, 19(3), 317–331. https://doi.org/10.4103/2230-8210.152762
  • Tandon, N., Kalra, S., Balhara, Y. P. S., Baruah, M. P., Chadha, M., Chandalia, H. B., Prasanna Kumar, K. M., Madhu, S. V., Mithal, A., Sahay, R., Shukla, R., Sundaram, A., Unnikrishnan, A. G., Saboo, B., Gupta, V., Chowdhury, S., Kesavadev, J., & Wangnoo, S. K. (2017). Forum for Injection Technique and Therapy Expert Recommendations, India: The Indian Recommendations for Best Practice in Insulin Injection Technique, 2017. Indian Journal of Endocrinology and Metabolism, 21(4), 600–617. https://doi.org/10.4103/ijem.IJEM_97_17
  • Varghese, S. T., Balhara, Y. P. S., George, S. A., & Sagar, R. (2006). Risperidone and dysphagia. Journal of Postgraduate Medicine, 52(4), 327–328.
  • Varghese, S. T., Balhara, Y. P. S., & Mondal, A. (2006). Unconventional substances of abuse: Scorpions and lizards. Journal of Postgraduate Medicine, 52(4), 325–326.
  • Varghese, S. T., Balhara, Y. P. S., Shyamsunder, S., & Mondal, A. (2005). Dermatological side effects of olanzapine. Indian Journal of Medical Sciences, 59(7), 320–321.
  • Varshney, M., Gupta, R., & Balhara, Y. P. S. (2015). Yes, India has done it: Decriminalization of suicide in India. Asian Journal of Psychiatry, 17, 103. https://doi.org/10.1016/j.ajp.2015.07.005
  • Verma, R., Balhara, Y. P. S., & Deshpande, S. N. (2011a). Workplace inhalant abuse in adult female: Brief report. Case Reports in Psychiatry, 2011, 905380. https://doi.org/10.1155/2011/905380
  • Verma, R., Balhara, Y. P. S., & Deshpande, S. N. (2011b). Inhalant abuse: A study from a tertiary care de-addiction clinic. East Asian Archives of Psychiatry : Official Journal of the Hong Kong College of Psychiatrists = Dong Ya Jing Shen Ke Xue Zhi : Xianggang Jing Shen Ke Yi Xue Yuan Qi Kan, 21(4), 157–163.
  • Verma, R., Balhara, Y. P. S., & Deshpande, S. N. (2012). Angular cheilitis after paroxetine treatment. Journal of Clinical Psychopharmacology, 32(1), 150–151. https://doi.org/10.1097/JCP.0b013e31823f878a
  • Verma, R., Balhara, Y. P. S., & Dhawan, A. (2011). Inhalant abuse: An exploratory study. Industrial Psychiatry Journal, 20(2), 103–106. https://doi.org/10.4103/0972-6748.102493
  • Verma, R., Balhara, Y. P. S., & Gupta, C. S. (2011). Gender differences in stress response: Role of developmental and biological determinants. Industrial Psychiatry Journal, 20(1), 4–10. https://doi.org/10.4103/0972-6748.98407
  • Verma, R., Balhara, Y. P. S., & Mathur, S. (2011). Management of attention-deficit hyperactivity disorder. Journal of Pediatric Neurosciences, 6(1), 13–18. https://doi.org/10.4103/1817-1745.84400
  • Verma, R., Mina, S., Ul-Hassan, S., & Balhara, Y. P. S. (2013). A descriptive analysis of patients presenting to psychosexual clinic at a tertiary care center. Indian Journal of Psychological Medicine, 35(3), 241–247. https://doi.org/10.4103/0253-7176.119473
  • Verma, R., Sachdeva, A., Singh, Y., & Balhara, Y. P. S. (2013). Acute mania after thyroxin supplementation in hypothyroid state. Indian Journal of Endocrinology and Metabolism, 17(5), 922–923. https://doi.org/10.4103/2230-8210.117220
  • Vi, V. T. T., Diep, N. T. N., Han, V. H. N., Van Dung, D., Nguyen, N. L. H., Binh, L. Q., & Balhara, Y. P. S. (2022). Experience and insights from the emergency multiday take-home dose methadone dispensing in Ho Chi Minh City in context of COVID-19. Journal of Addictive Diseases, 1–5. https://doi.org/10.1080/10550887.2022.2116254
  • Yadav, T., Arya, K., Kataria, D., & Balhara, Y. P. S. (2012). Impact of psychiatric education and training on attitude of medical students towards mentally ill: A comparative analysis. Industrial Psychiatry Journal, 21(1), 22–31. https://doi.org/10.4103/0972-6748.110944
  • Yadav, T., Balhara, Y. P. S., & Kataria, D. K. (2012). Pseudocyesis Versus Delusion of Pregnancy: Differential Diagnoses to be Kept in Mind. Indian Journal of Psychological Medicine, 34(1), 82–84. https://doi.org/10.4103/0253-7176.96167
Prof. ATUL AMBEKAR

Prof.
ATUL AMBEKAR

Male

MBBS, MD

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
atul.ambekar@gmail.com
atul.ambekar@aiims.edu

Field of Interest

  • Public Health Issues related to Alcohol and Drug Use
  • Opioid Substitution Therapy (OST) and Harm Reduction
  • Training and human resource development
  • Gender and drug use
  • Drug Policies and Programs
  • Epidemiology of drug use
  • Community based research to facilitate access to services
  • Use of Information and Communication Technology in addiction-related issues

Total number of publications till date: 185

  • Awarded, Meritorious Award for outstanding contribution for the prevention & control of Non-Communicable Diseases (NCDs), April 2022, National Resource Centre for Non- Communicable Diseases, Thiruvalla, Kerala and Alcohol and Drug Information Centre (ADIC)
  • Awarded “ Venus International Medical Award 2019 (VIMA 2019)” for Excellence in Psychiatry, April 2019
  • Awarded “JJ Memorial Oration on Mental Health”: Govt. Grant Medical College, Mumbai, January 2017 (Topic- Alcohol and Public Health: Impact and Solutions)
  • Winner of “ BMJ Awards South Asia 2016” for the category, “Non-Communicable Disease Initiative of the Year”, November 2016
  • Awarded Travel Grant (Scholarship) for the Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong (Oct 2019)
  • Awarded Travel Grant (Scholarship) for the Annual Conference of International Society for the Study of Drug Policy, Sydney, Australia, May 2016
  • Any other relevant information:

Nominated member

  • Inter-Ministerial committee on 'dual use' and illicit trafficking of prescription drugs and precursors - Narcotics Control Bureau, Ministry of Home Affairs, Government of India (2022-ongoing)
  • Expert Committee for Reviewing the Current Model for the Integrated Rehabilitation Centre for Addicts (IRCA) Under NAPDDR - Ministry of Social Justice and Empowerment, Government of India (2022-2023)
  • Subject Expert Committee (Psychiatry and Neurology) – Central Drug Standards Control Organization, Ministry of Health and Welfare, Government of India (2017 - ongoing)
  • Global Burden of Disease (GBD), India Mental Health Expert Group – Public Health Foundation of India(2017- ongoing)
  • National Technical Resource Group, Injecting Drug Use - National AIDS Control Organisation, Government of India (2013 - ongoing)
  • Project Selection Committee  for setting up of District De-Addiction Centres (DDACs) under National Action Plan for Drug Demand Reduction (NAPDDR) - Ministry of Social Justice and Empowerment, Government of India (2022-ongoing)
  • Honorary Fellow, School of Criminology, University of Hong Kong (2019-ongoing)
  • Expert committee on “Exploring the possibility of blocking of illicit use of ‘dual use’ precursor chemicals for the manufacture of narcotic drugs, psychotropic substances and new psychoactive substances”, - Ministry of Home Affairs, Government of India (2020-2021)
  • National Consultative Committee on Drug Addiction and Rehabilitation - Ministry of Social Justice and Empowerment, Government of India (2015-2020)
  • Expert Advisory Panel on Drug Dependence - World Health Organization (WHO), Geneva (2012 -2019)
  • Strategic Advisory Group to United Nations, IDU and HIV - UNAIDS, UNODC and WHO (2012-2016)
  • Chairperson, Addictive Disorders Speciality Section, Indian Psychiatric Society (2019-2021)
  • Punjab Drug Addiction Rehabilitation Board, Government of Punjab, India (2018 - 2021)
  • National Task Force for Integrating Mental Health in Comprehensive Primary Health Care – Ministry of health and Family Welfare, Government of India (2018-19)
  • Steering Committee for Alcohol Control and Health – Ministry of Health and Family Welfare, Government of India (2014-2016)
  • National Task Force on Drug Demand Reduction and Capacity Building –Ministry of Social Justice and Empowerment, Govt. of India (2011-12)
  • Governing Body, Rajkumari Amrit Kaur College of Nursing, Delhi University (2021 - ongoing)

Membership Of Professional Societies

  • Addiction Psychiatry Society of India (APSI) – Secretary General
  • American Society of Addiction Medicine (ASAM)
  • Asia Pacific Society for Alcohol and Addiction Research (APSAAR) – Board of Directors (2017-21)
  • Harm Reduction International (HRI)
  • Indian Association for Social Psychiatry (IASP) – Elected Member, Executive Council (2017-20)
  • Indian Association of Private Psychiatry (IAPP) – Member, National Advisory Board
  • Indian Psychiatric Society (IPS) – Member, Certification and course committee
  • International AIDS Society (IAS)
  • International Doctors for Healthier Drug Policies (IDHDP)
  • International Society for Substance Use Treatment & Prevention Professionals (ISSUP)
  • International Society for the Study of Drug Policy (ISSDP)
  • International Society of Addiction Medicine (ISAM) – Member, Board of Directors

Membership Of Editorial And Advisory Boards Of Academic Journals

International Consultancies / Expert Services

  • Developing an online training program on ‘Unhealthy Substance Use’ for Primary Care Physicians (for the NCD Academy platform on Mental Health Disorders). Consultancy for World Psychiatric Association (WPA) and American College of Cardiology (ACC) (2021)
  • Demonstration Project on Opioid Substitution with Buprenorphine at Myanmar.Community Partners International (with support fromUSAID and UNAIDS) (2019-ongoing)
  • Drafting thematic chapter of INCB Annual Report 2017 (“Treatment & rehabilitation of drug use disorders: Essential component of demand reduction”).International Narcotics Control Board (INCB), Vienna (2017)
  • Rapid Assessment of Drug Use Pattern in Sri Lanka.Alliance Regional Technical Support Hub South Asia and the National STD/AIDS Control Programme, Sri Lanka (2017-2018)
  • Developing (a) “Standard Policy and Practice Guidelines ” and “Training Manual” and (b) conducting training programmes for Counsellors. National Drug Law Enforcement Agency (NDLEA), Government of Nigeria andUNODC, Vienna (2015-2017)
  • Review of Methodology and data on estimates of Injecting Drug Users and HIV service-coverage for World Drug Report 2014.UNODC, Vienna, (2013-2014)
  • Developing a E-health portal on Problem alcohol use in India, [https://www.alcoholwebindia.in ]WHO, Geneva (2010-13)
  • National Drug Use Survey in Maldives. UNODC, Maldives Project Office (2011-2012)
  • Capacity Building on Methadone Maintenance Treatment for service providers from Nepal and Bangladesh.UNODC, ROSA (2010)
  • A Review of OST Programme of Nepal. UNODC, ROSA (2010)

National Consultancies / Expert Services

Training and Capacity Building Consultancies

Research and Evaluation Consultancies

Other Activities

  • Represented Ministry of Health and Family Welfare, Government of India as a part of Indian delegation at the Indo-US Counter Narcotics Working Group (CNWG) meeting, New Delhi, July 2022
  • Represented Ministry of Health and Family Welfare, Government of India as a part of Indian delegation at the Commission on Narcotic Drugs (CND), Vienna, Mar 2020, April 2021, March 2022, September 2022
  • In-charge (and initiated): Women Substance Use Clinic (every Saturday) at NDDTC, AIIMS.
  • In-charge (and initiated): Community Outreach Clinic, (focused on homeless substance users) Kotla Mubarakpur, New Delhi
  • In-charge: Implementation of the scheme “Strengthening Drug De-Addiction Programme: Establishing Drug Treatment Clinics (DTCs)”, Ministry of Health and Family Welfare, Government of India. Details at: http://dtc-scheme.in/
  • In-charge: Implementation of the scheme “Establishing Addiction Treatment Facilities (ATFs) in government hospitals in India”, Ministry of Social Justice and Empowerment, Government of India. Details at: https://atf-scheme.in/
  • Organizing Secretary for the 1st National Conference of Addiction Psychiatry Society of India (APSI) – ADDICON 2021, December 2021
  • Organizing Secretary for the National CME, “Emerging Issues in Substance Use Disorders”, AIIMS, New Delhi, July 2017
  • Organizing Secretary for the National CME, “Opioid Substitution Therapy: Policy and Practice”, AIIMS, New Delhi, April 2015
  • Chairperson, Website & IT Committee for the Global congress of International Society of Addiction Medicine (ISAM 2019)
  • Contributed towards developing the “Substance Use Treatment Unit (SUTU)” at AOD Hospital, Indian Oil Refinery, Digboi, Assam.

Awards and Honours

  • Awarded, Meritorious Award for outstanding contribution for the prevention & control of Non-Communicable Diseases (NCDs), April 2022, National Resource Centre for Non- Communicable Diseases, Thiruvalla, Kerala and Alcohol and Drug Information Centre (ADIC)
  • Awarded “ Venus International Medical Award 2019 (VIMA 2019)” for Excellence in Psychiatry, April 2019
  • Awarded “JJ Memorial Oration on Mental Health”: Govt. Grant Medical College, Mumbai, January 2017 (Topic- Alcohol and Public Health: Impact and Solutions)
  • Winner of “ BMJ Awards South Asia 2016” for the category, “Non-Communicable Disease Initiative of the Year”, November 2016
  • Awarded Travel Grant (Scholarship) for the Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong (Oct 2019)
  • Awarded Travel Grant (Scholarship) for the Annual Conference of International Society for the Study of Drug Policy, Sydney, Australia, May 2016
  • Any other relevant information:

Presentations made at scientific meetings/ conferences/ workshops (2017 onwards)

  • Opioid Substitution Treatment: Policy and legal considerations. Invited plenary presentation at the ADDICON 2022, Annual conference of Addiction Psychiatry Society of India (APSI), Bengaluru, 3 December 2022
  • Drugs and Children in the context of Right to a drug free childhood. Invited plenary presentation at the conference, “Children Matter” organized by the 4th wave foundation and world federation against drugs, Thiruvananthapuram, 17 Nov 2022
  • Laws and policies related to addiction treatment. Invited plenary presentation at the Annual conference of Indian Association of Private Psychiatry - Haryana, Solan 12 November 2022
  • Overview of drug use and addiction. Invited plenary presentation at the Annual conference of Indian Association of Private Psychiatry - Haryana, Solan 11 November 2022
  • How to address substance use in Mental health programs? Panel discussion as a part of Mental Health Forum 2022, organized by the World Health Organization (Geneva), 10 Oct 2022
  • Challenges in the meaningful involvement of civil society in drug policies. Symposium presentation at ISAM 2022 global congress, Malta, 5 Oct 2022
  • ISAM-GEN Structure and Expert Contact Points: From Individuals to Addiction Societies and Treatment Centers. (With Preethy K). Symposium presentation at ISAM 2022 global congress, Malta, 4 Oct 2022
  • Time for India to End Its War on Drugs? Panel discussion by “Argumentative Indians”, (online), 25 Sep 2022
  • Treatment of Opioid Dependence: Policy and Legal Considerations. CME organized by the Hyderabad Psychiatric Society, Hyderabad, 24 Sep 2022
  • Understanding Drug Use (and how to deal with it?). Online Training on Drug Law Enforcement, organized by National Academy of Customs, Indirect Taxes and Narcotics (NACIN), Mumbai, 20 Sep 2022
  • Laws and Policies related to Addiction Psychiatry. NationalWebinar presented for the resident doctors of National Board of Examination (DNB-Psychiatry), 14 Sep 2022
  • Substance Use and Suicide. Invited lectureat the Annual National Conference of Society for Rural Mental Health, Solan, 10 Sep 2022
  • Drug Use in India: What role could police play?, Training program Police Officers, Delhi Police Academy New Delhi, 8 Sep 2022
  • Harm Reduction: Concept, Philosophy and application to Tobacco. Round table organized by the Policy Circle, New Delhi 4 Sep 2022
  • Harm Reduction: Opioid Substitution Therapy and Needle Exchange Programs for people who inject drugs. Training program for medical and paramedical staff at Delhi Prisons, New Delhi, 24 August 2022
  • SUBSTANCE USE DISORDERS & BIPOLAR DISORDER: Assessment & Management. Invited lecture in the Post Graduate Development Program of Indian Psychiatric Society – North Zone, Srinagar, 21 August 2022
  • Substance Use Disorders & their treatment: Situation in India. Invited presentation in the panel discussion on World Mental Health Report 2022, India International Centre, New Delhi, 12 August 2022
  • Long Acting pharmacological options for opioid dependence: Effectiveness and Ethics. Webinar organized by the Indian Association of Biological Psychiatry (IABP), 5 August 2022
  • Drug Addiction & its treatment: Situation in India. Invited lecture at the conference on “Drug trafficking and National security”, Narcotics Control Bureau, Chandigarh, 31 July 2022
  • Cannabis: The Changing Landscape of Perception and Policies. Invited lecture at GPsyCon 2022, Annual conference of Goa Psychiatric Society, Goa, 23 July 2022
  • Drug Addiction situation & responses in India: Focus on North-East. Invited lecture at North East Police Coordination Committee meeting organized by DG police, Tripura, Agartala, 22 July 2022
  • Nasha – Ek Bimari. Ilaaj hai zaroori. Panel discussion organised by the Public Health Dept., Govt. of Maharashtra and Indian Psychiatric Society, West Zone, Mumbai, 17 July 2022, online
  • Drug Addiction & Drug Laws: The interface. ‘Core Competence Conference on Knowledge, Skills & Perspective Development for Special Judges – NDPS Act’, Delhi Judicial Academy, New Delhi, 16 July 2022
  • Treatment of Opioid Dependence: Policy and Legal Issues. CME on addiction psychiatry organized by AIIMS, Bhubaneswar, 10 July 2022
  • Indo-Us Enhanced cooperation related to substance use prevention, treatment and rehabilitation. Presented on behalf of MoH&FW, Govt. of India at India-US Counter-Narcotics Working Group (CNWG), meeting; New Delhi, 7 July, 2022
  • Facts about drug use and addiction. E-SYMPOISUM on Trends in Narcotic Drugs Psychotropic Substances, organized by the Forensic Science laboratory, Govt of Delhi; 27 June 2022; online
  • Recent Policy Update in Decriminalisation of Drug Use.  CME - 'Recent Advances in Addiction Psychiatry’ organized by AIIMS Jodhpur; 26 June 2022, online
  • Substance Use: Government Policies and Laws.  Capacity Building Program for Govt. college teachers (Assistant professor level) of social sciences; NDDTC AIIMS; Ghaziabad, 18 June 2022 
  • Substance Abuse & Alcohol Addiction: Deciphering its Impact on the Mental Health of Adolescents & Young Adults. Panel discussion (webinar) organized by the Asia Society India; 25 May 2022, online
  • Magnitude of drug use in India & our drug policies. Panel discussion on the occasion of inauguration of National Resource Centre on NCDs; 28 April 2022; Thiuvalla, Kerala.
  • Epidemiological research on substance use in India. Lessons from the field. Webinar on ‘Innovations in Addictions Research in India’ organized by Sangath, Goa; 21 April 2022; online
  • Substance Use: Attitudes, Policies and Stigma in India. Annual Conference of American Society of Addiction Medicine (ASAM), 15 April 2022; online
  • Use of addictive substances: Myths and facts. World Health Day event for students and resident doctors at AIIMS, New Delhi, 7 April 2022; New Delhi
  • Brief Interventions for Tobacco and Alcohol use disorders. 7th International Course on Public Health Approaches to Non-communicable Diseases (NCDs), organized by Centre for Community Medicine, AIIMS New Delhi in partnership with World NCD Federation and World Health Organization (WHO); 7 April 2022; New Delhi
  • NDPS Act and the Psychiatrist. Panel discussion moderated at the national CME during the Annual National Conference of Indian Psychiatric Society (ANCIPS); 24Mar 2022; Vishakhapatnam
  • Amendments in the NDPS Act. Panel discussion and workshop organized by the Department of Revenue, Min. of Finance, Government of India; 9 Mar 2022; New Delhi
  • Decriminalization of drug use- Need of the hour. CME organized by the Indian Psychiatric Society North Zone; 9 Feb 2022; Online
  • Drug Addiction among children. Training workshop organized by Narcotics Control Bureau (NCB), Govt of India and National Commission for protection of child rights (NCPCR); 8 Feb 2022; Online
  • Magnitude of drug use in India. Training workshop organized by Narcotics Control Bureau (NCB), Govt of India and National Commission for protection of child rights (NCPCR); 8 Feb 2022; Online
  • The International Scheduling System for Narcotic Drugs & Psychotropic Substances: Implications for South Asia. Conference of SAARC Psychiatric Federation (SPF), Kolkata, 18 December 2021
  • Newer Pharmacotherapies for treatment of opioid dependence: Evidence and Ethics. Annual meeting of Indonesian Psychiatric Association, 5 December 2021
  • The International Scheduling System for Narcotic Drugs & Psychotropic Substances: Does It Need an Overhaul?. Plenary lecture in ISAM 2021 Global congress, 21 Nov 2021
  • India: COVID19, Lockdown & Addiction Treatment. Symposium in ISAM 2021 Global congress 21 Nov 2021
  • Newer Pharmacotherapies for treatment of opioid dependence: A Critique. Annual conference of East Zone Indian Psychiatric Society 12 Nov 2021
  • Management of Alcohol Use Disorders in medical settings. Conference of IMA West Zone, 12 Oct 2021
  • Leveraging Information Technology for capacity building in Addiction Treatment. CME organized by IPS West Zone 9 Oct 2021
  • Newer Pharmacotherapies for treatment of opioid dependence: Evidence and Ethics. Annual conference by UP IPS, 25 Sep 2021
  • E-Health Screening & Brief Interventions: Implications for LAMI countries. Plenary lecture in INEBRIA conference, 24 Sep 2021
  • The Genesis of APSI. Symposium presented in WASP 2021, 16 Sep 2021
  • ICD – 11 classification for substance use and addictive behaviors. National CME organized by PGIMER Chandigarh, 15 Sep 2021
  • Opioid Dependence: An overview of management. National Workshop organized by Dept of Addiction Medicine, LGBRIMH, Tezpur, 4 Sep 2021
  • Substance Use Disorders: A public health concern. Guest lecture (online) delivered for the faculty and students from Armed Forces Medical College (AFMC), Pune, 12 August 2021
  • Facts about drugs and addiction. Lecture delivered to the senior officials on Sashastra Seema Bal (SSB), on the occasion of International Day against Drug Abuse and Illicit Trafficking, 30 June 2021
  • National Policies and Programmes on treatment of substance use disorders. Webinar organized by the Nursing Division, Ministry of Health and Family Welfare, Govt. of India on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021
  • The International Framework for Drug Control. Webinar organized by the Central Institute of Psychiatry (CIP) on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021
  • Laws and Policies related to Addiction Psychiatry. Online CME organized by AIIMS, Nagpur on the occasion of International Day against Drug Abuse and Illicit Trafficking, 26 June 2021
  • Opioid Agonist Treatment: Evidence for effectiveness in Opioid Use Disorders. Webinar organized by the Institute of Mental Health and Neurosciences, GMC, Srinagar J&K, on the occasion of International Day against Drug Abuse and Illicit Trafficking, 25 June 2021
  • Why India does not have an overdose crisis (so far)? Workshop delivered (online) in the International conference ‘Let’s talk overdose’ organized by the University of British Columbia, Vancouver, Canada, 23 June 2021
  • India, COVID19 and Addictions. International conference on Technology Addiction, organized by Turkish Green Crescent Society, online, 2 June 2021
  • Cannabis: the changing landscape of perceptions and policies. CME of Indian Psychiatric Society – South Zone, online – 24 April 2021
  • Addiction treatment services duringCOVID19 in India. Side event during the CND meeting (virtual), organized by the International Doctors on Healthier Drug Policies (IDHDP) – 12 April 2021
  • Addictions To Cyberspace & Their Management. Delivered at CME organized by the Indian Psychiatric Society – West Zone, Online – 11 April 2021
  • Brief interventions and MET in substance use disorders. ‘Thursday Musings’ webinar series organized by the Indian Psychiatric Society – Odisha branch, 18 March 2021 
  • Treatment of Substance Use Disorders. National Webinar on ‘Dimensions of Social Defence & Linkages with SDGs’ organized by the FORE school of management, 24 February 2021
  • Epidemiology of Substance Use. PG Development program organized by the Indian Psychiatric Society – Central Zone, 20 February 2021
  • Drug Addiction: An overview and strategies for management. Forensic and Technical Course on Narcotic Drugs and Psychotropic Substances for Sri Lankan Police officers, organized by the Central Academy of Police Training, 12 February 2021
  • Newer Technologies for treatment of opioid dependence: Evidence and Ethics. Annual National conference of Indian Association of Biological Psychiatry, 7 February 2021
  • ICD-11 Disorder related to Substance Use and Addictive Behaviour: Field Trial India. National CME organized by the Addiction Psychiatry Society of India (APSI), 31 January 2021
  • Harm Reduction: Concept, Philosophy and application to Tobacco. Webinar organized by the Association for Harm Reduction Education and Research, 19 January 2021
  • Cannabis Policies: The Way forward. Webinar organized by Indian Psychiatric Society, West Bengal, 17 January 2021
  • Evidence Based Treatment of Cannabis Dependence. Webinar organized by the Behavioural and Neuroscience Academy of India, 5 January 2021
  • COVID19 pandemic: Impact on Addiction Psychiatry. Annual National Conference of Indian Association of Private Psychiatry, 5 December 2020
  • Opioid Use Epidemic in India: Changing Pattern and Policy Implications. Keynote address delivered in the ISAM Asia Regional conference, 5 December 2020
  • Medicolegal issues with reference to NDPS & MHCA in management of Substance Use Disorders. Webinar organized by Indian Psychiatric Society, 27 October 2020
  • Public health and addictive drugs: Laws and Policies: What works and What doesn’t. Webinar organized by Meghalaya legal services authority and Government of Meghalaya on Mental health day, 9 October 2020
  • SUBSTANCE USE IN NAGALAND. State level consultation organized by Kripa Foundation, Nagaland, 4 August 2020
  • Laws and Policies related to Addiction Psychiatry. Webinar organized by Kolkata Psychiatry Club and Indian Psychiatric Society, West Bengal. 26 July 2020
  • Opioid Substitution Treatment : An Overview. Webinar organized by Indian Psychiatric Society, Odisha, 26 July 2020
  • Benzodiazepine use disorders in clinical practice. Webinar organized by the Indian Psychiatric Society, Karnataka Chapter, 2 July 2020
  • India: COVID19, Lockdown and Addictions. Webinar organized by Govt. of NCT of Delhi, 26 June 2020
  • India: COVID19, Lockdown and Addictions. Webinar organized by International Society of Addiction Medicine, 20 May 2020
  • Services for Drug Use among youth. Moderated the Panel Discussion, during the Indo Scotland Mental Health Conclave, New Delhi, 29 January 2020
  • Alcohol: Evidence for impact of Prohibition. National Conference ‘From Neurons to Neighbourhood’, by Sun Pharma Research Foundation, New Delhi, 27 January 2010
  • Magnitude of drug use in India and the existing policy and program framework for response: A road map for evidence-informed drug supply control and demand reduction, Symposium deliveredat the Annual National Conference of Indian Psychiatric Society (ANCIPS), Kolkata, 24 January 2020
  • Behavioural Addiction: A Primer for Mental Health Professionals, workshop conducted at the National CME during the Annual National Conference of Indian Psychiatric Society (ANCIPS), Kolkata, 22 January 2020
  • Pharmaceutical drug addiction. Training workshop for Police officers from Sri Lanka, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 20 January 2020
  • Classification of Psychoactive Substances: Based on Science? CME of Addictive Disorder Specialty section, Indian Psychiatric Society, Mumbai, 5 January 2020
  • Substance Use Disorders: An Overview. Workshop for undergraduate Medicalstudents of Rajasthan, Jaipur, 21 December 2019
  • Opioid Substitution Treatment: An Overview. National Consultation on OST, Yangon, Myanmar, 11 December 2019
  • Long term pharmacotherapy for alcohol use disorders. CME of Indian Psychiatric Society, West Zone, Goa, 7 December 2019
  • Pharmaceutical drug use disorders. Training workshop for Drug Law Enforcement officers from Afghanistan, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 5 December 2019
  • Debate: OST is the most evidence-based, ethical and appropriate treatment for opioid dependence (For). PSCHIATRICKS, New Delhi, 24 November 2019
  • Drug Laws and Policies: International trends. Annual Conference of Indian Psychiatric Society, North Zone, Amritsar, 3 November 2019
  • Concept and Philosophy of Drug Harm Reduction: Application in India. Stakeholder consultation on substance use harm reduction, Knowledge Action Change, New Delhi, 17 October 2019
  • A Road map for evidence informed drug supply control response in India. Asia Regional Meeting of International Society for the Study of Drug Policy, Hong Kong, 15 October 2019
  • Drug Use Situation in India. Conference on Comprehensive Approach to Combating Illicit Trafficking of Afghan Opiates and Drug Situation in North East, Imphal, 30 September 2019
  • Drug Policy responses in India. Asian Regional Forum Against Drugs, Kochi, 25 September 2019
  • Outpatient management of Opioid Dependence. Annual National Conference of Indian Association for Biological Psychiatry, Agra, 20 September 2019
  • Drug Testing: A new harm reduction intervention at the interface of Toxicology and Addiction Psychiatry. Conference of Indian Association of Medico Legal Experts and Medico Legal Conference Nepal, Kathmandu, 13 September 2019
  • Integrated Package Of Services For Injecting Drug Users. National consultation organized by NACO, Govt. of India, New Delhi, 3 September 2019
  • Size estimation of Injecting Drug Users in India. Meeting of Technical Experts organized by NACO, Govt. of India, 26 August 2019
  • Substance Use and Sexual Dysfunction. National Mid Term CME of Indian Psychiatric Society, Mysore, 10 August 2019
  • Substance Use situation in India: evidence-informed prevention strategies. National workshop on Substance Use Prevention for State Council of Education Research and Training (SCERTs), New Delhi, 2 August 2019
  • Drug Use in India: What role could police play?, Orientation program on National Action Plan for Police key coordinators, New Delhi, 18 June 2019
  • Preventing Substance Use: What Works, What doesn’t. AnnualCME of Indian Psychiatric Society – West Zone, Nashik, 27 April 2019
  • Magnitude of Substance Use in India. Regional Consultation on Drug Use organized by United Nations Office on Drugs and Crime, New Delhi, 24 April 2019
  • Epidemiology of Substance Use in India. CME of Society for Rural Mental Health, Hisar, 21 April 2019
  • National Drug Use Survey: “Magnitude of Substance Use in India”. Annual Meeting of Narcotics Coordinaton NARCORD, Ministry of Home Affairs, New Delhi 12 March 2019
  • Preventing Substance Use: What Works, What doesn’t. Annual Psychology Festival, Aryabhata College, Delhi University, New Delhi, 1 March 2019
  • Magnitude of Substance Use in India. National Conference of Principle Secretaries of State Governments, organized by MoSJE, Govt. of India, 26 February 2019
  • Drug Use situation in India. training programme for Drug Law Enforcement officers from NCB, National Academy of Customs, Indirect Tax and Narcotics (NACIN), New Delhi, 25 February 2019
  • Magnitude of Substance Use in India. Panel Discussion on ‘10 years of Drug Policy in Asia: How far we have come?’ New Delhi, 20 February 2019
  • Drug Abuse scenario in India, vulnerable population and treatment services. Interactive Workshop under National Action Plan for Drug Demand Reduction organized by the National Institute of Rural Development & Panchayati Raj, Hyderabad, 1 February 2019
  • Management of Opioid Dependence. CME update organized by the Jammu and Kashmir Psychiatric Society, Jammu, 18 January 2019
  • Drug Use and HIV: Interface with Law enforcement: National Consultation with Police Training Academies, Organized by NACO, Govt. of India, New Delhi, 10 January 2019
  • Opioid Pharmaceuticals: Policy and legal issues. Indian Pharmaceutical Congress, NOIDA, 22 December 2018
  • Policy and legal issues related to Opioid analgesics in palliative care and addiction treatment. Workshop “opioids in palliative care” organized by FDA, Punjab, Chandigarh, 18 Dec 2018
  • Preventing Substance Use: What Works, What Doesn’t. National CME of Preventive Psychiatry Section of Indian Psychiatric Society, Patna, 8 December 2018
  • Abuse of Pharmaceutical drugs in India. training programme for Drug Law Enforcement officers from Myanmar, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 6 December 2018
  • Opioid Substitution Treatment (OST) is the Best strategy for management of Opioid Use Disorders. (Debate – For). National Conference of Indian Association of Private Psychiatry (ANCIAPP), Hyderabad, 1 December 2018
  • Intervention Strategies for Alcohol Use Disorders. National Conference of Indian Society of Gastroentrology, Kochi, 30 November 2018
  • Drug Laws and Policies. What Works and What Doesn’t. Law Economics Policy Conference (LEPC 2018), organized by the National Institute of Public Finance and Policy (NIPFP), New Delhi, 27 November 2018
  • Addiction in North East: Opportunities, Challenges and the way forward. North East Health Care Leadership Summit 2018, Shillong, 29 October 2018
  • Mental Health Care Act (MHCA) 2017: Implications for Addiction Treatment in India. Annual Conference of Indian Psychiatric Society – Rajasthan State, Bikaner, 20 October 2018
  • Treatment of Opioid Dependence: Policy and Legal Issues. National conference of Society for Rural Mental Health, Karnal, 29 September 2018
  • Pharmaceutical drug use – South Asia, training programme for officers from Department of Narcotics Control, Bangladesh, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 26 September 2018
  • Drug Laws and Policies: Scientific arguments for criminalization and De-Criminalization. training programme for judiciary, Delhi Judicial Academy, 15 September 2018
  • Sleep and Opioids: Neurobiology and clinical aspects. Global Conference of Biological Psychiatry, Mumbai, 25 August 2018
  • Changing legal and policy scenario for drugs: Implications for Psychiatrists. Mid Tem CME of IPS East Zone, Dibrugarh, 18 August 2018
  • Cannabis: From Neurobiology to Policy. Mid Tem CME of IPS East Zone, Dibrugarh, 18 August 2018
  • Data collection and analysis for Drug Use Epidemiology: An overview. Training Programme on “Planning and Designing of large scale sample surveys” for officers of Indian Statistical Service, National Statistical Systems Training Academy (NSSTA), Greater Noida, 19 June 2018
  • Economic Cost (and benefit) of Scale-up of Opioid Substitution Treatment in National AIDS Control Program, India: Comparison of three scenarios. Conference of International Society for the Study of Drug Policy (ISSDP 2018), Vancouver, Canada, 17 May 2018
  • Cannabis: The Final Word, RISE 2018, organized the Behavioural and Neurosciences Academy of India, Goa, 11 May 2018
  • National Drug Use Survey: An Overview. Delivered at National Conference of Drug Law Enforcement agencies, 24 March 2018, New Delhi
  • Alcohol Use Disorder: Demand Reduction Strategies. Delivered at South East Asia Region course on Public Health Approaches for Non-Communicable Disease, 21 March 2018, New Delhi
  • Opioid Substitution Treatment: An Overview of Theory and Evidence Base, Workshop organized by National STD AIDS Control Program, Government of Sri Lanka, Colombo, 27 February 2018
  • An Overview of Drug Use Disorders. Training programme for Drug Law Enforcement officers from Government of Myanmar, Narcotics Control Bureaue, New Delhi, 23 February 2018
  • Pharmaceutical drug use – South Asia, training programme for officers from Department of Narcotics Control, Bangladesh, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 13 December 2017
  • Drug Use Epidemiology: Methodological Issues. Training Programme on “Advanced Sampling Techniques” for officers of Indian Statistical Service, National Statistical Systems Training Academy (NSSTA), Greater Noida, 7 Dec 2017
  • Co-morbid Cannabis Use Disorder and Gaming Disorder, Fourth WHO meeting on Public health Implications of Addictive Behaviors, Istanbul, Turkey, 1 December 2017
  • Trends in Drug Laws and Policies. National Conference of Addiction Psychiatry, AIIMS, New Delhi, 27 November 2017
  • Issues related to Pharmaceutical drugs Abuse, training programme for Drug Law enforcement officers from Tanzania, National Academy of Customs, Indirect Tax and Narcotics (NACIN), Faridabad, 10 November 2017
  • Cannabis Dependence: Neurobiology and treatment approaches. Annual Conference of Indian Association for Biological Psychiatry, Chandigarh, 19 August 2017
  • Beyond Alcohol: Issues and Strategies, meeting of Indian Psychiatric Society, Bihar (in the wake of alcohol prohibition), Patna, 24 July 2017
  • Alcohol Control: Identifying opportunities for civil society action in the current policy context. National Civil Society Consultation on Non-Communicable Diseases (NCDs) in India, New Delhi, 11 July, 2017
  • Abuse of Pharmaceutical drugs, training programme for Drug Law enforcement officers, National Academy of Customs, Excise and Narcotics (NACEN), Faridabad, 31 May 2017
  • Do drug policies impede the availability of treatment of opioid dependence in India (and more so for non-injecting opioid users)? Analysis of epidemiological data from Punjab, India, International Society for the Study of Drug Policy Conference 2017 (ISSDP 2017), Aarhus, Denmark, 16 May 2017
  • Can economic analysis of household income and expenditure inform alcohol policies? Analysis of household data from nationally representative sample from India, International Society for the Study of Drug Policy Conference 2017 (ISSDP 2017), Aarhus, Denmark, 17 May 2017
  • Managing Pain in Palliative care with Opioids: Perspective of an Addiction Treatment Provider, Annual Conference on Indian Association of Palliative Care, Coimbatore, 11 February 2017
  • Alcohol and Public Health: Impact and Solutions. JJ Memorial oration on mental health, delivered at Govt. Grants Medical College, Mumbai, 24 January 2017
  • National Survey on Extent and Pattern of Substance Use in India: Methodology and Operational Issues, Annual National Conference of Indian Psychiatric Society, Raipur, 6 Jan 2017

Investigator/ Co-investigator in funded projects along with year completed/ongoing

As Principal Investigator

  • National Survey on Extent and Pattern of Substance use in India, Supported by the Ministry of Social Justice and Empowerment, Government of India (2016-2021)
  • Development and evaluation of service delivery models for management of substance use disorders among the homeless population receiving urban shelter services in Delhi, Supported by the Department of Women and Child Development, Government of NCT of Delhi (2021 – ongoing)
  • Establishing Addiction Treatment Facilities in Government Health care settings, Supported by the Ministry of Social Justice and Empowerment, Government of India (2019-ongoing)
  • Field Testing of ICD-11 Classification for Disorders related to Substance Use and Addictive Behaviours, Supported by WHO (Geneva), (2018-2020)
  • Developing Training Mechanisms for use of Essential Narcotic Drugs (Methadone) for the treatment of Opioid Dependence, Supported by the Dept. of Revenue, Government of India (2017 – ongoing)
  • Effectiveness of the revised version of DrinkLess – A Web based self help intervention to reduce alcohol consumption in harmful hazardous drinkers: A Transnational RCT. Supported by World Health Organization (Geneva). (2016-ongoing)
  • Punjab Opioid Dependence Survey, supported by the Society for Promotion of Youth and Masses (SPYM), with financial support from Ministry of Social Justice and Empowerment, Government of India (2014 – 2015)
  • Development of an online training programme on Opioid Substitution Therapy, Project supported by Public Health Foundation of India (2014 – 2017)
  • Post Marketing Surveillance of Methadone in India, Project supported by the Rusan Pharma (2013 – 2014)
  • Drug Use Pattern Assessment in Bihar, Haryana and Uttarakhand, project supported by India HIV/AIDS Alliance and NACO (2013 – 2014)
  • Opioid Substitution Therapy under the National AIDS Control Program: A situation Assessment, supported by GFATM Round 9 grant and NACO, 2012
  • Risk of Transition to Injecting Drug Use among non-injecting opioid users: A Multi-site study in Northwest India, supported by Regional Resource Training Centre, MoSJE, Government of India (2012)
  • A pilot study of feasibility and efficacy of Brief intervention compared with Simple Advice when linked to the Brief ASSIST for Substance Use Disorders in Primary Health Care and Community Settings: Project of University of Adelaide, WHO Collaborating Centre, (2011)

As Co-Investigator

  • Experience of Patients on Methadone Maintenance Treatment receiving Take-Home Methadone doses during COVID-19 pandemic In India: A mixed-method study. Investigators:Ravindra Rao, Atul Ambekar, Rakesh Chadda, Alok Agrawal, Roshan Bhad (2021 – ongoing)
  • Establishing and Implementing Capacity Building Mechanisms for Addiction Treatment Facilities in India Investigators: Alok Agrawal, Atul Ambekar, Rakesh Chadda, Roshan Bhad, Ravindra Rao, (2019-ongoing)
  • Field Testing of International Standards for Treatment of Drug Use Disorders, Investigators: Rakesh Chadda, Atul Ambekar, Roshan Bhad, Ravindra Rao, Alok Agrawal (2017 – 2019)
  • Rapid Assessment of Drug Use Patterns (RADUP) among People Who Use and/or Inject Drugs (PWUD/PWID) in Sri Lanka, Investigators: Sathya Herath, Atul Ambekar (2017-2018)
  • Mapping and size estimation of drug using street children in Delhi. Investigators: Anju Dhawan, Atul Ambekar, Ashwani Mishra, Rachna Bhargava, Biswadip Chatterjee, Alok Agrawal, 2015 – 2016
  • Workplace intervention for Drug and Alcohol use at Indian Oil Refinery, Digboi, Assam, Investigators: Prof Rajat Ray, Atul Ambekar, Rakesh Lal, Deepak Yadav (2010-ongoing)
  • Methadone Maintenance Treatment in India: A multi-site feasibility and effectiveness study. Investigators: Anju Dhawan, Atul Ambekar, Rajat Ray, Deepak Yadav, Anita Chopra, Raka Jain 2011 – 2014
  • OST program in Government health-care settings: treatment compliance and retention’, Investigators: Deepak Yadav, Atul Ambekar, Anju Dhawan, Alok Agrawal, Jyoti Mehra, Hem Sethi, report submitted to DFID TAST and NACO, Government of India
  • Mapping and size estimation of High Risk Groups in Jammu and Kashmir and Tripura, in collaboration with Society for Promotion of Youth and Masses, New Delhi, conducted for and report submitted to National AIDS Control Organisation (NACO), New Delhi, 2008
  • A Rapid situation assessment of inhalant use among street children in Delhi and development of an intervention, Investigators: Rajat Ray, Anju Dhawan, Atul Ambekar, Deepak Yadav, Anita Chopra, 2008-2009
  • Developing community-based drug treatment services at four districts in the country – Mandsaur, MP, Bilaspur, Chattisgarh, Meerut, UP and Morigaon, Assam, Investigators: Rajat Ray, Atul Ambekar, Rakesh Lal, Deepak Yadav, Anita Chopra, 2008-2013

Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing

Thesis supervised for MD/ DM/PhD

- as guide: 12

-as co-guide: 23

Details of publications since 2010 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications):

Papers And Articles (In Peer Reviewed Scientific Journals)

  • Teck JTW, Zlatkute G, Perez A, Dritschel H, Ghosh A, Potenza MN, Ambekar A, Ekhtiari H, Stein D, Khazaal Y, Arunogiri S, Torrens M, Ferri M, Galea-Singer S, Baldacchino A. Key implementation factors in telemedicine-delivered medications for opioid use disorder: a scoping review informed by normalisation process theory. Lancet Psychiatry. 2023 Jan;10(1):50-64. 
  • Forget P, Patullo C, Hill D, Ambekar A, Baldacchino A, Cata J, et al (2022). System-level policies on appropriate opioid use, a multi-stakeholder consensus. BMC Health Serv Res. 2022 Mar 12;22(1):329. doi: 10.1186/s12913-022-07696-x
  • Ambekar A (2022). Decriminalisation of drug use in India: A long overdue legal reform (editorial). Ind J Soc Psy. 2022, 38(3): 209-212. DOI: 10.4103/ijsp.ijsp_183_22
  • Ambekar A, Gautam M, Matcheswalla Y, Kar S, Kadam K (2022). Medicolegal Issues with Reference to NDPS and MHCA in Management and Rehabilitation of Persons with Substance Use Disorders. Indian J Psychiatry 2022 Mar;64(Suppl 1):S146-S153. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_724_21
  • Quraishi R, Varshney M, Rao RV, Ambekar A (2022). Evaluation of alcohol use pattern among OST patients using alcohol biomarkers: Report from community clinics in India. Indian J Psychiatry 2022 May-Jun;64(3):312-315
  • Singh R, Gupta R, Grover T, Ambekar A, Jain R, Vaswani M, Mishra A, Sharma A. Role of the Serotonin and GABAA Receptor Gene Polymorphisms in patients with Alcohol Dependence. Asian J Psychiatry,  2022 Nov 12;80:103326. doi: 10.1016/j.ajp.2022.103326.
  • Quraishi R, Sarkar S, Parmar A, Jain R, Das BK, Ambekar A (2022). Exploring the clinical variables among drug-dependent HIV-Positive patients: Implications for treatment strategies. Indian J Public Health 2022 Jul-Sep;66(3):331-333.
  • Choudhary N, Singh S, Rathore P, Ambekar A, Bhatnagar S (2021). Opioid Use Disorders among patients on long-term morphine for management for chronic cancer pain: A pilot study from a tertiary palliative care facility. Indian Journal of Palliative Care, 27(2); 264-268
  • Saini R, Parmar A, Rao R, Mishra AK, Ambekar A, Agrawal A (2021). Psychiatric and Substance Use Comorbidities among People who Inject Drugs in India: A Cross-Sectional, Community-Based Study. World Soc Psychiatry 2021;3:195-202.
  • Singh A, Rao R, Chatterjee B, Mishra AK, Kaloiya G, Ambekar A (2021). Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study, Asian Journal of Psychiatry, 61, 102697, https://doi.org/10.1016/j.ajp.2021.102697
  • Singh et al (India State-Level Disease Burden Initiative Neurological Disorders Collaborators) (2021). The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019. The Lancet Global Health, https://doi.org/10.1016/S2214-109X(21)00164-9
  • Schaub MP, Tiburcio M, Martínez-Vélez N, Ambekar A, Bhad R, Wenger A, Baumgartner C, Padruchny D, Osipchik S, Poznyak V, Rekve D, Landi Moraes F, Monezi Andrade AL, Oliveira Souza-Formigoni ML; WHO E-Health Project On Alcohol And Health Investigators Group (2021).  The Effectiveness of a Web-Based Self-Help Program to Reduce Alcohol Use Among Adults With Drinking Patterns Considered Harmful, Hazardous, or Suggestive of Dependence in Four Low- and Middle-Income Countries: Randomized Controlled Trial. J Med Internet Res. 2021 Aug 27;23(8):e21686. doi: 10.2196/21686.
  • Quraishi R, Sharma J, Jain R, Ambekar A (2021). Influence of catechol‑O‑methyltransferase enzyme gene polymorphism on alcohol and tobacco consumption in North Indian treatment seeking population. Indian J Psychiatry 2021;63:240-4
  • Manomy PA, Yenamandra VK, Dabas G, Joshi P, Ambekar A, Sreenivas V, Sharma VK, Vatsa M, Ravindran S, Sethuraman (2021). Impact of a psychodermatological education package on the subjective distress, family burden, and quality of life among the primary caregivers of children affected with epidermolysis bullosa. Indian Dermatol Online J 2021;12:276-80.
  • Chawla N, Verma S, Ganesh R, Sarkar S & Ambekar A (2021). Sexual relationship, self-esteem, dysfunction, and sexual satisfaction in treatment naïve men with heroin dependence. Journal of Psychoactive Drugs, doi.org/10.1080/02791072.2020.1870779
  • Castro‐Calvo, J., King, D. L., Stein, D. J., Brand, M., Carmi, L., Chamberlain, S. R., Demetrovics, Z., Fineberg, N. A., Rumpf, H.‐J., Yücel, M., Achab, S., Ambekar, A., Bahar, N., Blaszczynski, A., Bowden‐Jones, H., Carbonell, X., Chan, E. M. L., Ko, C.‐H., de Timary, P., Dufour, M., Grall‐Bronnec, M., Lee, H. K., Higuchi, S., Jimenez‐Murcia, S., Király, O., Kuss, D. J., Long, J., Müller, A., Pallanti, S., Potenza, M. N., Rahimi‐Movaghar, A., Saunders, J. B., Schimmenti, A., Lee, S.‐Y., Siste, K., Spritzer, D. T., Starcevic, V., Weinstein, A. M., Wölfling, K., and Billieux, J. (2021) Expert appraisal of criteria for assessing gaming disorder: An international Delphi study. Addiction, https://doi.org/10.1111/add.15411.
  • Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A; ISAM-PPIG Global Survey Consortium, Potenza MN, Ekhtiari H, Baldacchino AM (2021). Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Front Psychiatry. 2021 Apr 29;12:639393. doi: 10.3389/fpsyt.2021.639393. PMID: 34025471; PMCID: PMC8135096.
  • Farhoudian A, Radfar SR, Mohaddes Ardabili H, Rafei P, Ebrahimi M, Khojasteh Zonoozi A, De Jong CAJ, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Hansen H, Brady KT; ISAM Global Survey Consortium (ISAM-GSC), Potenza MN, Baldacchino AM, Ekhtiari H (2021). A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic.Front Psychiatry. 2021 Aug 6;12:646206. doi: 10.3389/fpsyt.2021.646206. PMID: 34421664; PMCID: PMC8377291.
  • Mohan, A., & Ambekar, A. (2020). Telepsychiatry and Addiction Treatment.Indian Journal of Psychological Medicine, 42(5_suppl), 52S-56S. https://doi.org/10.1177/0253717620958169
  • Sartaj D, Krishnan V, Rao R, Ambekar A, Dhingra N, Sharan P. (2020). Mental illnesses and related vulnerabilities in the Hijra community: A cross-sectional study from India.Int J Soc Psychiatry. 2020 Aug 20:20764020950775. doi: 10.1177/0020764020950775.
  • Gupta R, Grover S, Basu A, Krishnan V, Tripathi A, Subramanyam A, Nischal A, Hussain A, Mehra A, Ambekar A, Saha G, Mishra KK, Bathla M, Jagiwala M, Manjunatha N, Nebhinani N, Gaur N, Kumar N, Dalal PK, Kumar P, Midha PK, Daga R, Tikka SK, Praharaj SK, Goyal SK, Kanchan S, Sarkar S, Das S, Sarkhel S, Padhy SK, Sahoo S, Satyanarayana Rao TS, Dubey V, Menon V, Chhabra V, Lahan V, Avasthi A (2020). Changes in sleep pattern and sleep quality during COVID-19 lockdown.Indian J Psychiatry. 2020 Jul-Aug;62(4):370-378. doi: 10.4103/psychiatry.IndianJPsychiatry_523_20
  • Grover T, Gupta R, Arora G, Bal CS, Ambekar A, Basu Ray S, Vaswani M, Sharma A (2020).Dopamine transporter availability in alcohol and opioid dependent subjects - a 99m Tc-TRODAT-1SPECT imaging and genetic association study.Psychiatry Res Neuroimaging. 2020 Sep 10;305:111187. doi: 10.1016/j.pscychresns.2020.111187
  • Dhagudu, N.K., Ambekar, A., Agrawal, A., Rao, R., Mishra, A.K., Jain, R. and Singh, S (2020). Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects.Drug Alcohol Rev. 2020; 39: 595-603 doi:10.1111/dar.13057
  • Sagar R et al (India State-Level Disease Burden Initiative Mental Disorders Collaborators) (2020). The burden of mental disorders across the states of India: the Global Burden of Disease Study 1990–2017,The Lancet Psychiatry; 7 (2): 148-161
  • Rao R, Panda U, Gupta SK, Ambekar A, Gupta S, Agrawal A (2020). Portrayal of alcohol in Bollywood movies: A mixed methods study.Indian J Psychiatry, 62(2): 159-166
  • Goyal SG, Ambekar A, Jain R, Mehta M, Mishra AK (2020). Intravenous buprenorphine does not impair psychomotor and cognitive functioning in opioid-dependent patients using oral dextropropoxyphene: A randomized, double-blind, crossover study.J Mental Health Hum Behav 2020;25:45-52
  • Chawla N, Verma S, Sarkar S, Ambekar A (2020). Assessment of sexual behavior among patients seeking treatment for opioid dependence and their knowledge and attitude about high-risk sexual behavior: A cross-sectional observational study.Indian J Soc Psychiatry 2020;36:29-36
  • Vishwakarma A, Tarwani J, Chawla N, Dayal P, Agrawal A, Mandal P & Ambekar A (2020) Mephentermine dependence with induced psychosis: a series of two cases, Journal of Substance Use, 25:6, 569-571, DOI: 10.1080/14659891.2020.1749949
  • Rao R, Gupta SK, Swaminathan P, Gupta V, Dhawan A, Agrawal A & Ambekar A (2020) Predictors of long-term retention on opioid agonist treatment with buprenorphine: a 6-year, community-based retrospective cohort study in India, Journal of Substance Use, 25:5, 489-494, DOI: 10.1080/14659891.2020.1736666
  • Gupta S, Lal R, Ambekar A, Mishra AK, Rao R (2020). The pattern of alcohol use and its relationship with consequences among problem alcohol users: A community-based cross-sectional study from India. Indian J Psychiatry. 2020;62(2):152‐158. doi:10.4103/psychiatry.IndianJPsychiatry_194_19
  • Srivastava P, Mehta M, Sagar R, Ambekar A. Smartteen- a computer assisted cognitive behavior therapy for Indian adolescents with depression- a pilot study. Asian J Psychiatr. 2020;50:101970. doi:10.1016/j.ajp.2020.101970
  • Dhawan A, Mishra AK, Ambekar A, Chatterjee B, Agrawal A, Bhargava R (2020). Estimating the size of substance using street children in Delhi using Respondent-Driven Sampling (RDS),Asian Journal of Psychiatry: 48 (2020) 101890
  • Ambekar A, Mishra A, Parmar A, Kumar R, Kumar M, Rao R, Agrawal A (2019), Are non-injecting opioid users at risk of transition to injecting drug use? A multi-site study from India Asian Journal of Psychaitry, 42:79-84.
  • Jyani G, Prinja S, Ambekar A, Bahuguna P, Kumar R (2019). Health impact and economic burden of alcohol consumption in IndiaInternational Journal of Drug Policy, 69; 34-42
  • Kathiresan P, Ambekar A, Sarkar S. (2019). Opioid Substitution Treatment Using Buprenorphine for Management of Dependence on Natural Opioids: Case Series,Indian J Psychol Med 11;41(6):586-588
  • Sood A, Mishra A, Ambekar A (2019), Trends in alcohol consumption and expenditure: Analysis of household data from nationally representative sample from India,Asian Journal of Psychaitry, 22;40:116-123.
  • Saini R, Rao R, Parmar A, Mishra AK, Ambekar A, Agrawal A, Dhingra N. (2019), Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugs in India: A community-based study.Drug Alcohol Rev.. doi: 10.1111/dar.13016.
  • Jain R, Quraishi R, Verma A, Ambekar A. (2019). Development and clinical evaluation of a dried urine spot method for detection of morphine among opioid users.Indian J Pharmacol; 51(1):40-44.
  • Rao R, Varshney M, Singh S, Agrawal A, Ambekar A(2019), Mental Healthcare Act, 2017 and Addiction Treatment: Potential Pitfalls and Trepidations Indian J Psychiatry, 61(2); 208-212
  • Mandal P, Parmar A, Ambekar A, Dhawan A(2019), Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian Journal of Psychaitry22;41:17-19
  • Ambekar A, Rao R, Agrawal A, Kathiresan P (2019) Research on opioid substitution therapy in India: A brief, narrative review. Indian J Psychiatry; 60:265-70
  • Quraishi R, Varshney M, Singh A, Singh D, Kumar M, Rao R, Jain R, Ambekar A. (2019). Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study. Indian J Psychol Med. Nov 11;41(6):529-534.
  • Chattopadhyay A, Gupta S, Dayal P, Mandal P, Agrawal A, Ambekar A (2019). Butorphanol dependence in a health-care professional: A case report with narrative review. Journal of Substance Use, doi.org/10.1080/14659891.2019.1604839
  • Dandona R, Kumar GA, Dhaliwal RS, Naghavi M, Vos T, Shukla DK, Vijayakumar L, Gururaj G, Thakur JS, Ambekar A, Sagar R, Arora M, Bhardwaj D, Chakma JK, Dutta E, Furtado M, Glenn S, Hawley C, Johnson SC, Khanna T, Kutz M, Mountjoy-Venning WC, Muraleedharan P, Rangaswamy T, Varghese CM, Varghese M, Reddy KS, Murray CJL, Swaminathan S, Dandona L (2018). Gender differentials and state variations in suicide deaths in India: the Global Burden of Disease Study 1990-2016. Lancet Public Health.  Oct;3(10):e478-e489. doi: 10.1016/S2468-2667(18)30138-5.
  • Ambekar A, Mongia M, (2018). Planning research in psychosocial interventions. Indian Journal of Psychiatry; 60 (8): 575-582
  • Rumpf HJ, Achab S, Billieux J, Bowden-Jones H, Carragher N, Demetrovics Z, Higuchi S, King DL, Mann K, Potenza M, Saunders JB, Abbott M, Ambekar A, Aricak OT, Assanangkornchai S, Bahar N, Borges G, Brand M, Chan EM, Chung T, Derevensky J, Kashef AE, Farrell M, Fineberg NA, Gandin C, Gentile DA, Griffiths MD, Goudriaan AE, Grall-Bronnec M, Hao W, Hodgins DC, Ip P, Király O, Lee HK, Kuss D, Lemmens JS, Long J, Lopez-Fernandez O, Mihara S, Petry NM, Pontes HM, Rahimi-Movaghar A, Rehbein F, Rehm J, Scafato E, Sharma M, Spritzer D, Stein DJ, Tam P, Weinstein A, Wittchen HU, Wölfling K, Zullino D, Poznyak V (2018). Including gaming disorder in the ICD-11: The need to do so from a clinical and public health perspective. J Behav Addict.:1-6. doi: 10.1556/2006.7.2018.59.
  • Sahni S, Tickoo M, Gupta R, Vaswani M, Ambekar A, Grover T, Sharma A. (2018). Association of serotonin and GABA pathway gene polymorphisms with alcohol dependence: A preliminary study. Asian J Psychiatry. pii: S1876-2018(17)30466-5. doi: 10.1016/j.ajp.2018.04.023
  • Ambekar A, Parmar A, Mandal P & Therthani S. (2017) High proportion of pentazocine dependence among treatment-seeking female injecting drug users (FIDUs) in India: A distinct population? Journal of Substance Use. DOI: 10.1080/14659891.2017.1364306
  • Dandona L. et al, (India State-level Disease Burden Initiative Collaborators). (2017) Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. LANCET, DOI: http://dx.doi.org/10.1016/S0140-6736(17)32804-0
  • Ambekar A, Murthy P, Basu D, Rao GP & Mohan A. (2017) Challenges in the scale-up of Opioid Substitution Treatment (OST) in India (Guest Editorial), Indian Journal of Psychiatry;59:6-9
  • Dhawan A,Rao R, Ambekar A, Pusp A & Ray R. (2017) Treatment of substance use disorders through the government health facilities: Developments in the Drug De-addiction Programme of Ministry of Health and Family Welfare, Government of India Indian Journal of Psychiatry. DOI:10.4103/psychiatry.IndianJPsychiatry_19_17 
  • Gupta S, Lal R, Rao R, Mishra A K & Ambekar A. (2017) Pattern of alcohol use among problem alcohol users in a community-based setting in India: A cross-sectional study. Journal of Substance Use. DOI: 10.1080/14659891.2017.1366557
  • Schaub MP, Tiburcio M, Martinez N, Ambekar A, Balhara YPS, Wenger A, Andrade ALM, Padruchny D, Osipchik S, Gehring E, Poznyak V, Rekve D & Souza-Formigoni MLO, WHO e-health project on Alcohol and Health Investigators Group (2017) Alcohol e-Help: Study protocol for a Web-based self-help program to reduce alcohol use in adults with drinking patterns considered harmful, hazardous, or suggestive of dependence in middle-income countries. Addiction. doi: 10.1111/add.14034
  • Saunders J B, Hao W, Long J, King DL, Mann K, Fauth-Bühler M, Rumpf HJ, Bowden-Jones H, Rahimi-Movaghar A, Chung T, Chan E, Bahar N, Achab S, Lee HK, Potenza M, Petry N, Spritzer D, Ambekar A, Derevensky J, Griffiths MD, Pontes HM, Kuss D, Higuchi S, Mihara S, Assangangkornchai S, Sharma M, Kashef A E, Ip P, Farrell M, Scafato E, Carragher N & Poznyak V. (2017) Gaming disorder: Its delineation as an important condition for diagnosis, management, and prevention J Behav Addict:1-9. doi: 10.1556/2006.6.2017.039
  • Singh R, Grover T, Gupta R, Ambekar A, Jain R and Sharma A. (2017) An Association Study of the COMT and GABA Gene Variants with Alcohol Dependence. J Addict Res Ther, 8:6 DOI: 10.4172/2155-6105.1000350
  • Gupta R, Grover T, Ambekar A, Singh R, Vaswani M and Sharma A. (2017) An Association Study on the Glutamate Pathway GRIN2A Gene Polymorphisms with Heroin Dependence. J Addict Res Ther, 8:6 DOI: 10.4172/2155-6105.1000348
  • Qureshi R, Jain R, Ambekar A & Mishra AK. (2017) Association of ankyrin repeats & kinase domain containing 1 (ANKK1) polymorphism with co-morbid alcohol and nicotine dependence: A pilot study from a tertiary care treatment center in North India. Indian Journal of Medical Research, (145); 33-38
  • Gupta SK, Ambekar A, Dhawan A & Mehta M (2017). Personality profile of alcohol and injecting opioid users: A comparative study from India, Asian Journal of Psychatry, 25: 142-146
  • Mandal P, Parmar A, Therthani S & Atul Ambekar (2016). Profile of elderly women seeking treatment for substance use disorders at a tertiary care treatment center, Journal of Substance Use, DOI: 10.1080/14659891.2016.1217092
  • Kuppili PP, Bhad R, Rao R, Dayal P & Ambekar A, (2016)The mis-adventurous use of prescription opioids in chronic non-cancer pain, National Medical Journal of India DOI: 10.3109/14659891.2015.1040092
  • Rao R, Ambekar A, Agrawal A, Pawar AK, Mishra AK & Khandelwal S. (2016) Evaluation of a five-day training programme on opioid substitution therapy in India, Drugs: Education, Prevention and Policy: DOI: 10.3109/09687637.2016.1167166
  • Rao R, Mandal P, Gupta R, Ramashankar P, Mishra AK, Ambekar A, Jhanjee S & Dhawan A. (2015) Factors affecting drug use during incarceration: a cross-sectional study of opioid-dependent persons from India, Journal of Substance Abuse Treatment: DOI:10.1016/j.jsat.2015.08.009
  • Bhad R, Dayal P, Kumar S & Ambekar A, (2015) The drug ketamine: a double edged sword for mental health professionals J Subst Use; DOI: 10.3109/14659891.2015.1040092
  • Varshney M, Ambekar A, Lal R, Yadav D, Rao R & Mishra AK, (2015) Brief Interventions for harmful alcohol use in opioid-dependent patients on maintenance treatment with buprenorphine: A prospective study from India, Addictive Disorders and Their Treatment,: doi: 10.1097/ADT.0000000000000076
  • Ambekar A, Rao R, Agrawal A, Mishra AK, Kishore K, Mukherjee D & Albertin C, (2015) Pattern of drug use and associated behaviours among female injecting drug users from northeast India: a multi-centric, cross-sectional, comparative study, Substance Use and Misuse,: 50:10, 1332-1340; DOI: 10.3109/10826084.2015.101313
  • Prakash S, Ambekar A & Dayal P, (2015) Occasional alcohol use, relapse to opioids and the role of disulfiram, Journal of Substance Use,DOI: 10.3109 / 14659891. 2015. 1029024
  • Ramdurg S, Ambekar A & Lal R. (2015) Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence. Ind Psychiatry J;24:29-34
  • Dhawan A, Chopra A, Ambekar A & Ray R. (2015) Treatment seeking behavior of inhalant using street children: Are we prepared to meet their treatment needs. Indian J Psychol Med;37:282-7
  • Ambekar A, Rao R, Mishra AK & Agrawal A, (2014) Type of opioids injected: Does it matter? A multicentric cross-sectional study of people who inject drugs, Drug Alcohol Rev 34: 97-104. doi: 10.1111/dar.12208
  • Gupta SK, Ambekar A, Dhawan A & Mehta M, (2014) Psychosocial factors associated with HIV-related high-risk injection behavior among people who inject drugs; 19 (2): 62-68
  • Bhad R, Ambekar A, and Dayal P, The lizard: an unconventional psychoactive substance?, Journal of Substance Use, Early Online: 1–2, DOI: 10.3109/14659891.2014.987836
  • Goyal S, Ambekar A & Ray R. Jul - Sep 2014 Ketamine Dependence in an Anesthesiologist: An Occupational Hazard? Indian Journal of Psychological Medicine,; Vol 36; 3
  • Pal A, Ambekar A & Bera SC, (2014) Pharmacovigilance in psychiatry: time to take notice Journal of Drug Discovery and Therapeutics, 2 (20), 38-39
  • Ambekar A, Rao R, Pun A, Kumar S & Kishore K (2013), The trajectory of Methadone Maintenance Treatment in Nepal, International Journal of Drug Policy 2013 Jul 8. doi:pii: S0955-3959(13)00094-7. 10.1016/j.drugpo.2013.06.001
  • Ambekar A, Rao R, Agrawal A (2013). India’s National Narcotic Drugs and Psychotropic Substances Policy 2012: A 20th Century Document in 21st Century. International Journal of Drug Policy 2013 Jul;24(4):374-5
  • Rao R, Agrawal A, Kishore K & Ambekar A (2013). Delivery models of opioid agonist maintenance treatment in South Asia: A good beginning. Bulletin of the World Health Organisation, Volume 91, Number 2, February 2013
  • Prasad P, Ambekar A & Vaswani M,(2013) Case–control association analysis of Dopamine receptor polymorphisms in alcohol dependence: a pilot study in Indian males, BMC Research Notes, 6:418
  • Quraishi R, Jain R & Ambekar A (2013), The Use of Dried Blood Spot Samples in Screening Drugs of Abuse Pharmacology & Pharmacy,4 (2); 152
  • Ambekar A & Pawar A, (2012) Low Dead-Space Syringes for HIV prevention among people who inject drugs: Interesting, but a much stronger case is required. International Journal of Drug Policy. pii: S0955-3959(12)00149-1. doi: 10.1016/j.drugpo.2012.09.009.
  • Singh RR & Ambekar A, (2012) Opioid substitution treatment in a public health setting: A collaboration between hospitals and NGOs in the Punjab. International Journal of Drug Policy, 23; 169– 171
  • Rao R, Ambekar A, Yadav S, Sethi H & Dhawan A, (2011)Slow-release oral morphine as a maintenance agent in opioid dependence syndrome: an exploratory study from India Journal of Substance Use; Early Online:1–7
  • Larance B, Ambekar A, Azim T, Murthy P, Panda S, Degenhardt L & Mathers B,(2011) The availability, diversion and injection of pharmaceutical opioids in South Asia, Drug Alcohol Rev. May;30(3):246-54.
  • Ramdurg S, Ambekar A & Lal R.(2011) Sexual Dysfunction among Male Patients Receiving Buprenorphine and Naltrexone Maintenance Therapy for Opioid Dependence J Sex Med. Mar 2. doi: 10.1111
  • Sood M & Ambekar A,(2011) Giving ‘fresh fruit juice’ to patient as a metaphor for giving care by family members / care takers. National Medical Journal of India, 24 (6): 375
  • Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A & Strathdee SA, (2010) HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, LANCET, 375(9719)  1014-1028; DOI:10.1016/S0140-6736(10)60232-2
  • Prasad P, Ambekar A & Vaswani M, (2010) Dopamine D2 receptor polymorphisms and susceptibility to alcohol dependence in Indian males: a preliminary study, BMC Med Genet. 11;11:24  

Books And Monographs (authored / Edited): Training Manuals / Resource Materials

Books And Monographs (authored / Edited): Research reports

Chapters In Books / Monographs

  • Ambekar A, Singh S (2022). “Dealing with Drug Addiction”. In Chadda RK, Pratap S, Sood M, Deb KS (eds) Mental Health at Crossroads: Challenges and Solutions. New Delhi: White Falcon Publishing
  • Ambekar A (2021), “Challenges in managing substance use disorders during COVID19 pandemic”. In Bhattacharyya R, Dalui A, Bandhopadhyay T, Sen A (eds)Guidelines for managing mental health issues during COVID 19 pandemic. Kolkata: Indian Medical Association – Bengal State Branch
  • Ambekar A., Rao R., Agrawal A. (2021). “Contribution towards national policies and programs related to addiction treatment services during COVID-19 pandemic: An experiential account” (pp 70-74). In Chadda R, Sood M, Deep R (eds),COVID19 pandemic and Mental Health: Experiences of organizing services at a tertiary care healthcare institution. New Delhi: Dept. of Psychiatry and NDDTC, AIIMS, New Delhi
  • Ambekar A, George A (2020). “Integrating the biological basis and the pharmacotherapy of Alcohol dependence: Focus on current and potential interventions.” In Gupta N, Kumar P, Mohan A (eds)Recent Advances in Biological Psychiatry – Theme: Addiction Psychiatry (2nd ed). Mumbai: Indian Association of Biological Psychiatry
  • Ambekar A, Mandal P (2020). “Substance related disorders” In Singh PK, Singh OP, Kumar V (eds)IPS Text book of Undergraduate Psychiatry. New Delhi: Jaypee brothers medical publishers
  • Qureshi R, Ambekar A (2018). “Genetics of Alcohol Use Disorders” in Bhuyan D (Ed).Psychiatry Update. Dibrugarh: Assam Medical College
  • Ambekar A, Chawla N (2018). “Cannabis: From Neurobiology to Policy” in Bhuyan D (Ed).Psychiatry Update. Dibrugarh: Assam Medical College
  • Dabholkar H, Ambekar A & Benegal V,(2017) “Psychiatric Emergencies in Substance Abuse” in Thara R, Vijayakumar L (eds), Emergencies in Psychiatry in Low and Middle Income countries, Edition - II, New York: Routledge
  • Qureshi R, Jain R & Ambekar A. (2017) “Dried Blood Spots for Testing Drugs of Misuse”, in Wolff K (Ed),Detection of Drug Misuse : Biomarkers, Analytical Advances and Interpretation, Cambridge: Royal Society of Chemistry
  • Ambekar A & Goyal S (2016), “Clinical Practice Guidelines for treatment of Amphetamine Type Stimulants”, in Basu D, Dalal PK (eds),Clinical Practice Guidelines on Newer and Emerging Addictive Disorders in India, New Delhi: Indian Psychiatric Society
  • Srivastava P, Mehta M, Ambekar A & Sagar R (2015), “Depression” in Mehta M, Sagar R (eds),A Practical Approach to Cognitive Behaviour Therapy for Adolescents, New Delhi: Springer India
  • Ambekar A & Pawar A (2015), “Epidemiology of Substance Use in India: Emerging insights”. Hyderabad: Souvenir of Annual National Conference of Indian Psychiatric Society, 2015 (ANCIPS-2015).
  • Ambekar A & Goyal S (2015), “Clinical Practice Guidelines for treatment of Opioid Use Disorders”, in Basu D, Dalal PK (eds), Handbook -Clinical Practice Guidelines for Substance Use Disorders, New Delhi: Indian Psychiatric Society
  • Ambekar A (2014), “Management of Substance Use in India: Where we are and where do we need to go?”.Souvenir of Annual Conference of Indian Psychiatric Society – East Zone, 2014 (CEZIPS-2014), Dibrugarh:Department of Psychiatry, Assam Medical College
  • Ambekar A & Deb KS , (2013). “Import of Narcotics for Clinical Trial Supplies”, in Kshirsagar N, Kulkarni T, Desai A, Shah J (eds), Emergencies in Psychiatry in Low and Middle Income countries , New Delhi: Indian Council of Medical Research (ICMR)
  • Ambekar A (2013), “Pharmacotherapy for opioid dependence”, in Rakesh Lal, Ramandeep Pattnayak (eds), Substance Use Disorders: Handbook for Physicians. New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
  • Ambekar A & Goyal S (2013), “Methadone Maintenance Treatment” in Dhawan A, Jhanjhi S (eds) Manual for Long-term pharmacotherapy of alcohol and opiate dependence New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
  • Ambekar A & Kattimani S (2013), Anti-craving medications for long-term treatment of alcohol dependence, in Dhawan A, Jhanjhi S (eds) Manual for Long-term pharmacotherapy of alcohol and opiate dependence . New Delhi: National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
  • Dabholkar H, Ambekar A & Benegal V, “Psychiatric Emergencies in Substance Abuse” in Thara R, Vijayakumar L (eds), Emergencies in Psychiatry in Low and Middle Income countries , (2012), Manipal: Byword Books
Default Woman Doctor Image

Prof.
Sonali Jhanjee

Female

MD, DNB(Psychiatry)

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
sonalijhanjee@gmail.com

General OPD

Friday

Special Clinic

Monday (Tobacco Cessation Clinic, NDDTC)
Wednesday (Ward Rounds)
Thursday (Patient education facility)

Field of Interest

Interventional (both pharmacological and psychosocial) research in tobacco cessation, Teaching/Training/Capacity building for treatment of nicotine dependence and substance abuse treatment,Yoga and meditation in stress reduction and treatment of drug abuse, Opioid substitution treatment, community based treatment of drug use

Total number of publications till date : 65

Significant events

  • Part of the SRNT Global Curriculum Review Board
  • Resource person for WHO-ERS “Train the trainer” tobacco cessation  workshop in Dhaka, Bangladesh on 8th-9th January,2017
  • Part of an Roundtable discussion in 2014 held under National Tobacco Control Programme to discuss the current evidence around the existing and potential impact Of Electronic Nicotine Delivery Systems (ENDS) on public health and discuss regulation of e-cigarettes under existing legislative framework
  • Expert Groups
  • Finalizing course modules on “Tobacco Quit Line Services” under MOH&FW,2016
  • Finalizing modules of the project “mHealth for Tobacco Cessation” under MOH&FW, 2015
  • Meeting dealing with  ‘Development of Training module / Strategy’ under NTCP, MOH&FW
  • Part of ICMR task force on proposal for ICMR-funded task force project on epidemiology of substance abuse in the state of Punjab (esasp)(2013-14)
  • Part of an expert team convened by UNODC (United Nations Office of Drugs and Crime, Regional Office for South Asia, New Delhi)  to evaluate oral substitution(with buprenorphine) sites in India in 2007.
  • As desired by Standing Parliamentary committee on demand for grants, was part of AIIMS team to carry out site visits to Ministry Of Health funded drug deaddiction centres for evaluation of number of cases in treatment and outcome following treatment in 2008.

8 Presentations made at scientific meetings/ conferences/ workshops 50

Investigator in funded projects along with year completed

1.Rolling out of Opioid Substitution Treatment (OST) in Tihar prisons, India-A collaborative project of AIIMS,UNODC-ROSA & TIHAR PRISONS.(PI) Funded by UNODC ROSA)(2008-12)

2.Community based brief intervention vs simple advice for women tobacco users.(PI) Funded by ICMR 2013-14

Investigator in non-funded projects along with year and completed

  • Demographic, clinical characteristics and treatment outcome of opioid drug users on OST with buprenorphine in a community mobile clinic (2011-14)
  • Tobacco use in opioid dependent patients on maintenance treatment.(2014-15)
  • A retrospective chart review of tobacco use parameters and  outcome of tobacco cessation treatment in polydrug users (2010-12)

Investigator in funded projects along with year and title ongoing

Investigator in non-funded projects along with year and title ongoing

  • Patterns of use and psychosocial consequences of cannabis use in a community setting(2015-ongoing)
  • Risk behaviors of young Injection drug users (IDU) in community setting(ongoing)

Co-investigator in funded projects along with year and title completed

  • 1. Efficacy of Varenicline for smokeless tobacco use.Funded by  National Institute of Health(NIH), U.S.A  2011- 13
  • 2.Cognitive Behavioural based Intervention in Group Setting for Tobacco Cessation in tertiary de-addiction center in Northern India. Funded by ICMR,2015-2016
  • 3.Impact of a package of intensive smoking-cessation interventions versus basic smoking-cessation advice on outcomes in smear-positive patients with pulmonary tuberculosis. Funded by  EU FP7 Programme & ICMR (2009- 16)
  • 4. Oral substitution with buprenorphine Co-I Funded by UNODC- ROSA(2007-2008)
  • 5. Developing a network of De-addiction services from the government, NGO and private sector. (funded by WHO,2011)

Co- investigator in non-funded projects along with year and completed

  • A study of experience related to crime and imprisonment among service recipients in community drug treatment clinic(2013-15)
  • Comparison of Self-Report of Tobacco Use And Urinary Cotinine Levels Among Drug Dependents: A Pilot Study.(2009-10)

Co- investigator in funded projects along with year  and title ongoing

Co- investigator in non-funded projects along with year and title ongoing

  • Effect of smoking on Platelets Monoamine Oxidase B activity levels  in Opioid Dependent  Patients on maintenance treatment: An exploratory study (2016-till date)

Thesis supervised for MD/ PhD/DM

  • - as guide (number only)  4
  • -as co-guide (number only) 10

Details of publications since 2004 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Journals

  • Jhanjee S, Lal R, Mishra A, Yadav D. A Randomized Pilot Study of Brief Intervention versus Simple Advice for Women Tobacco Users in an Urban Community in India. Indian Journal of Psychological Medicine(Accepted for publication).
  • Jhanjee S. Putting tobacco harm reduction in perspective: is it a viable alternative? Indian Journal of Medical Research. 2016; 143(1): 25-9
  • Rao R, Mandal P, Gupta R, Ramshankar P, Mishra A, Ambekar A, Jhanjee S, Dhawan A. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. Journal of substance abuse treatment. 2016; 61:13-7
  • Jhanjee S. Sethi H. Characteristics of opioid drug users in an urban community clinic. Indian Journal of Social Psychiatry. 2016;32(2): 154-57
  • Jhanjee S, SuruchiP ,Girdhar N,  Gunasekhar R, Jain R,  Sethi H, Sarangi J. Opioid Substitution Treatment in Tihar prisons, India: Process of implementation. International Journal on Drug Policy 2015; 26: 890–891
  • Jhanjee S, Lal R, Mishra A, Yadav D. Tobacco use and dental myths In India: need for specific intervention Gerodontology 2015; doi: 10.1111/ger.12200
  • Jhanjee S, Jain R, Jain V, Gupta T, Mittal S, Goelz P, Schnoll RA. Evaluating the effects of varenicline on craving, withdrawal and affect in a randomized double-blind placebo-controlled clinical trial of varenicline for smokeless tobacco dependence in India. Journal of Psychoactive Drugs. 2015 ;47(4):331-5.
  • Jain R, Jhanjee S, Jain V, Gupta T, Mittal S, Chauhan, P, Raghav R, Goelz P, Schnoll RA. Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from A Clinical Trial of Varenicline in India Journal of Psychoactive Drugs 2015;47(4):331-5.
  • Jhanjee S. Sethi H. Characteristics of opioid drug users in an urban community clinic. Indian Journal of Social Psychiatry. 2016;32(2): 154-57
  • Jhanjee S. Dyslexia and Substance abuse: the under-recognized link. Indian Journal of Psychological Medicine. 2015;37 3 374-5
  • Piyali M, Jain R, Jhanjee S, Sreenivas V. Psychological barriers to tobacco cessation in Indian buprenorphine-naloxone maintained patients -A pilot study. Indian Journal of Psychological Medicine. 2015; 37(3):299-304
  • Sethi H, Jhanjee S. Use of Alcohol among treatment seeking illicit drug users in India. Journal of Mental Health and Human Behaviour 19(1): 2014: 19(1). 29-31
  • Jhanjee S. Evidence Based Psychosocial Interventions in Substance Use. Indian Journal of Psychological Medicine. 2014;36:112-8
  • Jain R, Jhanjee S, Jain V, Gupta T, Mittal S, Goelz P, Wileyto EP, Schnoll RA (2014). A Double-Blind Placebo-Controlled Randomized Trial of Varenicline for Smokeless Tobacco Dependence in India. Nicotine and Tobacco Research.16(1):50-7.
  • Jhanjee S, Kumar R (2013). Mobile clinic services for opioid users: a feasible treatment modality. Asian Journal of Psychiatry 6(6):626.
  • Jhanjee S (2012). Providing Drug abuse Treatment in prison: A call for action. Asian Journal of Psychiatry 5 : 114-115
  • Arora S, Gupta S, Jhanjee S (2012): A descriptive study to assess dysthymia and select variables associated with tobacco use among adolescents. Indian Journal of Psychiatric Nursing Volume 3(1): 13-15
  • Jain R, Balhara Y P, Jhanjee S &Sethi HM(2012): Concordance Between Urinary Cotinine Levels and Self-Reported Tobacco Use Among Drug-Dependent Persons: A Pilot Study, Substance Abuse, 33:2, 99-102
  • Goyal S, Jhanjee S (2011): Opioid use in prison population and its relationship to crime: A review . Journal of Mental Health and Human Behaviour, 16(2).
  • Jhanjee S. Sethi H (2011): Tobacco use in drug dependent patients- an even greater dilemma. Indian journal of Medical Specialities, 2(2):165-166
  • Jhanjee S, Lal T, Mondal A, Jain K (2011):  Heroin dependent family: A biopsychosocial context. Substance Abuse, 32:157–158
  • Jhanjee S (2011):   Tobacco control in India- Where are we now? Delhi Psychiatry journal. 14(1), 26-32.
  • Jhanjee S, Sethi H (2010): The Fagerström Test For Nicotine Dependence in An Indian Sample of Daily smokers With Poly Drug Use. Nicotine and  Tobacco  Research.12(11):1162-6.
  • Jhanjee S, Prakash B (2010):BuprenorphineMaintainence in pregnancy. Asian Journal of Psychiatry. 3(3), 157
  • Basu A, Jhanjee S (2010). Review of current pharmacotherapy for nicotine dependence. Delhi Psychiatry journal 13(2): 240-246
  • Jhanjee S, Balhara Y P, Sethi H (2009) Tobacco use among drug dependent patients in treatment setting Delhi Psychiatry journal. 12(2), 247-251.
  • Jhanjee S (2007) Substance use among women: Indian Scenario.In Drug Abuse: News-n-Views; 3-5
  • Varghese S. Sagar R, Jhanjee S. (2006) Chronic renal failure and Electroconvulsive Therapy Indian Journal of Medical Science 60 : 114-115
  • Jhanjee S, Goyal P, Kattimani S. (2006) Recent pharmacological Term treatment of Alcohol dependence: a review. Delhi Psychiatry Bulletin Vol.9 No.2 pg 111-118

Principal author

  • Principal Author: Scientific report- Rolling out OST in Tihar prisons India(2013)
  • Principal Author:  Monograph Scientific. Community based brief Intervention vs simple advice for women tobacco users.

Book Co-editor

  • Dhawan A, JhanjeeS(eds)(Revised 2013). Manual for long term pharmacotherapy. Sponsored by WHO (India) and Ministry of Health and Family Welfare, Government of India
  • Kochupillai V, Dhawan A, Jhanjee S, Pattanayak R (eds). Book of Abstracts. Conference on Stress reduction skills. Scientific update, 30th and 31st august, 2014

Chapter in Books

  • Jhanjee S (2015). Behavioural and Psychological Approaches for Cessation. In Tobacco cessation for primary care providers in India. Public Health Foundation of India (under publication)
  • Jhanjee S (2013). Nicotine dependence. In Lal R, PattanayakR(eds). Substance use disorders: Handbook for physicians, NDDTC, AIIMS. pp 88-97.
  • Jhanjee S, Mohan I (2007) Long term use of naltrexone for opiate dependence. In Dhawan A, Jhanjee  S(eds)   Manual for long term pharmacotherapy pp.38-50.
  • Jhanjee S,  Agrawal A (2005) Opioid intoxication and management of withdrawal state. In Hemraj Pal (ed) Case Book on Substance Use Disorder –Manual for Physicians, pp.41-44

Abstracts published

  • Jhanjee S, Bhad R,  Sethi H, Rao R. Tobacco use in Opioid Dependent Patients on Buprenorphine Maintenance Treatment. Indian Journal of Psychiatry. 2016; 58(Suppl): S48-49
  • Jhanjee S, Lal R, Mishra A, Yadav D. Tobacco use characteristics amongst women in an urban community.Indian Journal of Psychiatry. 2015 Jan; 57(Suppl 1): S11–S112.
  • Jhanjee S, SuruchiP ,Girdhar N,  Gunasekhar R, Jain R,  Sethi H. In-prison outcomes of Buprenorphine maintenance for prisoners: results from a pilot intervention in Tihar prisons, India. Alcohol and Alcoholism 2014 vol 49, supp1 i64
  • Mandal P, Jain R, Jhanjee S,  Sreenivas V. Barriers of tobacco cessation among Indian Buprenorphine- naloxone maintained patients. Alcohol and Alcoholism  2014 vol 49, supp1i6
  • Jhanjee S, Lal R, Mishra A, Yadav D. Tobacco use characteristics amongst women in an urban Community. Indian J Psychiatry 2015 57 (Supplement) S60-61
  • Jhanjee S, Mandal P, Singh D. Tobacco use in opioid dependent patients maintained on Buprenorphine naloxone treatment. Indian Journal of Psychiatry. 2014; 56 Suppl, S55
  • Jhanjee S. Prevalence and correlates of tobacco use among youth: In Symposium “Opportunities and challenges for youth Tobacco cessation” Indian Journal of Social Psychiatry,  2014, 30 (3-4):  A10
  • Jhanjee S. Putting tobacco harm reduction in perspective: Is  there any evidence?: SonaliJhanjee Indian Journal of Social Psychiatry, 2013, 29 (3-4), A9-A16
  • Jhanjee S. Efficacy of psychosocial  interventions in substance  use. Indian Journal of Social Psychiatry.2012; 28(3-4),  A-19
  • Jhanjee S, Sethi H. Differential characteristics of injectable drug users in community setting. Indian Journal of Psychiatry. 2011;53:S 38
  • Jhanjee S, Sethi H. Oral substitution with buprenorphine in a community mobile clinic for opioid dependent patients. Indian Journal of Psychiatry. 2010; 52: S 19
  • Jhanjee S, Balhara Y.P, Sethi H. Tobacco use pattern and severity of dependence in drug dependent patients. Relation of Opioid use and the use of Tobacco products Indian Journal of Psychiatry. 2009;51: S135
  • Jhanjee S, Sethi H. Demographic and clinical characteristics of Opiod Drug Users In A Community Mobile Clinic Canadian Journal of Addiction Medicine. 2009;1(1):P 23
  • Balhara Y.P, Jhanjee S, Majumdar P. Relation of Opioid use and the use of Tobacco products Indian Journal of Psychiatry.2008; 50 Suppl, P14
  • Balhara Y.P, Jhanjee S, VermaR : Factors associated with Initiation, Maintenance and Decision to quit in Tobacco Indian Journal of Psychiatry. 2008; 50 Suppl, P14
  • Jhanjee S , Goyal P, Chopra A(2007); One year profile of patients attending tobacco cessation clinic in a National level de-addiction center. Indian Journal of Psychiatry. 2007; 49 Suppl, P27
  • Kushwaha V, Verma R, Jhanjee S, Ambekar A. Amphetamine type stimulants: Forewarned is forearmed  Indian Journal of Psychiatry. 2007; 49 Suppl, P27
Prof. Anju Dhawan

Prof.
Anju Dhawan

Female

MBBS, MD Psychiatry

Affiliation

Professor
Department of
National Drug Dependence Treatment Centre

Contact

Email :
dranjudhawan@gmail.com

General OPD

Monday

Special Clinic

Wednesday (Administrative rounds)
Thursday (Adolescent Clinic)
Friday (Ward Rounds)

Awards and Honors

National

  • Member of the Working Group on Drug Abuse and Addiction among children constituted by NCPCR (2012)
  • Awarded membership of the Technical Resource Group of the Adolescent Health Division, MOHFW for contribution to public health strategy for adolescent health (2015-16)

International

  • Awarded Fogarty International Training and Research Fellowship for HIV AIDS- UCLA (2004)
  • Member WHO Expert Committee on Development of Treatment Guidelines for Management of Drug Use in Pregnant Women (2013)
  • Contributed as an expert to the expert and authors meeting organized by Colombo Plan and US Department of State to the Development of Training Curricula for Service Providers to Address Child Drug Addiction on held at Washington DC for development of a module for children 2014-15(22 –24 October, 2014)
  • Awarded Membership of the International Society of Addiction Medicine Education and Training Committee (2015-22)
  • Member WHO Expert Committee on Drug Use and TB

Investigator/ Co-investigator in funded projects along with year completed/ongoing

Projects as Chief InvestigatorSource of fundingYear
Psychotropic substance abuseUnited Nations Drug Control Programme, Regional Office for South Asia (UNDCP ROSA)2001-02
Evaluation of functioning of de-addiction centres in the countryWHO (India)2001-2002
Opioid Substitution Treatment with BuprenorphineUnited Nations Office on Drugs and Crime, Regional Office for South Asia (UNODC-ROSA)2006-2009
Assessment of feasibility and effectiveness of Methadone Maintenance Treatment in IndiaUNODC (ROSA)2011-2013
Effectiveness of Yoga in patients of Opioid DependenceCentral Council for Research in Yoga and Naturopathy, AYUSH, Ministry of Health and Family Welfare2009-2011
Assessment of pattern, profile and correlates of substance use in childrenNCPCR2012-2013
Training of doctors on Substance Use DisordersDepartment of Revenue, Ministry of Finance2010-15
Mapping and Size Estimation of Street Children Who Use Drugs in DelhiDepartment of Women and Child development, Delhi Govt2015-16
Extent of Mental Health issues & Addictive Behavior among Adolescents seeking help in Adolescent Friendly Health Clinics in DelhiAdolescent Health Division, Directorate of Family Welfare, Govt of NCT of Delhi2019-2020
Survey on Substance use among School and College StudentsMinistry of Social Justice and Empowerment, Government of India2019-20
Screening and Intervention for Drug/Substance Use among Secondary School going ChildrenUEE Mission, Education Department Delhi2020-21
A prospective double blind, randomized clinical study to evaluate the antibody response after Covid-19 vaccine when provided along with KabasuraKudineer, a siddha medicineSSIAR2021-22
A prospective double blind, randomized clinical study to evaluate the antibody response after Covid-19 vaccine when provided along with NOQ19, an Ayurvedic medicineSSIAR2022

Research Projects as co-investigator-

Projects as Co-InvestigatorSource of fundingYear
Rapid Assessment Survey Project on Alcohol, Tobacco and other substances in Districts of Darjeeling, Kohima, AizwalWHO (India)1999
Rapid Assessment Survey Project on Alcohol, Tobacco and other substances in Districts of North Goa, Jodhpur, MadrasWHO (India)2000
Buprenorphine maintenance programme in Kohima districtWHO (India)2000
Global study on illegal drug marketsUNDCP and UNICRI2000-2001
A survey of prevalence of drug dependence and comorbidity in the general population of ThrissurWHO (India)2001-2002
Advance Statistical Analysis of National Survey Data using new methodologies without the addition of dataWHO (India)2001-2002
To undertake a study to examine the relationship of tobacco as a gateway drug and to determine the prevalence of substance use behavioural disorders including tobacco in Metropolis DelhiWHO (India)2002-2003
Database on Drug Abuse and HIV/AIDSUNODC (ROSA)2005-2009
Assessment of drug use in out of School AdolescentsWHO (India) 2008 
Development of intervention for drug use in out of school adolescents  WHO (India) 2008-2009
Coordination & convergence of Delhi District Health Services programmes & drug use intervention for the out of school childrenWHO (India)2010-2011
Developing a network of de-addiction services from the Government, NGO & Private sectorWHO (India)2010-2011
Extent of internet use amongst adolescents with non-psychotic disorders: A case control studyAIIMS2016
Validation of Teen Addiction Severity IndexAIIMS2016
Screening and Intervention for Drug/Substance Use among Elementary School going ChildrenUEE Mission, Education Department Delhi2020-21
A study to examine dependence, harm perception and motivation to quit amongst Indian areca nut users and pilot test an intervention moduleWHO (India)2020-22
Real World Effectiveness of add-on Yoga for patients with opioid dependence stabilized on treatmentDST SATYAM2022-23
A study to examine psych-social and behavioral domains among school going adolescents during covid-19 pandemic: Mixed study designICMR2022-24

Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing Substance use among adolescents seeking treatment at NDDTC (2014-15)

Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence (2018-19) 

Retrospective study to analyze the profile, the pattern of substance

use and outcome of treatment of adolescent patients who sought

treatment for opioid use (on-going)

To assess the effect of intervention of yoga and meditation-based structured programme for youth on the psychological functioning of medical students (on-going)

Thesis supervised for MD/ DM/PhD

- as guide (number only)- 8 

-as co-guide (number only)-PhD thesis-8, MD and DM thesis-16

Total number of publications till date- 144

Details of publications since 2010 onwards (the full citation)- these should be divided into journal articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Articles

  • Ray Rajat, Dhawan A (2010). Drug Scheduling-Science and Cultural Perspective. Addiction, 105, 1150-55.
  • Balhara YPS, Jain R, Dhawan A, Mehta M (2010). Assessment of Abuse Liability of Pheniramine among Opioid Dependent Human Subjects. Journal of Substance Use, Posted online on December 7, 2010. (doi:10.3109/14659891.2010.513753).
  • Jain Kushal, Jain R, Dhawan A (2011). Double-Blind, Double-Dummy Randomized Controlled Study of Memantine versus Buprenorphine in Naloxone Precipitated Acute Withdrawal in Heroin Addicts. Journal of Opioid Management 7(1), 11-20.
  • Yadav D, Dhawan A, Balhara YPS, Yadav S (2010). Occupational Rehabilitation of Opiate Users on Maintenance Treatment. Journal of Social Work Practice in the Addictions, 10 (4), 413 – 422.
  • Ray Rajat, Dhawan A (2011). Diagnostic Orphans. Addiction, 106(5), 891-892.
  • Verma R, Balhara YPS, Dhawan A (2011). Inhalant abuse: An exploratory Study. Ind Psychiatry J, 20(2): 103-106.
  • Gupta T, Shah N, Mathur VP, Dhawan A (2012). Oral health status of a group of illicit drug users in Delhi, India. Community Dent Health, 29(1): 49-54.
  • Rao RV, Ambekar A, Yadav S, Sethi H, Dhawan A (2012). Slow release oral morphine as a maintenance agent in opioid dependence syndrome: an exploratory study from India. Journal of Substance Use, 17(3), 294-300.
  • Jyotsna VP, Joshi A, Ambekar S, Kumar N, Dhawan A, Sreenivas V (2012). Comprehensive yogic breathing program improves quality of life in patients with diabetes. Indian J Endocrinol Metab, 16(3): 423-8.
  • Dhawan A, Chopra A (2013). Does buprenorphine maintenance improve the quality of life of opioid users? Indian J Med Res, 137: 130-135.
  • Ray R, Dhawan A, Chopra A (2013). Addiction Research Centres and the Nurturing of Creativity, National Drug Dependence Treatment Centre - A profile. Addiction, 108(10):1705-10.
  • Quraishi R,  PattanayakJain R,  Dhawan A (2013). A descriptive study of clinical, hematological, and biochemical parameters of inhalant users seeking treatment at a tertiary care center in India. Indian J Psychol Med Apr, 35(2):174-9.
  • Gupta A, Mandal P, Bhargava R, Pattanayak RD, Sagar R, Dhawan A (2014). Marked exacerbation of ADHD after onset of inhalant use: a case report. J Neuropsychiatry Clin Neurosci, 26(4):E6-7.
  • Gupta K, Ambekar A, Dhawan A, Mehta M (2014) Psychosocial Factors Associated with HIV‑Related High‑risk Injection Behavior among People Who Inject Drugs. Journal of Mental Health and Human Behaviour, 19(2): 62-68.
  • Balhara YP, Ranjan R, Dhawan A, Yadav D (2014).Experiences from a community based substance use treatment centre in an urban resettlement colony in India. J Addict, 98:20-28.
  • Ranjan R, Pattanayak RD, Dhawan A (2014). Long-term agonist and antagonist therapy for adolescent opioid dependence: a description of two cases. Indian J Psychol Med, 36(4):439-43.
  • Jyotsna VP, Dhawan A, Sreenivas V, Deepak KK, Singla R (2014). Completion report: Effect of Comprehensive Yogic Breathing program on type 2 diabetes: A randomized control trial. Indian J EndocrinolMetab, 18(4):582-4.
  • Ranjan R, Kumar S, Pattanayak RD, Dhawan A, Sagar R (2014). (De-) criminalization of attempted suicide in India: A review. Ind Psychiatry J, 23(1):4-9.
  • Bhad R, Jain R, Dhawan A, Mehta M (2014). Biochemical Assessment of Inhalant Use among Adolescents: A Pilot Study from Tertiary De-Addiction Center of India. J Subst Abuse Alcohol, 2(3): 1021-1024.
  • Dhawan A, Chatterjee B, Balhara YPS, Bhargava R (2015). Issues in Child and adolescent substance use. Indian Journal of Psychiatry, 57(5): S186.
  • Ambekar A, Dhawan A, Lenin Singh RK, Rao R (2015). How to deliver Methadone Maintenance Treatment (MMT) for Opioid Dependence. Indian Journal of Psychiatry 57(5): S180.
  • Dhawan A, Chopra A, Ambekar A, Ray R (2015). Treatment Seeking Behavior of Inhalant Using Street Children: Are We Prepared to Meet Their Treatment Needs. Indian J Psychol Med, 37(3): 282-287.
  • Dhawan A, Chopra A, Jain R, Yadav D, Vedamurthachar (2015). Effectiveness of yogic breathing intervention on quality of life of opioid dependent users. Int J Yoga, 8(2): 144-147.
  • Rao R, Mandal P, Gupta R, Ramshankar P, Mishra A, Ambekar A, Jhanjee S, Dhawan A (2016). Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India. J Subst Abuse Treat, 61: 13-17.
  • Dhawan A, Chopra A, Ray R (2016). Preference for Treatment Setting by Substance Users in India. Indian J Psychol Med, 38(1): 42-45.
  • Bhad R, Jain R, Dhawan A, Mehta M (2016). Why do young people sniff? An exploratory study of adolescent inhalant abuse from north India. Journal of Substance Use, Published online 24 Mar 2016.
  • Bhad R, Jain R, Dhawan A, Mehta M (2016). A Clinic Based Study in Treatment Seeking Adolescent Inhalant Users in India: Implications for Management. Journal of Child and Adolescent Substance Abuse, Published online 22 Sept 2016, DOI: 10.1080/1067828X.2016.1222977
  • Dhawan A, Pattanayak R , Chopra A, Tikoo VK, Kumar R (2016) Injection drug use among children and adolescents in India: Ringing the alarm bells. Ind J Psy, 58:387-93.
  • Gupta P, Mandal P, Singh D,Pattanyak R,  Bhargava R, Dhawan A (2016). Detection of Optic Neuropathy and 3-month Follow-up of an Adolescent Inhalant User: Are we Paying Enough Attention? Indian J Psychol Med Med , 38(5): 486–488.doi:  10.4103/0253-7176.191390
  • Das M M,  Jain R,  Dhawan A,  Kaur A (2016). Assessment of abuse liability of Tramadol among experienced drug users: Double-blind crossover randomized controlled trial. J Opioid Manag, 12(6):421-430.
  • Gupta K, Dhawan A, Ambekar A, Mehta M (2016) High- Risk Sexual Behaviors in Young Men Seeking Treatment for Alcohol Dependence: A Qualitative Study. Journal of Psychosocial Research, 11(1): 103-114.
  • Gupta K, Ambekar A, Dhawan A, Mehta M (2017) Personality profile of alcohol and injecting opioid users: A comparative study from India. Asian Journal of Psychiatry, 25: 142–146.
  • Dhawan A, Pattanayak RD, Chopra A, Tikoo VK, Kumar R (2017) Pattern and profile of children using substances in India: Insights and recommendations. Natl Med J India, 30(4): 224-229.
  • Jain S, Dhawan A, Kumaran SS, Pattanayak RD, Jain R (2017) Cue-induced craving among inhalant users: Development and preliminary validation of a visual cue paradigm. Asian J Psychiatr 30: 202-207.
  • Dhawan A, Rao R, Ambekar A, Pusp A, Ray R (2017) Treatment of substance use disorders through the government health facilities: Developments in the "Drug De-addiction Programme" of Ministry of Health and Family Welfare, Government of India. Indian J Psychiatry 59(3): 380-384.
  • Dhawan A, Mandal P (2017) Preventive Strategies for Substance Use. Indian Journal of Social Psychiatry 33 (2): 108-111.
  • Singh G, Kaloiya GS, Dhawan A, Balhara YPS, Mishra AK (2018) Need for evaluation of underlying dysfunctional cognition in problem drinkers. Asian Journal of Psychiatry 31: 71-72.
  • Mandal P, Dhawan A (2018) Interventions in individuals with specific needs. Indian J Psychiatry 60(8): 553-558.
  • Raghav R, Jain R, Dhawan A, Ray TS, Kumar P (2018). Chronic co-administration of nalbuphine attenuates the development of opioid dependence. Pharmacology Biochemistry and Behavior 175: 130-138.
  • Dhawan A, Modak T, Sarkar S (2019). Transdermal  buprenorphine  patch :  Potential  for  role  in  management  of  opioid dependence. Asian J Psychiatr   40:88-91.
  • Mandal P, Parmar A, Ambekar A, Dhawan A (2019). Substance use among treatment seeking Indian adolescent girls: Are they unique? Asian J Psychiatr
  • Chawla N, Mandal P, Chatterjee B, Dhawan A (2019). Tramadol-associated pica. Psychiatry ClinNeurosci. 2019;73(1):43.
  • Tripathi R, Dhawan A, Rao R, Mishra AK, Jain R, Sinha S (2019). Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine. Journal of Addiction Medicine doi: 10.1097/ADM.0000000000000539
  • Tripathi, R., Rao, R., Dhawan, A., Jain, R., &Sinha, S. (2020). Opioids and sleep–a review of literature. Sleep medicine67, 269-275.
  • Kethawath, S. M., Jain, R., Dhawan, A., &Sarkar, S. (2020). A review of peripheral brain-derived neurotrophic factor levels in alcohol-dependent patients: Current understanding. Indian journal of psychiatry62(1), 15.
  • Dhawan, A., Mishra, A. K., Ambekar, A., Chatterjee, B., Agrawal, A., &Bhargava, R. (2020). Estimating the size of substance using street children in Delhi using respondent-driven sampling (rds). Asian journal of psychiatry48, 101890.
  • Gupta, S., Bhatia, G., Sarkar, S., Chatterjee, B., Balhara, Y. P. S., &Dhawan, A. (2020). Adult attention-deficit hyperactivity disorders and its correlates in patients with opioid dependence: An exploratory study. Indian Journal of Psychiatry62(5), 501.
  • Kethawath, S. M., Jain, R., Dhawan, A., &Sarkar, S. (2020). Trajectory of liver function tests during the initial alcohol detoxification period: A preliminary analysis. Indian journal of psychiatry62(2), 225.
  • Jain, S., Dhawan, A., Kumaran, S. S., Deep, R., & Jain, R. (2020). BOLD activation during cue induced craving in adolescent inhalant users. Asian Journal of Psychiatry52, 102097.
  • Kethawath, S. M., Jain, R., Dhawan, A., Sarkar, S., & Kumar, M. (2020). An Observational Study of Serum Brain Derived Neurotrophic Factor Levels in Patients with Alcohol Dependence during Withdrawal. Journal of Psychoactive Drugs52(5), 440-446.
  • Verma, V., Mishra, A. K., Dhawan, A., &Nath, D. C. (2020). Diversity in substance use behaviour among street children of Delhi under Bayesian paradigm. BMC Medical Research Methodology20(1), 1-9.
  • Rao R, Dhawan A, Parmar A, Yadav D, Bhad R. (2021) Improving treatment of substance use disorders through community drug treatment clinics: An experiential account. IJCM.
  • Raghav, R., Jain, R., Jacob, T. G., Dhawan, A., & Roy, T. S. (2021). Co-administration of nalbuphine attenuates the morphine-induced anxiety and dopaminergic alterations in morphine-withdrawn rats. Psychopharmacology238(4), 1193-1211.
  • Batra P, Dhawan A, Pandey RM, Mehta M, Sagar R, Chopra A (2021). Substance use and its associated factors among school students. National medical journal of India, 1;34(2).
  • Singh, S., & Dhawan, A. (2021). Problematic substance and internet use among medical students. Indian Journal of Social Psychiatry37(2), 172.
  • Gupta, S., Jhanjee, S., & Dhawan, A. (2021). Effectiveness of Interventions Based on Yogic Breathing Practices (IB-YBP) on Substance Use Disorders—A Systematic Review of the Randomized Control Trials and Quasi-Experimental Trials. Substance Use & Misuse56(11), 1624-1641.
  • Singh, V. V., Dhawan, A., Chadda, R. K., Mishra, A. K., & Sarkar, S. (2022). A Prospective Three-Months Naturalistic Follow-Up Study of Outcomes of Patients with Opioid Dependence Discharged on Buprenorphine or Oral Naltrexone. Indian Journal of Psychological Medicine, 02537176211066739.
  • Sharma, R., Dhawan, A., Kaminer, Y., & Chopra, A. (2022). Teen Addiction Severity Index (T-ASI): Hindi Translation and Validation for Use in India. Indian Journal of Psychological Medicine, 02537176221090467.
  • Gupta, S., Dhawan, A. (2022). Methodological issues in conducting yoga- and meditation-based research: A narrative review and research implications. Journal of Ayurveda and integrative medicine13(3), 100620. https://doi.org/10.1016/j.jaim.2022.100620
  • Singh, V. V., Sarkar, S., Chadda, R. K., Mishra, A. K., & Dhawan, A. (2022). Reasons for leaving treatment among patients with opioid dependence: A 3-month prospective follow-up study. Journal of opioid management18(5), 455–466. https://doi.org/10.5055/jom.2022.0739

Abstracts

  • Pawar A., Dhawan A., Kr A., Varshney M. Profile of patients presenting to the child and adolescent substance use clinic at a tertiary care de-addiction center. .Indian J Psychiatry. 2013; 55(5:) 42-43.
  • Kr A, Pawar A, Dhawan A. Profile of substance using women presenting to a tertiary care de-addiction facility. Indian J Psychiatry. 2013; 55(5): 79.
  • Dhawan A, Chopra A, Balhara YPS. Building National Capacity For Management Of Substance Use Disorders. Alcohol and Alcoholism. 2014; 49 (suppl 1): i12 DOI: http://dx.doi.org/10.1093/alcalc/agu052.51

Chapter in Books

  • Ray Rajat, Dhawan A (2011) Substance Dependence: National policies and priorities. In Kulhara P, Avasthi A, Thirunavukarasu M, Grover S, Chankrabarti S (eds) Themes and issues in Contemporary Indian Psychiatry, Publication Committee, Indian Psychiatric Society, pg 70-101.
  • Dhawan A, PattanayakRamandeep (2011) Community based addiction psychiatry. In Chavan BS (ed) Textbook of Community Psychiatry.
  • Dhawan A, Deb KaushikSinha (2011). Situation update on the extent, pattern of drug abuse in street children. In A Trainers Manual on Drug Use Prevention, Treatment and Care for Street Children, Published by UNODC (ROSA).
  • Dhawan A, Prashanth R (2011). Brief orientation to medical management of drug abuse among street children. In A Trainers Manual on Drug Use Prevention, Treatment and Care for Street Children, Published by UNODC (ROSA).
  • Pattnayak R, Dhawan A (2013). Pharmacotherapy in Substance Use Disorder. In: Rakesh Lal, Sandhya Gupta (eds) Substance Use Disorders – Manual for Nursing Personnel, 2nd edition. New Delhi, Published by NDDTC, AIIMS, pp 25-45.
  • Dhawan A, Kumar A. Long term Pharmacotherapy of opioid dependence syndrome. In: RakeshLal (eds) Substance Use Disorders – Manual for Physicians, 2nd edition. New Delhi: Published by NDDTC, AIIMS; 2013: 77-85.
  • Dhawan A, Balhara YPS, Mohan I. Substance abuse in adolescents. In: Rakesh Lal (eds) Substance Use Disorders – Manual for Physicians, 2nd edition. New Delhi: Published by NDDTC, AIIMS; 2013: 191-198.
  • Sri Sri Ravi Shankar, Kenneth Paul Rosenberg, Anju Dhawan, AcharVedamurthachar. Meditation and Spirituality-Based Approaches for Addiction. In: Kenneth Paul Rosenberg, Laura Curtiss Feder (eds) Behavioral Addictions: Criteria, Evidence, and Treatment. UK: Published by Elsevier Inc; 2014: 343-360.
  • Renu Sharma, Mehta M, Dhawan A. Treatment of Substance Abusing Adolescents. In: Manju Mehta, Rajesh Sagar (eds) A Practical Approach to Cognitive Behaviour Therapy for Adolescents, New Delhi: Published by Springer; 2014: 331-361. ISBN 978-81-322-2241-5
  • Dhawan A, Pattanyak R (2014) Clinical Practice Guidelines on Management of Inhalant Use Disorders. In: Debashish Basu, PK Dalal (eds) Clinical Practice Guidelines for the Assessment and Management of Substance Use Disorders. Published by Indian Psychiatric Society.
  • Dhawan A, Pattanyak R (2015). Synopsis of the Clinical Practice Guidelines on Management of Inhalant Use Disorders. In: PK Dalal, Debashish Basu (eds) Synopsis of the Clinical Practice Guidelines on Substance Use Disorders. Published by Indian Psychiatric Society
  • Anju Dhawan, BiswadipChatterjee. Substance Use Disorders in Training handbook on counseling essential for staff of Child Care Institutions, published by NCPCR, New Delhi, 2016.
  • Dhawan A, Mongia M. Spirituality and Mental Health. In: RK Chadda, Vinay Kumar, Nitin Gupta, SiddharthSarkar (eds) Social Psychiatry: Principles and Clinical Perspective, New Delhi: Published by Jaypee Brothers; 2018: 133-140.
  • Dhawan A, Singh Shalini. Social Dimensions of Substance Use Disorders. In: RK Chadda, Vinay Kumar, Nitin Gupta, SiddharthSarkar (eds) Social Psychiatry: Principles and Clinical Perspective, New Delhi: Published by Jaypee Brothers; 2018: 217-226.
  • Dhawan A., Patil V., Gupta S., Chugh G. Mindfulness and Mental Health. In: Okpaku S.O.(eds) Innovations in Global Mental Health. Springer, Cham, 2021. https://doi.org/10.1007/978-3-319-70134-
  • Dhawan A, Mittal S. Spirituality and Mental Health. In: Rakesh Chadda, Pratap Sharan, Mamta Sood, Koushik Sinha Deb (eds), Mental Health at Cross-roads : Published by White Falcon Publishing 2022: page 229-233

Monographs/Books

  • Ray R, DhawanA, Ambekar A (2010). A manual for Quality Assurance of OST in Government Health Care settings, NACO.
  • Ray Rajat, Dhawan A, Ambekar A, Yadav D, Chopra A (2011). Coordination & convergence of Delhi District Health Services programmes & drug use intervention for the out of school children-Final Report. Submitted under the Government of India and WHO Collaborative Programme.
  • Ray Rajat, Dhawan A, Ambekar A, Jhanjhee S, Chopra A, Malhotra S (2011). Developing a network of de-addiction services from the Government, NGO & Private sector - Final Report. Submitted under the Government of India and WHO Collaborative Programme.
  • Ray R, Dhawan A, Ambekar A, Implementing OST: A Training Manual for service providers, DFID TAST and National AIDS Control Organisation, Government of India, New Delhi 2011.
  • Yadav D, Ambekar A, Dhawan A, Aggarwal A, Mehra J, Sethi H, OST program in Government health-care settings: treatment compliance and retention, report submitted to DFID TAST and NACO, Government of India 2011.
  • Report of the study on Assessment of pattern, profile and correlates of substance use among children in India. Conducted by NDDTC for the National Commission on Protection of Child Rights (NCPCR), India; 2013.
Dr. Raj Pal

Dr.
Raj Pal

Male

Affiliation

Professor of Ophthalmology
Department of
National Drug Dependence Treatment Centre

Chief Interests :

Vitreo- Retina and Ocular Trauma

Endopthalmitis

Eales' disease

ARMD

Diabetic Retinopathy

Retinopathy of prematurity

No active record(s) for this section.

National Drug Dependence Treatment Centre (NDDTC)

Introduction

Substance Use Prevention: Resource Material for Parents and Adolescents

The Drug Dependence Treatment Centre, AIIMS was established in the year 1988 and was functional from the premises of the Deen Dayal Upadhyay Hospital, New Delhi. In 2003 it was upgraded as the National Centre (National Drug Dependence Treatment Centre) and is fully operational from its new premises in Ghaziabad, Delhi-NCR since April 2003.

The National Drug Treatment Centre, Ghaziabad (NDDTC), AIIMS has been established as the apex centre for treatment of drugs and substance abuse disorders in the country. It provides a state of art model for de‐addiction treatments. This centre has full range of specialists & facilities. The NDDTC is situated on 10 acre beautiful campus near CGO Complex at Ghaziabad, Delhi-NCR. It is presently having 50 bedded treatment facilities with expansion plan for the future.

The centre has well qualified multi-disciplinary faculty and staff (medical doctors, pre-clinical scientists, social scientists, research staff, nursing staff, laboratory personnel and administrative staff) to render various modalities of care. Clinical care is provided through outpatient, inpatient settings and community clinics. Help is available for the treatment of disorders related to use of all the substances i.e. Alcohol, Opioids, Cannabis, Tobacco etc. and behavioral addictions. Treatment modalities include both pharmacological (i.e. with medications) and non-pharmacological (i.e. psychological / social) treatments. Both medically assisted and drug-free treatment related to drug use, and long-term supervised medications (Buprenorphine/Methadone/Naltrexone maintenance therapy) are provided. The centre carries out the relevant hematological, biochemical laboratory tests to monitor health damage. Further, several drugs of abuse are screened simultaneously through analysis of patients’ urine sample.

The centre has been involved in:

  • Assessing magnitude of addiction problem in the country
  • Providing clinical care to patients – outpatient, inpatient and community based -through daily OPD, specialty clinics, ward and community clinics in urban-slums of Delhi
  • Health education& prevention of addictive disorders in the country
  • Capacity building & human resourcedevelopment – including training of several categories of staff
  • Documentation, publication of resource material and creation of database
  • Establishment and development of laboratory services to detect drugs of abuse in body fluids and health damage
  • Research

The centre provides clinical care to about 4000 new patients and about 35000 old patients every year. It also provides clinical care to about 33000 patients in its community clinic. In addition, every year about 600 patients are seen in Tobacco use cessation clinic, about 40 patients in adolescent clinic and about 300 patients in dual diagnosis clinic.

The years 1999-2012 saw much growth and many achievements for the centre. The centre has developed curricula, training schedules, modalities and resource materials for training of trainers, Medical Doctors (GDMOs), nurses and laboratory personnel. Between January 1989 and October 2007, about 40 courses for doctors have been organized. Various manuals for doctors are available. The training programmes have been reviewed and modified through workshops of resource persons.

Besides clinical care, NDDTC has been involved in a multitude of other areas. Right from its inception, NDDTC has played a leadership role in the country and has worked on development of various replicable models of care, training of post-graduate psychiatry students and health professionals, development of resource materials, research and policy planning.

Following is a brief overview of recent contributions:

  • Development of Models of Care
  • Capacity Building
  • Collaborative research with National/International agencies
  • Oral Substitution Treatment (OST) using oral morphine, buprenorphine, buprenorphine & naloxone and methadone
  • Policy and Planning

Faculty members from NDDTC are members of various expert committees and technical groups at regional and international level, and contributing to policy development. The Ex-Chief of the Centre was a member of the International Narcotics Control Board (INCB), the monitoring body for the implementation of the United Nations international drug control conventions.

Other significant achievements of the centre are:

  • PhD Programmein the area of Addiction Psychiatry started since 2010
  • DM (Addiction Psychiatry) Programme started since year 2015
  • In past three years Centre’s faculty had several important research projects (N=21) on ‘Addictive Disorders”, funded by National and International agencies. Out of which many projects have been completed and the remaining are ongoing. The faculty of the Centre has published several articles in indexed national and international journals and chapters in books\manuals Reports\Proceedings\Manuals\monographs in past three years.
  • One of the major significant achievements in recent times has been that the NDDTChas been designated as a WHO Collaborating Centre on Substance Abuse (2012-2020)

No active record(s) for this section.

No active record(s) for this section.

No active record(s) for this section.

No active record(s) for this section.